give me detailed flowchart of posterior uveitis, few ideas such as with vitritis without vitritis , primary site of lesion retina choroid, solitory or multifocal, infectious non infectious, bilateral unilateral, retinitis choroiditis chorioretinitis retinochoroiditis neuroretinitis, with all examples

Reading File

Searching sources...

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

I now have sufficient information from the textbooks to build the detailed flowchart. Let me compile this into a comprehensive visual diagram.

Reading File

Now I have comprehensive data to build the full flowchart. Let me create it as a well-structured HTML/SVG file for download and also present it as detailed text.

Running Command

ls /home/daytona/workspace/ 2>/dev/null || echo "workspace empty or missing"

Writing File

.../posterior-uveitis-flowchart/posterior_uveitis_flowchart.html

<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Posterior Uveitis - Detailed Diagnostic Flowchart</title>
<style>
  * { box-sizing: border-box; margin: 0; padding: 0; }
  body { font-family: 'Segoe UI', Arial, sans-serif; background: #f0f4f8; color: #1a1a2e; }

  .page-title {
    text-align: center;
    background: linear-gradient(135deg, #1a1a2e 0%, #16213e 50%, #0f3460 100%);
    color: white;
    padding: 24px 20px 20px;
  }
  .page-title h1 { font-size: 26px; letter-spacing: 1px; margin-bottom: 6px; }
  .page-title p { font-size: 13px; opacity: 0.75; }

  .flowchart { padding: 30px 20px; max-width: 1600px; margin: 0 auto; }

  /* === ROOT NODE === */
  .root-box {
    background: linear-gradient(135deg, #e63946, #c1121f);
    color: white;
    border-radius: 12px;
    padding: 16px 30px;
    text-align: center;
    font-size: 20px;
    font-weight: 700;
    width: 320px;
    margin: 0 auto 10px;
    box-shadow: 0 6px 20px rgba(198,18,31,0.35);
    letter-spacing: 0.5px;
  }

  /* === CONNECTOR LINES === */
  .v-line { width: 3px; background: #666; height: 22px; margin: 0 auto; }
  .v-line-short { width: 3px; background: #aaa; height: 14px; margin: 0 auto; }
  .h-divider { border: none; border-top: 2px dashed #bbb; margin: 8px 0; }

  /* LEVEL 1 - VITRITIS branches */
  .level1-row {
    display: flex;
    justify-content: center;
    gap: 40px;
    margin: 0 auto;
    position: relative;
  }
  .level1-row::before {
    content: '';
    position: absolute;
    top: 0;
    left: calc(50% - 200px);
    width: 400px;
    height: 3px;
    background: #666;
  }

  .branch-col { display: flex; flex-direction: column; align-items: center; }

  /* VITRITIS BOXES */
  .vitritis-yes {
    background: linear-gradient(135deg, #e07b39, #c25e20);
    color: white;
    border-radius: 10px;
    padding: 12px 24px;
    font-size: 15px;
    font-weight: 700;
    text-align: center;
    width: 210px;
    box-shadow: 0 4px 14px rgba(194,94,32,0.3);
  }
  .vitritis-no {
    background: linear-gradient(135deg, #457b9d, #1d3557);
    color: white;
    border-radius: 10px;
    padding: 12px 24px;
    font-size: 15px;
    font-weight: 700;
    text-align: center;
    width: 210px;
    box-shadow: 0 4px 14px rgba(29,53,87,0.3);
  }

  /* === SECTION CONTAINERS === */
  .section { margin: 30px 0; }

  /* PRIMARY SITE BOXES */
  .site-row { display: flex; justify-content: center; gap: 30px; flex-wrap: wrap; margin: 10px auto; }

  .site-box {
    border-radius: 10px;
    padding: 10px 20px;
    font-size: 14px;
    font-weight: 700;
    text-align: center;
    min-width: 150px;
    border: 3px solid transparent;
  }
  .site-retina { background: #fff3e0; border-color: #e07b39; color: #b85c00; }
  .site-choroid { background: #e3f2fd; border-color: #1976d2; color: #0d47a1; }
  .site-both { background: #f3e5f5; border-color: #7b1fa2; color: #4a148c; }

  /* PATTERN BOXES */
  .pattern-row { display: flex; justify-content: center; gap: 20px; flex-wrap: wrap; margin: 8px auto; }
  .pattern-box {
    background: white;
    border-radius: 8px;
    padding: 8px 16px;
    font-size: 13px;
    font-weight: 600;
    border-left: 5px solid #888;
    box-shadow: 0 2px 8px rgba(0,0,0,0.08);
    min-width: 120px;
    text-align: center;
  }
  .pattern-focal { border-color: #43a047; }
  .pattern-multi { border-color: #fb8c00; }
  .pattern-geographic { border-color: #8e24aa; }
  .pattern-diffuse { border-color: #e53935; }

  /* === MAIN GRID === */
  .main-grid {
    display: grid;
    grid-template-columns: 1fr 1fr;
    gap: 24px;
    margin: 20px 0;
  }

  /* BIG CARDS */
  .big-card {
    background: white;
    border-radius: 14px;
    box-shadow: 0 4px 16px rgba(0,0,0,0.10);
    overflow: hidden;
  }
  .big-card-header {
    padding: 12px 18px;
    font-size: 15px;
    font-weight: 700;
    color: white;
    letter-spacing: 0.3px;
  }
  .hdr-infectious { background: linear-gradient(135deg, #d32f2f, #b71c1c); }
  .hdr-noninfectious { background: linear-gradient(135deg, #1565c0, #0d47a1); }
  .hdr-bilateral { background: linear-gradient(135deg, #2e7d32, #1b5e20); }
  .hdr-unilateral { background: linear-gradient(135deg, #6a1b9a, #4a148c); }
  .hdr-entity { background: linear-gradient(135deg, #00695c, #004d40); }

  .big-card-body { padding: 14px 18px; }

  /* SUB-CATEGORY within card */
  .sub-cat {
    margin-bottom: 14px;
    padding-bottom: 12px;
    border-bottom: 1px dashed #e0e0e0;
  }
  .sub-cat:last-child { border-bottom: none; margin-bottom: 0; padding-bottom: 0; }
  .sub-cat-title {
    font-size: 13px;
    font-weight: 700;
    margin-bottom: 6px;
    text-transform: uppercase;
    letter-spacing: 0.5px;
  }
  .sub-cat-title.retinal { color: #e07b39; }
  .sub-cat-title.choroidal { color: #1976d2; }
  .sub-cat-title.combined { color: #7b1fa2; }
  .sub-cat-title.neuro { color: #00695c; }
  .sub-cat-title.vascular { color: #c62828; }

  /* DISEASE PILLS */
  .pill-row { display: flex; flex-wrap: wrap; gap: 6px; }
  .pill {
    padding: 4px 10px;
    border-radius: 20px;
    font-size: 12px;
    font-weight: 600;
    white-space: nowrap;
    display: flex;
    align-items: center;
    gap: 4px;
  }
  .pill-dot { width: 8px; height: 8px; border-radius: 50%; flex-shrink: 0; }
  .pill-retinitis { background: #fff3e0; color: #e65100; border: 1.5px solid #ffb74d; }
  .pill-retinitis .pill-dot { background: #e65100; }
  .pill-choroiditis { background: #e3f2fd; color: #0d47a1; border: 1.5px solid #64b5f6; }
  .pill-choroiditis .pill-dot { background: #1976d2; }
  .pill-combined { background: #f3e5f5; color: #6a1b9a; border: 1.5px solid #ce93d8; }
  .pill-combined .pill-dot { background: #7b1fa2; }
  .pill-neuro { background: #e0f2f1; color: #004d40; border: 1.5px solid #80cbc4; }
  .pill-neuro .pill-dot { background: #00897b; }
  .pill-vascular { background: #fce4ec; color: #880e4f; border: 1.5px solid #f48fb1; }
  .pill-vascular .pill-dot { background: #c2185b; }

  /* === ENTITY EXPLANATION CARDS === */
  .entity-grid {
    display: grid;
    grid-template-columns: repeat(auto-fit, minmax(270px, 1fr));
    gap: 16px;
    margin: 20px 0;
  }
  .entity-card {
    background: white;
    border-radius: 12px;
    box-shadow: 0 3px 12px rgba(0,0,0,0.09);
    overflow: hidden;
  }
  .entity-card-header {
    padding: 10px 14px;
    font-size: 14px;
    font-weight: 700;
    color: white;
  }
  .entity-retinitis { background: linear-gradient(135deg, #e65100, #bf360c); }
  .entity-choroiditis { background: linear-gradient(135deg, #1565c0, #0d47a1); }
  .entity-chorioretinitis { background: linear-gradient(135deg, #6a1b9a, #4a148c); }
  .entity-retinochoroiditis { background: linear-gradient(135deg, #827717, #f57f17); }
  .entity-neuroretinitis { background: linear-gradient(135deg, #00695c, #004d40); }
  .entity-vasculitis { background: linear-gradient(135deg, #b71c1c, #880e4f); }

  .entity-card-body { padding: 12px 14px; }
  .entity-def { font-size: 12.5px; color: #333; margin-bottom: 8px; line-height: 1.5; }
  .entity-examples { font-size: 12px; color: #555; }
  .entity-examples strong { color: #222; }
  .entity-vitritis {
    display: inline-block;
    padding: 2px 8px;
    border-radius: 10px;
    font-size: 11px;
    font-weight: 700;
    margin-top: 6px;
  }
  .vitritis-present { background: #fff3e0; color: #e65100; border: 1px solid #ffb74d; }
  .vitritis-absent { background: #e8f5e9; color: #2e7d32; border: 1px solid #a5d6a7; }
  .vitritis-variable { background: #ede7f6; color: #4527a0; border: 1px solid #b39ddb; }

  /* === LEGEND === */
  .legend {
    background: white;
    border-radius: 12px;
    padding: 16px 20px;
    margin: 20px 0;
    box-shadow: 0 3px 10px rgba(0,0,0,0.08);
  }
  .legend h3 { font-size: 14px; margin-bottom: 10px; color: #333; }
  .legend-grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(180px, 1fr)); gap: 8px; }
  .legend-item { display: flex; align-items: center; gap: 8px; font-size: 12px; }
  .legend-swatch { width: 14px; height: 14px; border-radius: 3px; flex-shrink: 0; }

  /* === LATERALITY SECTION === */
  .laterality-grid {
    display: grid;
    grid-template-columns: 1fr 1fr;
    gap: 24px;
    margin: 20px 0;
  }

  /* === KEY SIGNS TABLE === */
  .signs-table { width: 100%; border-collapse: collapse; font-size: 12.5px; margin-top: 8px; }
  .signs-table th { background: #37474f; color: white; padding: 8px 10px; text-align: left; }
  .signs-table td { padding: 7px 10px; border-bottom: 1px solid #eceff1; vertical-align: top; }
  .signs-table tr:nth-child(even) td { background: #f9fbe7; }
  .signs-table tr:hover td { background: #e8f5e9; }

  /* LABEL BADGE */
  .label-badge {
    display: inline-block;
    padding: 3px 10px;
    border-radius: 20px;
    font-size: 11px;
    font-weight: 700;
    margin-bottom: 8px;
  }
  .badge-step { background: #37474f; color: white; }

  /* COLOR CLUE BOX */
  .color-clue-row { display: flex; gap: 16px; flex-wrap: wrap; justify-content: center; margin: 8px 0; }
  .color-clue {
    padding: 8px 16px;
    border-radius: 8px;
    font-size: 12.5px;
    font-weight: 600;
    text-align: center;
    min-width: 130px;
  }
  .clue-white { background: #fafafa; border: 2px solid #bdbdbd; color: #424242; }
  .clue-yellow { background: #fff9c4; border: 2px solid #f9a825; color: #e65100; }
  .clue-pigmented { background: #efebe9; border: 2px solid #795548; color: #3e2723; }

  /* STEP FLOW ARROW */
  .flow-arrow { text-align: center; font-size: 22px; color: #888; margin: 4px 0; }

  @media (max-width: 900px) {
    .main-grid, .laterality-grid { grid-template-columns: 1fr; }
    .level1-row { flex-direction: column; align-items: center; gap: 20px; }
    .level1-row::before { display: none; }
  }

  @media print {
    body { background: white; }
    .big-card, .entity-card, .legend { box-shadow: none; border: 1px solid #ddd; }
  }
</style>
</head>
<body>

<div class="page-title">
  <h1>POSTERIOR UVEITIS &mdash; Comprehensive Diagnostic Flowchart</h1>
  <p>Source: Kanski's Clinical Ophthalmology 10th Ed. &nbsp;|&nbsp; Wills Eye Manual &nbsp;|&nbsp; Firestein & Kelley's Textbook of Rheumatology</p>
</div>

<div class="flowchart">

  <!-- ====================== ROOT ====================== -->
  <div class="root-box">POSTERIOR UVEITIS</div>
  <div class="v-line"></div>

  <!-- DEFINITION STRIP -->
  <div style="text-align:center; background:#fff8f0; border:2px solid #e07b39; border-radius:10px; padding:10px 20px; max-width:700px; margin:0 auto 10px; font-size:13px; color:#555; line-height:1.6;">
    <strong style="color:#c25e20;">Definition:</strong> Encompasses retinitis, choroiditis, retinal vasculitis, neuroretinitis.<br>
    Inflammation primarily posterior to the vitreous base &mdash; retina, choroid, or both.
  </div>
  <div class="v-line"></div>

  <!-- ====================== STEP 1: VITRITIS ====================== -->
  <div style="text-align:center; margin-bottom:6px;">
    <span class="label-badge badge-step">STEP 1 &mdash; VITRITIS?</span>
  </div>
  <div class="v-line-short"></div>

  <div style="display:flex; justify-content:center; align-items:flex-start; gap:0; position:relative; max-width:700px; margin:0 auto;">
    <!-- horizontal connector -->
    <div style="position:absolute; top:0; left:50%; transform:translateX(-50%); width:360px; height:3px; background:#666; top:0;"></div>
  </div>

  <!-- VITRITIS SPLIT -->
  <div style="display:flex; justify-content:center; gap:80px; margin:0 auto 6px;">
    <div class="branch-col">
      <div style="width:3px; height:20px; background:#666; margin:0 auto;"></div>
      <div class="vitritis-yes">WITH VITRITIS<br><span style="font-size:11px; font-weight:400; opacity:0.9">(Vitreous cells present)</span></div>
      <div style="width:3px; height:14px; background:#e07b39; margin:0 auto;"></div>
      <div style="background:#fff3e0; border:2px solid #e07b39; border-radius:8px; padding:8px 12px; font-size:12px; color:#b85c00; max-width:200px; text-align:center;">
        <strong>Suggests retinal primary</strong><br>Retinitis, Retinochoroiditis, ARN, Neuroretinitis
      </div>
    </div>
    <div style="width:3px; height:60px; background:#666; align-self:flex-start; margin-top:20px;"></div>
    <div class="branch-col">
      <div style="width:3px; height:20px; background:#666; margin:0 auto;"></div>
      <div class="vitritis-no">WITHOUT VITRITIS<br><span style="font-size:11px; font-weight:400; opacity:0.9">(Vitreous clear)</span></div>
      <div style="width:3px; height:14px; background:#457b9d; margin:0 auto;"></div>
      <div style="background:#e3f2fd; border:2px solid #457b9d; border-radius:8px; padding:8px 12px; font-size:12px; color:#0d47a1; max-width:200px; text-align:center;">
        <strong>Suggests choroidal primary</strong><br>Choroiditis, PORN, White dot syndromes
      </div>
    </div>
  </div>

  <div class="v-line" style="height:30px;"></div>

  <!-- ====================== STEP 2: PRIMARY SITE ====================== -->
  <div style="text-align:center; margin-bottom:6px;">
    <span class="label-badge badge-step">STEP 2 &mdash; PRIMARY SITE OF LESION</span>
  </div>

  <div style="background:white; border-radius:12px; padding:14px 20px; max-width:800px; margin:8px auto; box-shadow:0 3px 12px rgba(0,0,0,0.08);">
    <div class="color-clue-row">
      <div class="color-clue clue-white">⬜ WHITE lesions<br><span style="font-size:11px; font-weight:400;">= Usually RETINAL<br>(full-thickness opacity)</span></div>
      <div class="color-clue clue-yellow">🟡 YELLOW lesions<br><span style="font-size:11px; font-weight:400;">= Usually CHOROIDAL<br>(seen through RPE)</span></div>
      <div class="color-clue clue-pigmented">🟫 PIGMENTED lesions<br><span style="font-size:11px; font-weight:400;">= Long-standing / healed<br>(chorioretinal scar)</span></div>
    </div>
    <div class="site-row" style="margin-top:10px;">
      <div class="site-box site-retina">RETINA<br><span style="font-size:11px; font-weight:400;">Retinitis<br>Retinochoroiditis</span></div>
      <div class="site-box site-choroid">CHOROID<br><span style="font-size:11px; font-weight:400;">Choroiditis<br>Chorioretinitis</span></div>
      <div class="site-box site-both">RETINA + CHOROID<br><span style="font-size:11px; font-weight:400;">Concurrent involvement<br>Panuveitis overlap</span></div>
      <div class="site-box" style="background:#e8f5e9; border-color:#2e7d32; color:#1b5e20;">OPTIC NERVE<br><span style="font-size:11px; font-weight:400;">Neuroretinitis<br>Papillitis</span></div>
      <div class="site-box" style="background:#fce4ec; border-color:#c62828; color:#880e4f;">VESSELS<br><span style="font-size:11px; font-weight:400;">Retinal vasculitis<br>Periphlebitis / Arteritis</span></div>
    </div>
  </div>

  <div class="v-line" style="height:24px;"></div>

  <!-- ====================== STEP 3: PATTERN ====================== -->
  <div style="text-align:center; margin-bottom:6px;">
    <span class="label-badge badge-step">STEP 3 &mdash; DISTRIBUTION PATTERN</span>
  </div>
  <div style="background:white; border-radius:12px; padding:12px 20px; max-width:760px; margin:8px auto; box-shadow:0 3px 12px rgba(0,0,0,0.08);">
    <div class="pattern-row">
      <div class="pattern-box pattern-focal">FOCAL / SOLITARY<br><span style="font-size:11px; color:#555; font-weight:400;">Single lesion<br>Toxoplasma</span></div>
      <div class="pattern-box pattern-multi">MULTIFOCAL<br><span style="font-size:11px; color:#555; font-weight:400;">Multiple discrete lesions<br>Sarcoid, Syphilis, MEWDS</span></div>
      <div class="pattern-box pattern-geographic">GEOGRAPHIC<br><span style="font-size:11px; color:#555; font-weight:400;">Map-like<br>Serpiginous choroiditis</span></div>
      <div class="pattern-box pattern-diffuse">DIFFUSE<br><span style="font-size:11px; color:#555; font-weight:400;">Widespread<br>CMV, ARN</span></div>
    </div>
  </div>

  <div class="v-line" style="height:24px;"></div>

  <!-- ====================== STEP 4: INFECTIOUS vs NON-INFECTIOUS ====================== -->
  <div style="text-align:center; margin-bottom:8px;">
    <span class="label-badge badge-step">STEP 4 &mdash; INFECTIOUS vs NON-INFECTIOUS</span>
  </div>

  <div class="main-grid">

    <!-- INFECTIOUS CARD -->
    <div class="big-card">
      <div class="big-card-header hdr-infectious">🦠 INFECTIOUS POSTERIOR UVEITIS</div>
      <div class="big-card-body">

        <div class="sub-cat">
          <div class="sub-cat-title retinal">RETINITIS (Primary Retinal)</div>
          <div class="pill-row">
            <span class="pill pill-retinitis"><span class="pill-dot"></span>Toxoplasma retinochoroiditis</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>CMV retinitis (immunocompromised)</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>Acute Retinal Necrosis (HSV/VZV)</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>PORN (VZV, HIV)</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>Candida retinitis</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>Syphilitic retinitis</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>TB retinitis</span>
          </div>
        </div>

        <div class="sub-cat">
          <div class="sub-cat-title choroidal">CHOROIDITIS (Primary Choroidal)</div>
          <div class="pill-row">
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Pneumocystis choroiditis</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Cryptococcal choroiditis</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Histoplasma chorioretinitis</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>TB choroiditis</span>
          </div>
        </div>

        <div class="sub-cat">
          <div class="sub-cat-title combined">CHORIORETINITIS / RETINOCHOROIDITIS</div>
          <div class="pill-row">
            <span class="pill pill-combined"><span class="pill-dot"></span>Toxoplasma (retinochoroiditis)</span>
            <span class="pill pill-combined"><span class="pill-dot"></span>Congenital CMV / Rubella</span>
            <span class="pill pill-combined"><span class="pill-dot"></span>Syphilis (chorioretinitis)</span>
            <span class="pill pill-combined"><span class="pill-dot"></span>TB (multifocal choroiditis)</span>
            <span class="pill pill-combined"><span class="pill-dot"></span>Onchocerciasis</span>
            <span class="pill pill-combined"><span class="pill-dot"></span>Cysticercosis</span>
          </div>
        </div>

        <div class="sub-cat">
          <div class="sub-cat-title neuro">NEURORETINITIS</div>
          <div class="pill-row">
            <span class="pill pill-neuro"><span class="pill-dot"></span>Bartonella (cat-scratch disease)</span>
            <span class="pill pill-neuro"><span class="pill-dot"></span>Lyme disease</span>
            <span class="pill pill-neuro"><span class="pill-dot"></span>Toxocara canis (DUSN)</span>
            <span class="pill pill-neuro"><span class="pill-dot"></span>Syphilis</span>
          </div>
        </div>

        <div class="sub-cat">
          <div class="sub-cat-title vascular">RETINAL VASCULITIS (Infectious)</div>
          <div class="pill-row">
            <span class="pill pill-vascular"><span class="pill-dot"></span>Syphilis</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>TB</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>Herpes (ARN - arteritis)</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>HIV</span>
          </div>
        </div>

      </div>
    </div>

    <!-- NON-INFECTIOUS CARD -->
    <div class="big-card">
      <div class="big-card-header hdr-noninfectious">🔵 NON-INFECTIOUS POSTERIOR UVEITIS</div>
      <div class="big-card-body">

        <div class="sub-cat">
          <div class="sub-cat-title retinal">RETINITIS (Primary Retinal)</div>
          <div class="pill-row">
            <span class="pill pill-retinitis"><span class="pill-dot"></span>Behçet disease (occlusive vasculitis)</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>ARN-like (autoimmune)</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>Intraocular lymphoma (masquerade)</span>
          </div>
        </div>

        <div class="sub-cat">
          <div class="sub-cat-title choroidal">CHOROIDITIS - WHITE DOT SYNDROMES</div>
          <div class="pill-row">
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Multifocal choroiditis (MFC)</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Punctate inner choroidopathy (PIC)</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>MEWDS (Multiple evanescent white dot)</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Acute posterior multifocal placoid (APMPPE)</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Serpiginous choroiditis</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Ocular histoplasmosis syndrome (OHS)</span>
          </div>
        </div>

        <div class="sub-cat">
          <div class="sub-cat-title combined">CHORIORETINITIS / RETINOCHOROIDITIS</div>
          <div class="pill-row">
            <span class="pill pill-combined"><span class="pill-dot"></span>Birdshot chorioretinopathy (HLA-A29)</span>
            <span class="pill pill-combined"><span class="pill-dot"></span>Sarcoidosis</span>
            <span class="pill pill-combined"><span class="pill-dot"></span>Vogt-Koyanagi-Harada (VKH)</span>
            <span class="pill pill-combined"><span class="pill-dot"></span>Sympathetic ophthalmia</span>
            <span class="pill pill-combined"><span class="pill-dot"></span>Systemic lupus (SLE)</span>
          </div>
        </div>

        <div class="sub-cat">
          <div class="sub-cat-title neuro">NEURORETINITIS (Non-infectious)</div>
          <div class="pill-row">
            <span class="pill pill-neuro"><span class="pill-dot"></span>IRVAN syndrome</span>
            <span class="pill pill-neuro"><span class="pill-dot"></span>Sarcoid neuroretinitis</span>
            <span class="pill pill-neuro"><span class="pill-dot"></span>VKH (disc edema)</span>
          </div>
        </div>

        <div class="sub-cat">
          <div class="sub-cat-title vascular">RETINAL VASCULITIS (Non-infectious)</div>
          <div class="pill-row">
            <span class="pill pill-vascular"><span class="pill-dot"></span>Sarcoidosis (candlewax exudates)</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>Eales disease (periphlebitis)</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>Behçet (occlusive)</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>Birdshot retinopathy</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>Multiple sclerosis (periphlebitis)</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>Susac syndrome</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>Frosted branch angiitis</span>
            <span class="pill pill-vascular"><span class="pill-dot"></span>Giant cell arteritis</span>
          </div>
        </div>

      </div>
    </div>

  </div>

  <div class="v-line" style="height:20px;"></div>

  <!-- ====================== STEP 5: LATERALITY ====================== -->
  <div style="text-align:center; margin-bottom:8px;">
    <span class="label-badge badge-step">STEP 5 &mdash; LATERALITY (UNILATERAL vs BILATERAL)</span>
  </div>

  <div class="laterality-grid">
    <div class="big-card">
      <div class="big-card-header hdr-unilateral">UNILATERAL</div>
      <div class="big-card-body">
        <div class="sub-cat">
          <div class="sub-cat-title retinal">Infectious</div>
          <div class="pill-row">
            <span class="pill pill-retinitis"><span class="pill-dot"></span>Toxoplasma retinochoroiditis</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>CMV retinitis (early)</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>ARN (often starts unilateral)</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>PORN</span>
          </div>
        </div>
        <div class="sub-cat">
          <div class="sub-cat-title choroidal">Non-infectious</div>
          <div class="pill-row">
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>MEWDS</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>PIC</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Eales disease</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Frosted branch angiitis</span>
          </div>
        </div>
        <div class="sub-cat">
          <div class="sub-cat-title neuro">Neuroretinitis</div>
          <div class="pill-row">
            <span class="pill pill-neuro"><span class="pill-dot"></span>Cat-scratch (Bartonella) - unilateral</span>
            <span class="pill pill-neuro"><span class="pill-dot"></span>Toxocara / DUSN - unilateral</span>
          </div>
        </div>
      </div>
    </div>

    <div class="big-card">
      <div class="big-card-header hdr-bilateral">BILATERAL</div>
      <div class="big-card-body">
        <div class="sub-cat">
          <div class="sub-cat-title retinal">Infectious</div>
          <div class="pill-row">
            <span class="pill pill-retinitis"><span class="pill-dot"></span>CMV retinitis (advanced HIV)</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>Bilateral ARN (33% become bilateral)</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>Syphilis</span>
            <span class="pill pill-retinitis"><span class="pill-dot"></span>TB</span>
          </div>
        </div>
        <div class="sub-cat">
          <div class="sub-cat-title choroidal">Non-infectious (typically bilateral)</div>
          <div class="pill-row">
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>VKH syndrome</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Sympathetic ophthalmia</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Birdshot chorioretinopathy</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Sarcoidosis</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>APMPPE</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Serpiginous choroiditis</span>
            <span class="pill pill-choroiditis"><span class="pill-dot"></span>Multifocal choroiditis (MFC)</span>
          </div>
        </div>
        <div class="sub-cat">
          <div class="sub-cat-title neuro">Neuroretinitis / Vasculitis</div>
          <div class="pill-row">
            <span class="pill pill-neuro"><span class="pill-dot"></span>Behçet (bilateral occlusive vasculitis)</span>
            <span class="pill pill-neuro"><span class="pill-dot"></span>Susac syndrome</span>
          </div>
        </div>
      </div>
    </div>
  </div>

  <div class="v-line" style="height:20px;"></div>

  <!-- ====================== ENTITY CARDS ====================== -->
  <div style="text-align:center; margin-bottom:10px;">
    <span class="label-badge badge-step">STEP 6 &mdash; CLINICAL ENTITY DEFINITIONS WITH EXAMPLES</span>
  </div>

  <div class="entity-grid">

    <!-- RETINITIS -->
    <div class="entity-card">
      <div class="entity-card-header entity-retinitis">RETINITIS</div>
      <div class="entity-card-body">
        <div class="entity-def">Primary inflammation of the retina. White, full-thickness opacification with indistinct borders due to surrounding edema. Overlying vitreous haze (vitritis) is usually present.</div>
        <div class="entity-examples">
          <strong>Classic sign:</strong> White retinal opacity, indistinct margins<br>
          <strong>Infectious examples:</strong><br>
          &bull; CMV retinitis - granular white patches + hemorrhage ("pizza-pie")<br>
          &bull; Toxoplasma retinitis - "headlight in fog" focal dense whitening<br>
          &bull; ARN - peripheral necrotizing retinitis, rapid progression<br>
          &bull; PORN - deep retinal opacification, no vitritis, in HIV<br>
          <strong>Non-infectious:</strong> Behçet (occlusive), intraocular lymphoma
        </div>
        <div>
          <span class="entity-vitritis vitritis-present">Vitritis: Usually PRESENT</span>
          <span class="entity-vitritis vitritis-absent" style="margin-left:4px;">PORN: Absent</span>
        </div>
      </div>
    </div>

    <!-- CHOROIDITIS -->
    <div class="entity-card">
      <div class="entity-card-header entity-choroiditis">CHOROIDITIS</div>
      <div class="entity-card-body">
        <div class="entity-def">Primary inflammation of the choroid. Yellow, deep lesions seen through the RPE. Vitreous is usually clear UNLESS secondary retinal spread occurs.</div>
        <div class="entity-examples">
          <strong>Classic sign:</strong> Round yellow nodule (deep to retina)<br>
          <strong>White Dot Syndromes (multifocal):</strong><br>
          &bull; APMPPE - bilateral placoid sub-RPE lesions, young adults<br>
          &bull; MFC - multiple punched-out scars, myopic women<br>
          &bull; PIC - small punctate choroidal lesions, high myopes<br>
          &bull; MEWDS - unilateral, evanescent, outer retina / choroid<br>
          &bull; Serpiginous - geographic, peripapillary spread<br>
          <strong>Infectious:</strong> Pneumocystis, Cryptococcus, Histoplasma
        </div>
        <div>
          <span class="entity-vitritis vitritis-absent">Vitritis: Usually ABSENT</span>
          <span class="entity-vitritis vitritis-variable" style="margin-left:4px;">MFC: Variable</span>
        </div>
      </div>
    </div>

    <!-- CHORIORETINITIS -->
    <div class="entity-card">
      <div class="entity-card-header entity-chorioretinitis">CHORIORETINITIS</div>
      <div class="entity-card-body">
        <div class="entity-def">Primary choroidal inflammation with SECONDARY spread to the overlying retina. Starts deep (yellow), extends superficially (white).</div>
        <div class="entity-examples">
          <strong>Classic examples:</strong><br>
          &bull; <strong>Birdshot chorioretinopathy</strong> - HLA-A29, bilateral cream-colored lesions radiating from disc, older adults, periphlebitis<br>
          &bull; <strong>Sarcoidosis</strong> - "candlewax drippings", bilateral, multifocal<br>
          &bull; <strong>VKH syndrome</strong> - bilateral exudative retinal detachment, granulomatous<br>
          &bull; <strong>Sympathetic ophthalmia</strong> - bilateral granulomatous after trauma<br>
          &bull; <strong>Histoplasma chorioretinitis</strong>
        </div>
        <div>
          <span class="entity-vitritis vitritis-variable">Vitritis: Variable (choroid&rarr;retina)</span>
        </div>
      </div>
    </div>

    <!-- RETINOCHOROIDITIS -->
    <div class="entity-card">
      <div class="entity-card-header entity-retinochoroiditis">RETINOCHOROIDITIS</div>
      <div class="entity-card-body">
        <div class="entity-def">Primary retinal inflammation with SECONDARY choroidal spread. Starts superficially (white), extends deep (pigmented scar).</div>
        <div class="entity-examples">
          <strong>Prototype:</strong><br>
          &bull; <strong>Toxoplasma retinochoroiditis</strong> - focal white retinitis adjacent to pigmented chorioretinal scar ("satellite lesion") - MOST COMMON cause of focal retinitis<br>
          &bull; Active lesion: white fluffy spot next to old black scar<br>
          &bull; Congenital: bilateral macular scars<br>
          &bull; Acquired (immunocompetent): unilateral, single focus<br>
          &bull; CMV (congenital): bilateral retinochoroidal scarring<br>
          &bull; Syphilis (can present as both)
        </div>
        <div>
          <span class="entity-vitritis vitritis-present">Vitritis: Usually PRESENT (dense over active lesion)</span>
        </div>
      </div>
    </div>

    <!-- NEURORETINITIS -->
    <div class="entity-card">
      <div class="entity-card-header entity-neuroretinitis">NEURORETINITIS</div>
      <div class="entity-card-body">
        <div class="entity-def">Optic disc edema (papillitis) PLUS peripapillary RNFL inflammation with macular star exudate (hard exudates in Henle's fiber layer = star pattern).</div>
        <div class="entity-examples">
          <strong>Classic triad:</strong> Disc swelling + Macular star + Vitritis<br>
          <strong>Infectious (most common causes):</strong><br>
          &bull; <strong>Bartonella henselae</strong> (cat-scratch disease) - #1 cause, unilateral, stellate macular exudate, positive serology<br>
          &bull; <strong>Lyme disease</strong> (Borrelia burgdorferi)<br>
          &bull; <strong>Toxocara</strong> - DUSN, children, nematode<br>
          &bull; <strong>Syphilis</strong><br>
          <strong>Non-infectious:</strong><br>
          &bull; IRVAN syndrome - disc aneurysms + neuroretinitis<br>
          &bull; Sarcoid neuroretinitis
        </div>
        <div>
          <span class="entity-vitritis vitritis-variable">Vitritis: Variable</span>
        </div>
      </div>
    </div>

    <!-- RETINAL VASCULITIS -->
    <div class="entity-card">
      <div class="entity-card-header entity-vasculitis">RETINAL VASCULITIS</div>
      <div class="entity-card-body">
        <div class="entity-def">Perivascular cuffing (yellowish/grey-white sheathing) of retinal vessels. Veins more commonly affected (periphlebitis). May cause branch RVO/RAO.</div>
        <div class="entity-examples">
          <strong>Periphlebitis (veins):</strong><br>
          &bull; <strong>Sarcoidosis</strong> - "candlewax drippings" along veins<br>
          &bull; <strong>Eales disease</strong> - young men, peripheral periphlebitis, neovascularization<br>
          &bull; Multiple sclerosis<br>
          &bull; Birdshot retinopathy<br>
          <strong>Arteritis (arteries):</strong><br>
          &bull; ARN (herpes), GCA, Polyarteritis nodosa, Churg-Strauss<br>
          <strong>Both veins + arteries:</strong><br>
          &bull; <strong>Behçet disease</strong> - occlusive vasculitis, devastating<br>
          &bull; <strong>Susac syndrome</strong> - retinal + cochlear + CNS
        </div>
        <div>
          <span class="entity-vitritis vitritis-variable">Vitritis: Variable</span>
        </div>
      </div>
    </div>

  </div>

  <!-- ====================== KEY SIGNS TABLE ====================== -->
  <div style="text-align:center; margin: 20px 0 8px;">
    <span class="label-badge badge-step">QUICK REFERENCE &mdash; KEY DIFFERENTIATING FEATURES</span>
  </div>

  <div style="background:white; border-radius:12px; box-shadow:0 3px 12px rgba(0,0,0,0.08); overflow:hidden; margin-bottom:20px;">
    <table class="signs-table">
      <thead>
        <tr>
          <th>Disease</th>
          <th>Entity Type</th>
          <th>Laterality</th>
          <th>Vitritis</th>
          <th>Key Feature</th>
          <th>Infectious?</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td><strong>Toxoplasma</strong></td>
          <td>Retinochoroiditis</td>
          <td>Unilateral</td>
          <td>Dense, focal</td>
          <td>"Headlight in fog"; satellite scar</td>
          <td style="color:#c62828;">Yes (parasite)</td>
        </tr>
        <tr>
          <td><strong>CMV</strong></td>
          <td>Retinitis</td>
          <td>Uni&rarr;Bilateral</td>
          <td>Mild / Absent</td>
          <td>"Pizza-pie" hemorrhagic granular; immunocompromised</td>
          <td style="color:#c62828;">Yes (viral)</td>
        </tr>
        <tr>
          <td><strong>ARN</strong></td>
          <td>Necrotizing retinitis</td>
          <td>Uni (33% bilateral)</td>
          <td>Marked</td>
          <td>Peripheral white patches; occlusive arteritis; VZV/HSV</td>
          <td style="color:#c62828;">Yes (viral)</td>
        </tr>
        <tr>
          <td><strong>PORN</strong></td>
          <td>Outer retinitis</td>
          <td>Bilateral</td>
          <td>Absent</td>
          <td>Deep opacification; spares vessels; severe HIV</td>
          <td style="color:#c62828;">Yes (VZV)</td>
        </tr>
        <tr>
          <td><strong>Bartonella</strong></td>
          <td>Neuroretinitis</td>
          <td>Unilateral</td>
          <td>Mild</td>
          <td>Macular star + disc edema; cat exposure</td>
          <td style="color:#c62828;">Yes (bacterial)</td>
        </tr>
        <tr>
          <td><strong>Syphilis</strong></td>
          <td>Any pattern</td>
          <td>Bilateral</td>
          <td>Variable</td>
          <td>"Great imitator"; vasculitis, retinitis, neuroretinitis</td>
          <td style="color:#c62828;">Yes (bacterial)</td>
        </tr>
        <tr>
          <td><strong>TB</strong></td>
          <td>Choroiditis / Vasculitis</td>
          <td>Bilateral</td>
          <td>Variable</td>
          <td>Choroidal tubercles; periphlebitis; systemic TB</td>
          <td style="color:#c62828;">Yes (bacterial)</td>
        </tr>
        <tr>
          <td><strong>Birdshot</strong></td>
          <td>Chorioretinitis</td>
          <td>Bilateral</td>
          <td>Present</td>
          <td>Cream-colored lesions; HLA-A29; periphlebitis</td>
          <td style="color:#1565c0;">No (autoimmune)</td>
        </tr>
        <tr>
          <td><strong>VKH</strong></td>
          <td>Chorioretinitis</td>
          <td>Bilateral</td>
          <td>Present</td>
          <td>Exudative RD; poliosis; tinnitus; sunset glow fundus</td>
          <td style="color:#1565c0;">No (autoimmune)</td>
        </tr>
        <tr>
          <td><strong>Sarcoidosis</strong></td>
          <td>Chorioretinitis + Vasculitis</td>
          <td>Bilateral</td>
          <td>Present</td>
          <td>Candlewax exudates; periphlebitis; disc granulomas</td>
          <td style="color:#1565c0;">No (granulomatous)</td>
        </tr>
        <tr>
          <td><strong>Behçet</strong></td>
          <td>Occlusive vasculitis</td>
          <td>Bilateral</td>
          <td>Marked</td>
          <td>Occlusive vasculitis; hypopyon; oral/genital ulcers</td>
          <td style="color:#1565c0;">No (vasculitis)</td>
        </tr>
        <tr>
          <td><strong>APMPPE</strong></td>
          <td>Choroiditis</td>
          <td>Bilateral</td>
          <td>Mild</td>
          <td>Placoid sub-RPE lesions; resolves spontaneously</td>
          <td style="color:#1565c0;">No</td>
        </tr>
        <tr>
          <td><strong>Serpiginous</strong></td>
          <td>Choroiditis</td>
          <td>Bilateral (asymm)</td>
          <td>Absent</td>
          <td>Geographic peripapillary spread; recurrent</td>
          <td style="color:#1565c0;">No</td>
        </tr>
        <tr>
          <td><strong>MEWDS</strong></td>
          <td>Choroiditis / outer retina</td>
          <td>Unilateral</td>
          <td>Mild</td>
          <td>Multiple evanescent white dots; young women; self-limiting</td>
          <td style="color:#1565c0;">No</td>
        </tr>
        <tr>
          <td><strong>Eales disease</strong></td>
          <td>Retinal vasculitis</td>
          <td>Bilateral</td>
          <td>Present</td>
          <td>Periphlebitis; peripheral neovascularization; young men</td>
          <td style="color:#1565c0;">No (idiopathic)</td>
        </tr>
        <tr>
          <td><strong>Sympathetic ophthalmia</strong></td>
          <td>Chorioretinitis</td>
          <td>Bilateral (post-trauma)</td>
          <td>Present</td>
          <td>Bilateral granulomatous after penetrating injury; Dalen-Fuchs nodules</td>
          <td style="color:#1565c0;">No (autoimmune)</td>
        </tr>
      </tbody>
    </table>
  </div>

  <!-- LEGEND -->
  <div class="legend">
    <h3>Color Legend</h3>
    <div class="legend-grid">
      <div class="legend-item"><div class="legend-swatch" style="background:#e65100;"></div><span>Retinitis (primary retinal)</span></div>
      <div class="legend-item"><div class="legend-swatch" style="background:#1976d2;"></div><span>Choroiditis (primary choroidal)</span></div>
      <div class="legend-item"><div class="legend-swatch" style="background:#7b1fa2;"></div><span>Chorioretinitis / Retinochoroiditis (combined)</span></div>
      <div class="legend-item"><div class="legend-swatch" style="background:#00897b;"></div><span>Neuroretinitis (disc + RNFL)</span></div>
      <div class="legend-item"><div class="legend-swatch" style="background:#c2185b;"></div><span>Retinal vasculitis</span></div>
      <div class="legend-item"><div class="legend-swatch" style="background:#d32f2f;"></div><span>Infectious etiology</span></div>
      <div class="legend-item"><div class="legend-swatch" style="background:#1565c0;"></div><span>Non-infectious / autoimmune etiology</span></div>
    </div>
  </div>

  <div style="text-align:center; font-size:11px; color:#999; padding:12px 0 20px;">
    Sources: Kanski's Clinical Ophthalmology 10th Ed. | Wills Eye Manual | Firestein & Kelley's Textbook of Rheumatology | Henry's Clinical Diagnosis
  </div>

</div>
</body>
</html>

Here is the comprehensive flowchart file:

posterior uveitis flowchart

HTML File · HTML

POSTERIOR UVEITIS - Detailed Diagnostic Flowchart

(Sources: Kanski's Clinical Ophthalmology 10th Ed., Wills Eye Manual, Firestein & Kelley's Rheumatology)

STEP 1 - WITH vs WITHOUT VITRITIS

Feature	WITH Vitritis	WITHOUT Vitritis
Suggests	Primary retinal disease	Primary choroidal disease
Entities	Retinitis, Retinochoroiditis, ARN, Neuroretinitis	Choroiditis, PORN, White dot syndromes
Examples	Toxoplasma ("headlight in fog"), ARN	PORN, Serpiginous, MEWDS, PIC

STEP 2 - PRIMARY SITE OF LESION

Lesion color gives the primary clue:

White lesion = Usually retinal (full-thickness opacity)
Yellow lesion = Usually choroidal (seen deep through RPE)
Pigmented lesion = Long-standing healed chorioretinal scar

Sites:

Retina → Retinitis, Retinochoroiditis
Choroid → Choroiditis, Chorioretinitis
Optic nerve head → Neuroretinitis, Papillitis
Retinal vessels → Periphlebitis, Arteritis, Retinal vasculitis

STEP 3 - DISTRIBUTION PATTERN

Pattern	Meaning	Examples
Focal / Solitary	Single lesion	Toxoplasma (classic)
Multifocal	Multiple discrete lesions	Sarcoid, Syphilis, Birdshot, MEWDS
Geographic	Map-like, irregular	Serpiginous choroiditis
Diffuse	Widespread	CMV retinitis, ARN, PORN

STEP 4 - INFECTIOUS vs NON-INFECTIOUS

INFECTIOUS

Entity Type	Disease	Key Notes
Retinitis	Toxoplasma retinochoroiditis	Most common identifiable focal retinitis; satellite scar
Retinitis	CMV retinitis	Pizza-pie pattern; immunocompromised (HIV)
Retinitis	ARN (HSV/VZV)	Peripheral necrotizing; marked vitritis; occlusive arteritis
Retinitis	PORN (VZV)	No vitritis; deep opacification; severe HIV
Retinitis	Candida retinitis	Fluffy yellow-white preretinal lesions; IV drug use
Choroiditis	Pneumocystis choroiditis	Bilateral yellow choroidal lesions; AIDS
Choroiditis	Cryptococcal choroiditis	Immunocompromised
Chorioretinitis	Histoplasma	"Punched-out" peripapillary scars; endemic
Chorioretinitis	Syphilis	"Great imitator" - any pattern; bilateral
Chorioretinitis	TB	Choroidal tubercles; periphlebitis
Neuroretinitis	Bartonella (cat-scratch)	#1 cause of neuroretinitis; macular star + disc edema; unilateral
Neuroretinitis	Lyme disease	Varied posterior uveitis
Neuroretinitis	Toxocara/DUSN	Children; nematode; unilateral; optic nerve swelling
Vasculitis	Syphilis / TB / ARN	Any vessel type

NON-INFECTIOUS

Entity Type	Disease	Key Notes
Choroiditis - White Dot	APMPPE	Bilateral placoid sub-RPE; young adults; self-limiting
Choroiditis - White Dot	Serpiginous	Geographic peripapillary; recurrent; bilateral asymmetric
Choroiditis - White Dot	MEWDS	Unilateral; evanescent; young women
Choroiditis - White Dot	MFC (Multifocal choroiditis)	Punched-out scars; myopic women; bilateral
Choroiditis - White Dot	PIC (Punctate inner choroidopathy)	Small punctate; high myopes
Chorioretinitis	Birdshot chorioretinopathy	HLA-A29; cream-colored lesions radiating from disc; bilateral; periphlebitis
Chorioretinitis	VKH syndrome	Bilateral exudative RD; poliosis; tinnitus; sunset glow fundus
Chorioretinitis	Sympathetic ophthalmia	Bilateral granulomatous; post penetrating trauma; Dalen-Fuchs nodules
Chorioretinitis	Sarcoidosis	Candlewax drippings; disc granulomas; bilateral
Retinal vasculitis	Eales disease	Peripheral periphlebitis; neovascularization; young men
Retinal vasculitis	Behçet disease	Occlusive; bilateral; hypopyon; oral/genital ulcers
Retinal vasculitis	Susac syndrome	Arterial; bilateral; cochlear + CNS involvement
Retinal vasculitis	Frosted branch angiitis	Dramatic sheathing of all vessels
Neuroretinitis	IRVAN	Disc aneurysms + macular star; non-infectious

STEP 5 - LATERALITY

UNILATERAL	BILATERAL (typical)
Toxoplasma retinochoroiditis	VKH syndrome
CMV (early)	Sympathetic ophthalmia
ARN (often starts uni)	Birdshot chorioretinopathy (HLA-A29)
PORN	Sarcoidosis
Bartonella neuroretinitis	APMPPE, Serpiginous, MFC
Toxocara / DUSN	Behçet, Susac
MEWDS, PIC	CMV (advanced AIDS), Syphilis, TB

STEP 6 - ENTITY DEFINITIONS

Entity	Primary Site	Secondary Spread	Vitritis	Prototype
Retinitis	Retina	None	Present (usually)	CMV, ARN, Toxoplasma
Choroiditis	Choroid	None	Absent (usually)	APMPPE, Serpiginous, MEWDS
Chorioretinitis	Choroid	→ Retina (secondary)	Variable	Birdshot, VKH, Sarcoid
Retinochoroiditis	Retina	→ Choroid (secondary)	Present, dense	Toxoplasma (over active lesion)
Neuroretinitis	Optic disc + RNFL	Macular star exudate	Variable	Bartonella, IRVAN
Retinal vasculitis	Vessel walls	Surrounding retina	Variable	Eales, Behçet, Sarcoid

Key textbook pearl (Wills Eye Manual): "Retinochoroiditis = primarily retinal with secondary choroidal involvement. Chorioretinitis = primarily choroidal with secondary retinal involvement." Active lesion color gives the primary site - white = retina, yellow = choroid.

give me a single flowchart for above

Writing File

~/posterior-uveitis-flowchart/single_flowchart.html

<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Posterior Uveitis – Single Flowchart</title>
<style>
  * { box-sizing: border-box; margin: 0; padding: 0; }
  body { background: #f5f7fa; font-family: 'Segoe UI', Arial, sans-serif; }
  svg { display: block; margin: 0 auto; }
  .page-wrap { padding: 16px; }
  h2 {
    text-align: center;
    font-size: 15px;
    color: #555;
    margin-top: 6px;
    font-weight: 400;
    letter-spacing: 0.3px;
  }
</style>
</head>
<body>
<div class="page-wrap">
<svg id="fc" xmlns="http://www.w3.org/2000/svg" width="2000" height="3100" viewBox="0 0 2000 3100">
  <defs>
    <marker id="arr" markerWidth="8" markerHeight="8" refX="6" refY="3" orient="auto">
      <path d="M0,0 L0,6 L8,3 z" fill="#555"/>
    </marker>
    <marker id="arr-red" markerWidth="8" markerHeight="8" refX="6" refY="3" orient="auto">
      <path d="M0,0 L0,6 L8,3 z" fill="#c62828"/>
    </marker>
    <marker id="arr-blue" markerWidth="8" markerHeight="8" refX="6" refY="3" orient="auto">
      <path d="M0,0 L0,6 L8,3 z" fill="#1565c0"/>
    </marker>
    <marker id="arr-grn" markerWidth="8" markerHeight="8" refX="6" refY="3" orient="auto">
      <path d="M0,0 L0,6 L8,3 z" fill="#2e7d32"/>
    </marker>
    <filter id="shadow" x="-5%" y="-5%" width="110%" height="115%">
      <feDropShadow dx="1" dy="2" stdDeviation="2" flood-color="#00000022"/>
    </filter>
  </defs>

  <!-- ═══════════════════════════════════ BACKGROUND ═══════════════════════════════════ -->
  <rect width="2000" height="3100" fill="#f5f7fa"/>

  <!-- ═══════════════════════════════════ ROOT ═══════════════════════════════════ -->
  <!-- ROOT BOX -->
  <rect x="700" y="30" width="600" height="64" rx="14" fill="#b71c1c" filter="url(#shadow)"/>
  <text x="1000" y="55" text-anchor="middle" font-size="22" font-weight="700" fill="white">POSTERIOR UVEITIS</text>
  <text x="1000" y="78" text-anchor="middle" font-size="13" fill="#ffcdd2">Retinitis · Choroiditis · Vasculitis · Neuroretinitis</text>

  <!-- down arrow -->
  <line x1="1000" y1="94" x2="1000" y2="128" stroke="#555" stroke-width="2.5" marker-end="url(#arr)"/>

  <!-- ═══════════════════════════════════ STEP 1: VITRITIS ═══════════════════════════════════ -->
  <rect x="840" y="130" width="320" height="40" rx="8" fill="#37474f"/>
  <text x="1000" y="155" text-anchor="middle" font-size="14" font-weight="700" fill="white">STEP 1 — VITRITIS?</text>

  <!-- branch lines left and right -->
  <!-- horizontal bar -->
  <line x1="400" y1="194" x2="1600" y2="194" stroke="#555" stroke-width="2"/>
  <!-- down from centre to bar -->
  <line x1="1000" y1="170" x2="1000" y2="194" stroke="#555" stroke-width="2"/>
  <!-- down from left end -->
  <line x1="400" y1="194" x2="400" y2="222" stroke="#e65100" stroke-width="2" marker-end="url(#arr)"/>
  <!-- down from right end -->
  <line x1="1600" y1="194" x2="1600" y2="222" stroke="#1565c0" stroke-width="2" marker-end="url(#arr-blue)"/>

  <!-- WITH VITRITIS BOX -->
  <rect x="200" y="224" width="400" height="58" rx="10" fill="#e65100" filter="url(#shadow)"/>
  <text x="400" y="248" text-anchor="middle" font-size="15" font-weight="700" fill="white">WITH VITRITIS</text>
  <text x="400" y="268" text-anchor="middle" font-size="12" fill="#ffe0b2">Suggests PRIMARY RETINAL disease</text>

  <!-- WITHOUT VITRITIS BOX -->
  <rect x="1400" y="224" width="400" height="58" rx="10" fill="#1565c0" filter="url(#shadow)"/>
  <text x="1600" y="248" text-anchor="middle" font-size="15" font-weight="700" fill="white">WITHOUT VITRITIS</text>
  <text x="1600" y="268" text-anchor="middle" font-size="12" fill="#bbdefb">Suggests PRIMARY CHOROIDAL disease</text>

  <!-- ═══════════════════════════════════ STEP 2: LESION COLOUR CLUE ═══════════════════════════════════ -->
  <!-- down from vitritis boxes to colour clue row -->
  <line x1="400" y1="282" x2="400" y2="316" stroke="#e65100" stroke-width="2" marker-end="url(#arr)"/>
  <line x1="1600" y1="282" x2="1600" y2="316" stroke="#1565c0" stroke-width="2" marker-end="url(#arr-blue)"/>

  <!-- COLOUR CLUE: WHITE = RETINAL -->
  <rect x="160" y="318" width="480" height="48" rx="8" fill="#fff3e0" stroke="#e65100" stroke-width="2"/>
  <text x="400" y="338" text-anchor="middle" font-size="13" font-weight="700" fill="#bf360c">⬜ WHITE lesion = RETINAL</text>
  <text x="400" y="356" text-anchor="middle" font-size="11.5" fill="#6d4c41">Full-thickness opacification · indistinct margins</text>

  <!-- COLOUR CLUE: YELLOW = CHOROIDAL -->
  <rect x="1360" y="318" width="480" height="48" rx="8" fill="#fff9c4" stroke="#f9a825" stroke-width="2"/>
  <text x="1600" y="338" text-anchor="middle" font-size="13" font-weight="700" fill="#e65100">🟡 YELLOW lesion = CHOROIDAL</text>
  <text x="1600" y="356" text-anchor="middle" font-size="11.5" fill="#6d4c41">Deep · seen through RPE · round nodule</text>

  <!-- STEP 2 LABEL in centre -->
  <rect x="820" y="318" width="360" height="48" rx="8" fill="#546e7a"/>
  <text x="1000" y="338" text-anchor="middle" font-size="13" font-weight="700" fill="white">STEP 2 — PRIMARY SITE</text>
  <text x="1000" y="356" text-anchor="middle" font-size="11" fill="#cfd8dc">🟫 Pigmented = healed scar (old disease)</text>

  <!-- ═══════════════════════════════════ STEP 3: PATTERN ═══════════════════════════════════ -->
  <line x1="1000" y1="366" x2="1000" y2="398" stroke="#555" stroke-width="2" marker-end="url(#arr)"/>
  <rect x="810" y="400" width="380" height="40" rx="8" fill="#37474f"/>
  <text x="1000" y="425" text-anchor="middle" font-size="14" font-weight="700" fill="white">STEP 3 — DISTRIBUTION PATTERN</text>

  <line x1="1000" y1="440" x2="1000" y2="458" stroke="#555" stroke-width="2"/>
  <!-- horizontal bar -->
  <line x1="260" y1="458" x2="1740" y2="458" stroke="#555" stroke-width="1.5"/>
  <!-- 4 verticals -->
  <line x1="300" y1="458" x2="300" y2="484" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>
  <line x1="690" y1="458" x2="690" y2="484" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>
  <line x1="1310" y1="458" x2="1310" y2="484" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>
  <line x1="1700" y1="458" x2="1700" y2="484" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>

  <!-- FOCAL -->
  <rect x="170" y="486" width="260" height="52" rx="8" fill="white" stroke="#43a047" stroke-width="2.5"/>
  <text x="300" y="506" text-anchor="middle" font-size="13" font-weight="700" fill="#2e7d32">FOCAL / SOLITARY</text>
  <text x="300" y="524" text-anchor="middle" font-size="11" fill="#555">Single lesion</text>
  <text x="300" y="537" text-anchor="middle" font-size="10.5" fill="#888">Toxoplasma (classic)</text>

  <!-- MULTIFOCAL -->
  <rect x="560" y="486" width="260" height="52" rx="8" fill="white" stroke="#fb8c00" stroke-width="2.5"/>
  <text x="690" y="506" text-anchor="middle" font-size="13" font-weight="700" fill="#e65100">MULTIFOCAL</text>
  <text x="690" y="524" text-anchor="middle" font-size="11" fill="#555">Multiple discrete lesions</text>
  <text x="690" y="537" text-anchor="middle" font-size="10.5" fill="#888">Sarcoid · Syphilis · MEWDS</text>

  <!-- GEOGRAPHIC -->
  <rect x="1180" y="486" width="260" height="52" rx="8" fill="white" stroke="#8e24aa" stroke-width="2.5"/>
  <text x="1310" y="506" text-anchor="middle" font-size="13" font-weight="700" fill="#6a1b9a">GEOGRAPHIC</text>
  <text x="1310" y="524" text-anchor="middle" font-size="11" fill="#555">Map-like spread</text>
  <text x="1310" y="537" text-anchor="middle" font-size="10.5" fill="#888">Serpiginous choroiditis</text>

  <!-- DIFFUSE -->
  <rect x="1570" y="486" width="260" height="52" rx="8" fill="white" stroke="#e53935" stroke-width="2.5"/>
  <text x="1700" y="506" text-anchor="middle" font-size="13" font-weight="700" fill="#c62828">DIFFUSE</text>
  <text x="1700" y="524" text-anchor="middle" font-size="11" fill="#555">Widespread retina</text>
  <text x="1700" y="537" text-anchor="middle" font-size="10.5" fill="#888">CMV · ARN · PORN</text>

  <!-- ═══════════════════════════════════ STEP 4: INFECTIOUS vs NON-INFECTIOUS ═══════════════════════════════════ -->
  <line x1="1000" y1="538" x2="1000" y2="572" stroke="#555" stroke-width="2" marker-end="url(#arr)"/>
  <rect x="790" y="574" width="420" height="40" rx="8" fill="#37474f"/>
  <text x="1000" y="599" text-anchor="middle" font-size="14" font-weight="700" fill="white">STEP 4 — INFECTIOUS vs NON-INFECTIOUS</text>

  <!-- big horizontal split line -->
  <line x1="1000" y1="614" x2="1000" y2="640" stroke="#555" stroke-width="2"/>
  <line x1="200" y1="640" x2="1800" y2="640" stroke="#555" stroke-width="2"/>
  <line x1="200" y1="640" x2="200" y2="668" stroke="#c62828" stroke-width="2.5" marker-end="url(#arr-red)"/>
  <line x1="1800" y1="640" x2="1800" y2="668" stroke="#1565c0" stroke-width="2.5" marker-end="url(#arr-blue)"/>

  <!-- ════ INFECTIOUS HEADER ════ -->
  <rect x="30" y="670" width="935" height="46" rx="10" fill="#c62828" filter="url(#shadow)"/>
  <text x="497" y="689" text-anchor="middle" font-size="16" font-weight="700" fill="white">🦠  INFECTIOUS POSTERIOR UVEITIS</text>
  <text x="497" y="708" text-anchor="middle" font-size="12" fill="#ffcdd2">Bacterial · Viral · Parasitic · Fungal</text>

  <!-- ════ NON-INFECTIOUS HEADER ════ -->
  <rect x="1035" y="670" width="935" height="46" rx="10" fill="#1565c0" filter="url(#shadow)"/>
  <text x="1502" y="689" text-anchor="middle" font-size="16" font-weight="700" fill="white">🔵  NON-INFECTIOUS POSTERIOR UVEITIS</text>
  <text x="1502" y="708" text-anchor="middle" font-size="12" fill="#bbdefb">Autoimmune · Granulomatous · Idiopathic</text>

  <!-- ─────────────────────────────── INFECTIOUS COLUMNS ─────────────────────────────── -->
  <!-- 3 columns under infectious: Retinitis | Choroiditis | Chorioretinitis+Neuroretinitis+Vasculitis -->

  <!-- column lines from infectious header -->
  <line x1="200" y1="716" x2="200" y2="748" stroke="#c62828" stroke-width="2"/>
  <line x1="497" y1="716" x2="497" y2="748" stroke="#c62828" stroke-width="2"/>
  <line x1="795" y1="716" x2="795" y2="748" stroke="#c62828" stroke-width="2"/>
  <line x1="100" y1="748" x2="900" y2="748" stroke="#c62828" stroke-width="1.5"/>
  <line x1="150" y1="748" x2="150" y2="776" stroke="#c62828" stroke-width="1.5" marker-end="url(#arr-red)"/>
  <line x1="497" y1="748" x2="497" y2="776" stroke="#c62828" stroke-width="1.5" marker-end="url(#arr-red)"/>
  <line x1="845" y1="748" x2="845" y2="776" stroke="#c62828" stroke-width="1.5" marker-end="url(#arr-red)"/>

  <!-- ── INFECTIOUS RETINITIS BOX ── -->
  <rect x="30" y="778" width="930" height="220" rx="10" fill="white" stroke="#e65100" stroke-width="2" filter="url(#shadow)"/>
  <!-- Header strip -->
  <rect x="30" y="778" width="930" height="36" rx="10" fill="#e65100"/>
  <rect x="30" y="800" width="930" height="14" fill="#e65100"/>
  <text x="495" y="801" text-anchor="middle" font-size="14" font-weight="700" fill="white">RETINITIS  (Primary Retinal · White lesion · Vitritis present)</text>

  <!-- Toxoplasma -->
  <rect x="48" y="824" width="275" height="158" rx="8" fill="#fff8f0" stroke="#e65100" stroke-width="1.5"/>
  <text x="185" y="842" text-anchor="middle" font-size="12.5" font-weight="700" fill="#bf360c">Toxoplasma Retinochoroiditis</text>
  <text x="185" y="859" text-anchor="middle" font-size="11" fill="#555">Most common identifiable</text>
  <text x="185" y="874" text-anchor="middle" font-size="11" fill="#555">focal retinitis</text>
  <text x="185" y="892" text-anchor="middle" font-size="11" fill="#444">• "Headlight in fog"</text>
  <text x="185" y="907" text-anchor="middle" font-size="11" fill="#444">• Focal dense vitritis</text>
  <text x="185" y="922" text-anchor="middle" font-size="11" fill="#444">• Adjacent pigmented scar</text>
  <text x="185" y="937" text-anchor="middle" font-size="11" fill="#444">  (satellite lesion)</text>
  <text x="185" y="956" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Unilateral · Focal</text>
  <text x="185" y="971" text-anchor="middle" font-size="10.5" fill="#e65100" font-weight="700">→ RETINOCHOROIDITIS</text>

  <!-- CMV -->
  <rect x="343" y="824" width="275" height="158" rx="8" fill="#fff8f0" stroke="#e65100" stroke-width="1.5"/>
  <text x="480" y="842" text-anchor="middle" font-size="12.5" font-weight="700" fill="#bf360c">CMV Retinitis</text>
  <text x="480" y="859" text-anchor="middle" font-size="11" fill="#555">Immunocompromised (HIV/AIDS)</text>
  <text x="480" y="877" text-anchor="middle" font-size="11" fill="#444">• "Pizza-pie" fundus</text>
  <text x="480" y="892" text-anchor="middle" font-size="11" fill="#444">• Granular + hemorrhagic</text>
  <text x="480" y="907" text-anchor="middle" font-size="11" fill="#444">• Vitritis: mild</text>
  <text x="480" y="922" text-anchor="middle" font-size="11" fill="#444">• Frosted branch angiitis 20%</text>
  <text x="480" y="937" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Uni → Bilateral · Diffuse</text>
  <text x="480" y="956" text-anchor="middle" font-size="10.5" fill="#e65100" font-weight="700">→ RETINITIS</text>

  <!-- ARN / PORN -->
  <rect x="638" y="824" width="304" height="158" rx="8" fill="#fff8f0" stroke="#e65100" stroke-width="1.5"/>
  <text x="790" y="842" text-anchor="middle" font-size="12.5" font-weight="700" fill="#bf360c">ARN / PORN (Herpes)</text>
  <text x="790" y="857" text-anchor="middle" font-size="11" fill="#555">HSV/VZV (ARN) · VZV/HIV (PORN)</text>
  <text x="790" y="875" text-anchor="middle" font-size="11" fill="#444">ARN: peripheral white patches</text>
  <text x="790" y="890" text-anchor="middle" font-size="11" fill="#444">  marked vitritis · occlusive arteritis</text>
  <text x="790" y="905" text-anchor="middle" font-size="11" fill="#444">PORN: deep opacification</text>
  <text x="790" y="920" text-anchor="middle" font-size="11" fill="#444">  NO vitritis · spares vessels</text>
  <text x="790" y="935" text-anchor="middle" font-size="11" fill="#444">  rapid progression (days)</text>
  <text x="790" y="954" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">ARN: Unilateral (33% bilateral)</text>
  <text x="790" y="971" text-anchor="middle" font-size="10.5" fill="#e65100" font-weight="700">→ RETINITIS (necrotizing)</text>

  <!-- ── INFECTIOUS CHOROIDITIS BOX ── -->
  <rect x="30" y="1010" width="930" height="168" rx="10" fill="white" stroke="#1976d2" stroke-width="2" filter="url(#shadow)"/>
  <rect x="30" y="1010" width="930" height="36" rx="10" fill="#1976d2"/>
  <rect x="30" y="1032" width="930" height="14" fill="#1976d2"/>
  <text x="495" y="1033" text-anchor="middle" font-size="14" font-weight="700" fill="white">CHOROIDITIS  (Primary Choroidal · Yellow lesion · Vitritis absent)</text>

  <rect x="48" y="1056" width="275" height="106" rx="8" fill="#e3f2fd" stroke="#1976d2" stroke-width="1.5"/>
  <text x="185" y="1073" text-anchor="middle" font-size="12.5" font-weight="700" fill="#0d47a1">Pneumocystis Choroiditis</text>
  <text x="185" y="1091" text-anchor="middle" font-size="11" fill="#444">• Bilateral creamy yellow lesions</text>
  <text x="185" y="1106" text-anchor="middle" font-size="11" fill="#444">• No vitritis</text>
  <text x="185" y="1121" text-anchor="middle" font-size="11" fill="#444">• AIDS (CD4 &lt; 50)</text>
  <text x="185" y="1150" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Multifocal</text>

  <rect x="343" y="1056" width="275" height="106" rx="8" fill="#e3f2fd" stroke="#1976d2" stroke-width="1.5"/>
  <text x="480" y="1073" text-anchor="middle" font-size="12.5" font-weight="700" fill="#0d47a1">Cryptococcal Choroiditis</text>
  <text x="480" y="1091" text-anchor="middle" font-size="11" fill="#444">• Deep yellow choroidal lesions</text>
  <text x="480" y="1106" text-anchor="middle" font-size="11" fill="#444">• Immunocompromised</text>
  <text x="480" y="1121" text-anchor="middle" font-size="11" fill="#444">• Associated meningitis</text>
  <text x="480" y="1150" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Multifocal</text>

  <rect x="638" y="1056" width="304" height="106" rx="8" fill="#e3f2fd" stroke="#1976d2" stroke-width="1.5"/>
  <text x="790" y="1073" text-anchor="middle" font-size="12.5" font-weight="700" fill="#0d47a1">TB Choroiditis</text>
  <text x="790" y="1091" text-anchor="middle" font-size="11" fill="#444">• Choroidal tubercles (multifocal)</text>
  <text x="790" y="1106" text-anchor="middle" font-size="11" fill="#444">• Yellow-white deep lesions</text>
  <text x="790" y="1121" text-anchor="middle" font-size="11" fill="#444">• ± periphlebitis</text>
  <text x="790" y="1150" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Multifocal</text>

  <!-- ── INFECTIOUS RETINOCHOROIDITIS / NEURORETINITIS / VASCULITIS ── -->
  <rect x="30" y="1190" width="930" height="200" rx="10" fill="white" stroke="#7b1fa2" stroke-width="2" filter="url(#shadow)"/>
  <rect x="30" y="1190" width="930" height="36" rx="10" fill="#7b1fa2"/>
  <rect x="30" y="1212" width="930" height="14" fill="#7b1fa2"/>
  <text x="495" y="1213" text-anchor="middle" font-size="14" font-weight="700" fill="white">CHORIORETINITIS · NEURORETINITIS · VASCULITIS  (Infectious)</text>

  <!-- Syphilis -->
  <rect x="48" y="1236" width="275" height="138" rx="8" fill="#f3e5f5" stroke="#7b1fa2" stroke-width="1.5"/>
  <text x="185" y="1254" text-anchor="middle" font-size="12.5" font-weight="700" fill="#4a148c">Syphilis ("Great Imitator")</text>
  <text x="185" y="1272" text-anchor="middle" font-size="11" fill="#444">• Any pattern of posterior uveitis</text>
  <text x="185" y="1287" text-anchor="middle" font-size="11" fill="#444">• Retinitis / chorioretinitis</text>
  <text x="185" y="1302" text-anchor="middle" font-size="11" fill="#444">• Retinal vasculitis</text>
  <text x="185" y="1317" text-anchor="middle" font-size="11" fill="#444">• Neuroretinitis</text>
  <text x="185" y="1362" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Multifocal</text>

  <!-- Bartonella Neuroretinitis -->
  <rect x="343" y="1236" width="275" height="138" rx="8" fill="#e0f2f1" stroke="#00897b" stroke-width="1.5"/>
  <text x="480" y="1254" text-anchor="middle" font-size="12.5" font-weight="700" fill="#004d40">Bartonella (Cat-Scratch)</text>
  <text x="480" y="1270" text-anchor="middle" font-size="11" fill="#555">#1 cause of Neuroretinitis</text>
  <text x="480" y="1288" text-anchor="middle" font-size="11" fill="#444">• Disc edema</text>
  <text x="480" y="1303" text-anchor="middle" font-size="11" fill="#444">• Macular STAR exudate</text>
  <text x="480" y="1318" text-anchor="middle" font-size="11" fill="#444">• Stellate pattern in Henle's layer</text>
  <text x="480" y="1333" text-anchor="middle" font-size="11" fill="#444">• Cat exposure history</text>
  <text x="480" y="1362" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Unilateral · Focal</text>
  <text x="480" y="1374" text-anchor="middle" font-size="10.5" fill="#00897b" font-weight="700">→ NEURORETINITIS</text>

  <!-- DUSN / Toxocara -->
  <rect x="638" y="1236" width="304" height="138" rx="8" fill="#e0f2f1" stroke="#00897b" stroke-width="1.5"/>
  <text x="790" y="1254" text-anchor="middle" font-size="12.5" font-weight="700" fill="#004d40">Toxocara / DUSN</text>
  <text x="790" y="1270" text-anchor="middle" font-size="11" fill="#555">Diffuse Unilateral Subacute Neuroretinitis</text>
  <text x="790" y="1288" text-anchor="middle" font-size="11" fill="#444">• Nematode migration</text>
  <text x="790" y="1303" text-anchor="middle" font-size="11" fill="#444">• Children / young adults</text>
  <text x="790" y="1318" text-anchor="middle" font-size="11" fill="#444">• Optic nerve swelling</text>
  <text x="790" y="1333" text-anchor="middle" font-size="11" fill="#444">• Gray-white retinal lesions</text>
  <text x="790" y="1348" text-anchor="middle" font-size="11" fill="#444">• → Optic atrophy (late)</text>
  <text x="790" y="1362" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Unilateral</text>
  <text x="790" y="1374" text-anchor="middle" font-size="10.5" fill="#00897b" font-weight="700">→ NEURORETINITIS</text>

  <!-- ─────────────────────────────── NON-INFECTIOUS COLUMNS ─────────────────────────────── -->
  <!-- column lines from non-infectious header -->
  <line x1="1200" y1="716" x2="1200" y2="748" stroke="#1565c0" stroke-width="2"/>
  <line x1="1497" y1="716" x2="1497" y2="748" stroke="#1565c0" stroke-width="2"/>
  <line x1="1795" y1="716" x2="1795" y2="748" stroke="#1565c0" stroke-width="2"/>
  <line x1="1100" y1="748" x2="1900" y2="748" stroke="#1565c0" stroke-width="1.5"/>
  <line x1="1150" y1="748" x2="1150" y2="776" stroke="#1565c0" stroke-width="1.5" marker-end="url(#arr-blue)"/>
  <line x1="1497" y1="748" x2="1497" y2="776" stroke="#1565c0" stroke-width="1.5" marker-end="url(#arr-blue)"/>
  <line x1="1845" y1="748" x2="1845" y2="776" stroke="#1565c0" stroke-width="1.5" marker-end="url(#arr-blue)"/>

  <!-- ── NON-INFECT WHITE DOT SYNDROMES (CHOROIDITIS) ── -->
  <rect x="1035" y="778" width="930" height="220" rx="10" fill="white" stroke="#1976d2" stroke-width="2" filter="url(#shadow)"/>
  <rect x="1035" y="778" width="930" height="36" rx="10" fill="#1976d2"/>
  <rect x="1035" y="800" width="930" height="14" fill="#1976d2"/>
  <text x="1500" y="801" text-anchor="middle" font-size="14" font-weight="700" fill="white">WHITE DOT SYNDROMES  (Primary Choroidal · No/Mild Vitritis)</text>

  <!-- APMPPE -->
  <rect x="1050" y="824" width="210" height="158" rx="8" fill="#e3f2fd" stroke="#1976d2" stroke-width="1.5"/>
  <text x="1155" y="842" text-anchor="middle" font-size="12" font-weight="700" fill="#0d47a1">APMPPE</text>
  <text x="1155" y="857" text-anchor="middle" font-size="10" fill="#555">Acute Post. Multifocal</text>
  <text x="1155" y="870" text-anchor="middle" font-size="10" fill="#555">Placoid Pigment Epith.</text>
  <text x="1155" y="888" text-anchor="middle" font-size="11" fill="#444">• Bilateral placoid lesions</text>
  <text x="1155" y="903" text-anchor="middle" font-size="11" fill="#444">• Post-viral, young adults</text>
  <text x="1155" y="918" text-anchor="middle" font-size="11" fill="#444">• Self-limiting</text>
  <text x="1155" y="956" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Multifocal</text>

  <!-- MEWDS -->
  <rect x="1270" y="824" width="210" height="158" rx="8" fill="#e3f2fd" stroke="#1976d2" stroke-width="1.5"/>
  <text x="1375" y="842" text-anchor="middle" font-size="12" font-weight="700" fill="#0d47a1">MEWDS</text>
  <text x="1375" y="857" text-anchor="middle" font-size="10" fill="#555">Multiple Evanescent</text>
  <text x="1375" y="870" text-anchor="middle" font-size="10" fill="#555">White Dot Syndrome</text>
  <text x="1375" y="888" text-anchor="middle" font-size="11" fill="#444">• Outer retina / choroid</text>
  <text x="1375" y="903" text-anchor="middle" font-size="11" fill="#444">• Young myopic women</text>
  <text x="1375" y="918" text-anchor="middle" font-size="11" fill="#444">• Evanescent; self-resolving</text>
  <text x="1375" y="956" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">UNILATERAL · Multifocal</text>

  <!-- Serpiginous -->
  <rect x="1490" y="824" width="210" height="158" rx="8" fill="#e3f2fd" stroke="#1976d2" stroke-width="1.5"/>
  <text x="1595" y="842" text-anchor="middle" font-size="12" font-weight="700" fill="#0d47a1">Serpiginous</text>
  <text x="1595" y="857" text-anchor="middle" font-size="10" fill="#555">Choroiditis</text>
  <text x="1595" y="875" text-anchor="middle" font-size="11" fill="#444">• Geographic map-like</text>
  <text x="1595" y="890" text-anchor="middle" font-size="11" fill="#444">• Peripapillary start</text>
  <text x="1595" y="905" text-anchor="middle" font-size="11" fill="#444">• Recurrent; no vitritis</text>
  <text x="1595" y="920" text-anchor="middle" font-size="11" fill="#444">• Bilateral (asymmetric)</text>
  <text x="1595" y="956" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Geographic</text>

  <!-- MFC / PIC -->
  <rect x="1710" y="824" width="240" height="158" rx="8" fill="#e3f2fd" stroke="#1976d2" stroke-width="1.5"/>
  <text x="1830" y="842" text-anchor="middle" font-size="12" font-weight="700" fill="#0d47a1">MFC / PIC</text>
  <text x="1830" y="858" text-anchor="middle" font-size="10" fill="#555">Multifocal Choroiditis /</text>
  <text x="1830" y="871" text-anchor="middle" font-size="10" fill="#555">Punctate Inner Choroidopathy</text>
  <text x="1830" y="889" text-anchor="middle" font-size="11" fill="#444">MFC: punched-out scars</text>
  <text x="1830" y="904" text-anchor="middle" font-size="11" fill="#444">PIC: small punctate</text>
  <text x="1830" y="919" text-anchor="middle" font-size="11" fill="#444">Both: myopic women</text>
  <text x="1830" y="956" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Multifocal</text>

  <!-- ── NON-INFECT CHORIORETINITIS ── -->
  <rect x="1035" y="1010" width="930" height="188" rx="10" fill="white" stroke="#7b1fa2" stroke-width="2" filter="url(#shadow)"/>
  <rect x="1035" y="1010" width="930" height="36" rx="10" fill="#7b1fa2"/>
  <rect x="1035" y="1032" width="930" height="14" fill="#7b1fa2"/>
  <text x="1500" y="1033" text-anchor="middle" font-size="14" font-weight="700" fill="white">CHORIORETINITIS / RETINOCHOROIDITIS  (Non-infectious)</text>

  <!-- Birdshot -->
  <rect x="1050" y="1056" width="275" height="126" rx="8" fill="#f3e5f5" stroke="#7b1fa2" stroke-width="1.5"/>
  <text x="1188" y="1074" text-anchor="middle" font-size="12.5" font-weight="700" fill="#4a148c">Birdshot Chorioretinopathy</text>
  <text x="1188" y="1092" text-anchor="middle" font-size="11" fill="#444">• HLA-A29 (strongly associated)</text>
  <text x="1188" y="1107" text-anchor="middle" font-size="11" fill="#444">• Cream lesions radiating from disc</text>
  <text x="1188" y="1122" text-anchor="middle" font-size="11" fill="#444">• Bilateral periphlebitis</text>
  <text x="1188" y="1137" text-anchor="middle" font-size="11" fill="#444">• Older adults (50s)</text>
  <text x="1188" y="1170" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Multifocal · Chorioretinitis</text>

  <!-- VKH -->
  <rect x="1345" y="1056" width="305" height="126" rx="8" fill="#f3e5f5" stroke="#7b1fa2" stroke-width="1.5"/>
  <text x="1497" y="1074" text-anchor="middle" font-size="12.5" font-weight="700" fill="#4a148c">VKH Syndrome</text>
  <text x="1497" y="1092" text-anchor="middle" font-size="11" fill="#444">• Bilateral exudative RD</text>
  <text x="1497" y="1107" text-anchor="middle" font-size="11" fill="#444">• Granulomatous (mutton-fat KPs)</text>
  <text x="1497" y="1122" text-anchor="middle" font-size="11" fill="#444">• Poliosis, tinnitus, vitiligo</text>
  <text x="1497" y="1137" text-anchor="middle" font-size="11" fill="#444">• Sunset-glow fundus (late)</text>
  <text x="1497" y="1170" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Diffuse · Chorioretinitis</text>

  <!-- Sympathetic Ophthalmia -->
  <rect x="1670" y="1056" width="280" height="126" rx="8" fill="#f3e5f5" stroke="#7b1fa2" stroke-width="1.5"/>
  <text x="1810" y="1074" text-anchor="middle" font-size="12.5" font-weight="700" fill="#4a148c">Sympathetic Ophthalmia</text>
  <text x="1810" y="1092" text-anchor="middle" font-size="11" fill="#444">• Post-penetrating trauma / surgery</text>
  <text x="1810" y="1107" text-anchor="middle" font-size="11" fill="#444">• Bilateral granulomatous</text>
  <text x="1810" y="1122" text-anchor="middle" font-size="11" fill="#444">• Dalen-Fuchs nodules (RPE)</text>
  <text x="1810" y="1137" text-anchor="middle" font-size="11" fill="#444">• Exciting + sympathizing eye</text>
  <text x="1810" y="1170" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Post-traumatic</text>

  <!-- ── NON-INFECT RETINAL VASCULITIS + NEURORETINITIS ── -->
  <rect x="1035" y="1210" width="930" height="180" rx="10" fill="white" stroke="#c62828" stroke-width="2" filter="url(#shadow)"/>
  <rect x="1035" y="1210" width="930" height="36" rx="10" fill="#c62828"/>
  <rect x="1035" y="1232" width="930" height="14" fill="#c62828"/>
  <text x="1500" y="1233" text-anchor="middle" font-size="14" font-weight="700" fill="white">RETINAL VASCULITIS + NEURORETINITIS  (Non-infectious)</text>

  <!-- Sarcoidosis -->
  <rect x="1050" y="1256" width="220" height="118" rx="8" fill="#fce4ec" stroke="#c62828" stroke-width="1.5"/>
  <text x="1160" y="1274" text-anchor="middle" font-size="12.5" font-weight="700" fill="#880e4f">Sarcoidosis</text>
  <text x="1160" y="1292" text-anchor="middle" font-size="11" fill="#444">• "Candlewax drippings"</text>
  <text x="1160" y="1307" text-anchor="middle" font-size="11" fill="#444">• Periphlebitis</text>
  <text x="1160" y="1322" text-anchor="middle" font-size="11" fill="#444">• Disc granulomas</text>
  <text x="1160" y="1355" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral</text>

  <!-- Eales -->
  <rect x="1285" y="1256" width="220" height="118" rx="8" fill="#fce4ec" stroke="#c62828" stroke-width="1.5"/>
  <text x="1395" y="1274" text-anchor="middle" font-size="12.5" font-weight="700" fill="#880e4f">Eales Disease</text>
  <text x="1395" y="1292" text-anchor="middle" font-size="11" fill="#444">• Peripheral periphlebitis</text>
  <text x="1395" y="1307" text-anchor="middle" font-size="11" fill="#444">• Neovascularization</text>
  <text x="1395" y="1322" text-anchor="middle" font-size="11" fill="#444">• Young men; idiopathic</text>
  <text x="1395" y="1355" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Periphlebitis</text>

  <!-- Behcet -->
  <rect x="1520" y="1256" width="220" height="118" rx="8" fill="#fce4ec" stroke="#c62828" stroke-width="1.5"/>
  <text x="1630" y="1274" text-anchor="middle" font-size="12.5" font-weight="700" fill="#880e4f">Behçet Disease</text>
  <text x="1630" y="1292" text-anchor="middle" font-size="11" fill="#444">• Occlusive vasculitis</text>
  <text x="1630" y="1307" text-anchor="middle" font-size="11" fill="#444">• Bilateral; devastating</text>
  <text x="1630" y="1322" text-anchor="middle" font-size="11" fill="#444">• Oral/genital ulcers</text>
  <text x="1630" y="1355" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">Bilateral · Occlusive</text>

  <!-- IRVAN -->
  <rect x="1755" y="1256" width="200" height="118" rx="8" fill="#e0f2f1" stroke="#00897b" stroke-width="1.5"/>
  <text x="1855" y="1274" text-anchor="middle" font-size="12.5" font-weight="700" fill="#004d40">IRVAN</text>
  <text x="1855" y="1289" text-anchor="middle" font-size="10.5" fill="#555">Idiopathic Retinal Vasculitis</text>
  <text x="1855" y="1301" text-anchor="middle" font-size="10.5" fill="#555">Aneurysms Neuroretinitis</text>
  <text x="1855" y="1319" text-anchor="middle" font-size="11" fill="#444">• Disc aneurysms</text>
  <text x="1855" y="1334" text-anchor="middle" font-size="11" fill="#444">• Macular star</text>
  <text x="1855" y="1355" text-anchor="middle" font-size="10.5" fill="#888" font-style="italic">→ NEURORETINITIS</text>

  <!-- ═══════════════════════════════════ STEP 5: LATERALITY ═══════════════════════════════════ -->
  <line x1="1000" y1="1400" x2="1000" y2="1432" stroke="#555" stroke-width="2" marker-end="url(#arr)"/>
  <!-- connect both sides to step5 -->
  <line x1="495" y1="1390" x2="495" y2="1432" stroke="#555" stroke-width="1.5"/>
  <line x1="495" y1="1432" x2="1000" y2="1432" stroke="#555" stroke-width="1.5"/>
  <line x1="1505" y1="1390" x2="1505" y2="1432" stroke="#555" stroke-width="1.5"/>
  <line x1="1505" y1="1432" x2="1000" y2="1432" stroke="#555" stroke-width="1.5"/>

  <rect x="790" y="1434" width="420" height="40" rx="8" fill="#37474f"/>
  <text x="1000" y="1459" text-anchor="middle" font-size="14" font-weight="700" fill="white">STEP 5 — LATERALITY</text>

  <line x1="1000" y1="1474" x2="1000" y2="1498" stroke="#555" stroke-width="2"/>
  <line x1="380" y1="1498" x2="1620" y2="1498" stroke="#555" stroke-width="2"/>
  <line x1="380" y1="1498" x2="380" y2="1524" stroke="#6a1b9a" stroke-width="2.5" marker-end="url(#arr)"/>
  <line x1="1620" y1="1498" x2="1620" y2="1524" stroke="#2e7d32" stroke-width="2.5" marker-end="url(#arr-grn)"/>

  <!-- UNILATERAL -->
  <rect x="80" y="1526" width="600" height="200" rx="10" fill="white" stroke="#6a1b9a" stroke-width="2" filter="url(#shadow)"/>
  <rect x="80" y="1526" width="600" height="38" rx="10" fill="#6a1b9a"/>
  <rect x="80" y="1550" width="600" height="14" fill="#6a1b9a"/>
  <text x="380" y="1550" text-anchor="middle" font-size="15" font-weight="700" fill="white">UNILATERAL</text>
  <text x="180" y="1582" text-anchor="start" font-size="12" fill="#333">• Toxoplasma retinochoroiditis</text>
  <text x="180" y="1598" text-anchor="start" font-size="12" fill="#333">• CMV retinitis (early)</text>
  <text x="180" y="1614" text-anchor="start" font-size="12" fill="#333">• ARN (often starts unilateral)</text>
  <text x="180" y="1630" text-anchor="start" font-size="12" fill="#333">• PORN (can be bilateral)</text>
  <text x="180" y="1646" text-anchor="start" font-size="12" fill="#333">• Bartonella neuroretinitis</text>
  <text x="180" y="1662" text-anchor="start" font-size="12" fill="#333">• Toxocara / DUSN</text>
  <text x="180" y="1678" text-anchor="start" font-size="12" fill="#333">• MEWDS · PIC · Eales (unilateral onset)</text>
  <text x="180" y="1694" text-anchor="start" font-size="12" fill="#333">• Frosted branch angiitis</text>
  <text x="180" y="1710" text-anchor="start" font-size="12" fill="#333">• Intraocular lymphoma (can be unilateral)</text>

  <!-- BILATERAL -->
  <rect x="1320" y="1526" width="600" height="200" rx="10" fill="white" stroke="#2e7d32" stroke-width="2" filter="url(#shadow)"/>
  <rect x="1320" y="1526" width="600" height="38" rx="10" fill="#2e7d32"/>
  <rect x="1320" y="1550" width="600" height="14" fill="#2e7d32"/>
  <text x="1620" y="1550" text-anchor="middle" font-size="15" font-weight="700" fill="white">BILATERAL (typical)</text>
  <text x="1420" y="1582" text-anchor="start" font-size="12" fill="#333">• VKH syndrome</text>
  <text x="1420" y="1598" text-anchor="start" font-size="12" fill="#333">• Sympathetic ophthalmia (post-trauma)</text>
  <text x="1420" y="1614" text-anchor="start" font-size="12" fill="#333">• Birdshot chorioretinopathy (HLA-A29)</text>
  <text x="1420" y="1630" text-anchor="start" font-size="12" fill="#333">• Sarcoidosis</text>
  <text x="1420" y="1646" text-anchor="start" font-size="12" fill="#333">• APMPPE · Serpiginous · MFC</text>
  <text x="1420" y="1662" text-anchor="start" font-size="12" fill="#333">• Behçet (occlusive vasculitis)</text>
  <text x="1420" y="1678" text-anchor="start" font-size="12" fill="#333">• Susac syndrome</text>
  <text x="1420" y="1694" text-anchor="start" font-size="12" fill="#333">• CMV retinitis (advanced AIDS)</text>
  <text x="1420" y="1710" text-anchor="start" font-size="12" fill="#333">• Syphilis · TB</text>

  <!-- ═══════════════════════════════════ STEP 6: ENTITY DEFINITIONS ═══════════════════════════════════ -->
  <line x1="1000" y1="1726" x2="1000" y2="1760" stroke="#555" stroke-width="2" marker-end="url(#arr)"/>
  <rect x="770" y="1762" width="460" height="40" rx="8" fill="#37474f"/>
  <text x="1000" y="1787" text-anchor="middle" font-size="14" font-weight="700" fill="white">STEP 6 — CLINICAL ENTITY DEFINITIONS</text>

  <line x1="1000" y1="1802" x2="1000" y2="1830" stroke="#555" stroke-width="2"/>
  <!-- horizontal spanning all 6 entities -->
  <line x1="166" y1="1830" x2="1833" y2="1830" stroke="#555" stroke-width="2"/>
  <!-- 6 verticals -->
  <line x1="166"  y1="1830" x2="166"  y2="1858" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>
  <line x1="499"  y1="1830" x2="499"  y2="1858" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>
  <line x1="666"  y1="1830" x2="666"  y2="1858" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>
  <line x1="999"  y1="1830" x2="999"  y2="1858" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>
  <line x1="1333" y1="1830" x2="1333" y2="1858" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>
  <line x1="1666" y1="1830" x2="1666" y2="1858" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>
  <line x1="1833" y1="1830" x2="1833" y2="1858" stroke="#555" stroke-width="1.5" marker-end="url(#arr)"/>

  <!-- ── ENTITY 1: RETINITIS ── -->
  <rect x="30"  y="1860" width="300" height="230" rx="10" fill="white" stroke="#e65100" stroke-width="2.5" filter="url(#shadow)"/>
  <rect x="30"  y="1860" width="300" height="38" rx="10" fill="#e65100"/>
  <rect x="30"  y="1884" width="300" height="14" fill="#e65100"/>
  <text x="180" y="1884" text-anchor="middle" font-size="14" font-weight="700" fill="white">RETINITIS</text>
  <text x="180" y="1910" text-anchor="middle" font-size="12" font-weight="700" fill="#555">Primary: RETINA</text>
  <text x="180" y="1928" text-anchor="middle" font-size="11" fill="#444">White, full-thickness opacity</text>
  <text x="180" y="1943" text-anchor="middle" font-size="11" fill="#444">Indistinct margins (edema)</text>
  <text x="50"  y="1963" font-size="12" font-weight="700" fill="#e65100">Vitritis: PRESENT</text>
  <text x="50"  y="1980" font-size="11" fill="#444">Infectious examples:</text>
  <text x="50"  y="1996" font-size="11" fill="#444">• CMV retinitis (pizza-pie)</text>
  <text x="50"  y="2011" font-size="11" fill="#444">• ARN (herpes, peripheral)</text>
  <text x="50"  y="2026" font-size="11" fill="#444">• Toxoplasma (focal, white)</text>
  <text x="50"  y="2042" font-size="11" fill="#888" font-style="italic">PORN: vitritis ABSENT</text>
  <text x="50"  y="2058" font-size="11" fill="#444">Non-infectious:</text>
  <text x="50"  y="2073" font-size="11" fill="#444">• Behçet (occlusive)</text>

  <!-- ── ENTITY 2: CHOROIDITIS ── -->
  <rect x="346" y="1860" width="300" height="230" rx="10" fill="white" stroke="#1976d2" stroke-width="2.5" filter="url(#shadow)"/>
  <rect x="346" y="1860" width="300" height="38" rx="10" fill="#1976d2"/>
  <rect x="346" y="1884" width="300" height="14" fill="#1976d2"/>
  <text x="496" y="1884" text-anchor="middle" font-size="14" font-weight="700" fill="white">CHOROIDITIS</text>
  <text x="496" y="1910" text-anchor="middle" font-size="12" font-weight="700" fill="#555">Primary: CHOROID</text>
  <text x="496" y="1928" text-anchor="middle" font-size="11" fill="#444">Yellow, deep to retina</text>
  <text x="496" y="1943" text-anchor="middle" font-size="11" fill="#444">Round nodule; seen through RPE</text>
  <text x="366" y="1963" font-size="12" font-weight="700" fill="#1976d2">Vitritis: ABSENT</text>
  <text x="366" y="1980" font-size="11" fill="#444">White dot syndromes:</text>
  <text x="366" y="1996" font-size="11" fill="#444">• APMPPE (bilateral placoid)</text>
  <text x="366" y="2011" font-size="11" fill="#444">• MEWDS (unilateral, evanescent)</text>
  <text x="366" y="2026" font-size="11" fill="#444">• MFC / PIC (punched-out)</text>
  <text x="366" y="2042" font-size="11" fill="#444">• Serpiginous (geographic)</text>
  <text x="366" y="2058" font-size="11" fill="#444">Infectious:</text>
  <text x="366" y="2073" font-size="11" fill="#444">• Pneumocystis · Cryptococcus</text>

  <!-- ── ENTITY 3: CHORIORETINITIS ── -->
  <rect x="662" y="1860" width="300" height="230" rx="10" fill="white" stroke="#7b1fa2" stroke-width="2.5" filter="url(#shadow)"/>
  <rect x="662" y="1860" width="300" height="38" rx="10" fill="#7b1fa2"/>
  <rect x="662" y="1884" width="300" height="14" fill="#7b1fa2"/>
  <text x="812" y="1884" text-anchor="middle" font-size="13" font-weight="700" fill="white">CHORIORETINITIS</text>
  <text x="812" y="1910" text-anchor="middle" font-size="12" font-weight="700" fill="#555">Choroid → secondary Retina</text>
  <text x="812" y="1928" text-anchor="middle" font-size="11" fill="#444">Starts deep (yellow)</text>
  <text x="812" y="1943" text-anchor="middle" font-size="11" fill="#444">Extends to retina (white)</text>
  <text x="682" y="1963" font-size="12" font-weight="700" fill="#7b1fa2">Vitritis: VARIABLE</text>
  <text x="682" y="1980" font-size="11" fill="#444">• Birdshot chorioretinopathy</text>
  <text x="682" y="1996" font-size="11" fill="#444">  (HLA-A29, cream lesions)</text>
  <text x="682" y="2012" font-size="11" fill="#444">• VKH (exudative RD)</text>
  <text x="682" y="2027" font-size="11" fill="#444">• Sympathetic ophthalmia</text>
  <text x="682" y="2042" font-size="11" fill="#444">• Sarcoidosis</text>
  <text x="682" y="2058" font-size="11" fill="#444">• Histoplasma (infectious)</text>
  <text x="682" y="2073" font-size="11" fill="#888" font-style="italic">Typically BILATERAL</text>

  <!-- ── ENTITY 4: RETINOCHOROIDITIS ── -->
  <rect x="978"  y="1860" width="310" height="230" rx="10" fill="white" stroke="#f57f17" stroke-width="2.5" filter="url(#shadow)"/>
  <rect x="978"  y="1860" width="310" height="38" rx="10" fill="#f57f17"/>
  <rect x="978"  y="1884" width="310" height="14" fill="#f57f17"/>
  <text x="1133" y="1884" text-anchor="middle" font-size="13" font-weight="700" fill="white">RETINOCHOROIDITIS</text>
  <text x="1133" y="1910" text-anchor="middle" font-size="12" font-weight="700" fill="#555">Retina → secondary Choroid</text>
  <text x="1133" y="1928" text-anchor="middle" font-size="11" fill="#444">Starts superficially (white)</text>
  <text x="1133" y="1943" text-anchor="middle" font-size="11" fill="#444">Heals with pigmented scar</text>
  <text x="998"  y="1963" font-size="12" font-weight="700" fill="#e65100">Vitritis: PRESENT (dense)</text>
  <text x="998"  y="1980" font-size="11" fill="#444">Prototype:</text>
  <text x="998"  y="1996" font-size="11" fill="#444">• Toxoplasma retinochoroiditis</text>
  <text x="998"  y="2012" font-size="11" fill="#888" font-style="italic">  "Headlight in fog"</text>
  <text x="998"  y="2028" font-size="11" fill="#444">  White lesion + adjacent old scar</text>
  <text x="998"  y="2043" font-size="11" fill="#444">  = "satellite lesion"</text>
  <text x="998"  y="2058" font-size="11" fill="#444">• Congenital CMV</text>
  <text x="998"  y="2073" font-size="11" fill="#888" font-style="italic">Typically UNILATERAL</text>

  <!-- ── ENTITY 5: NEURORETINITIS ── -->
  <rect x="1304" y="1860" width="310" height="230" rx="10" fill="white" stroke="#00897b" stroke-width="2.5" filter="url(#shadow)"/>
  <rect x="1304" y="1860" width="310" height="38" rx="10" fill="#00897b"/>
  <rect x="1304" y="1884" width="310" height="14" fill="#00897b"/>
  <text x="1459" y="1884" text-anchor="middle" font-size="13" font-weight="700" fill="white">NEURORETINITIS</text>
  <text x="1459" y="1910" text-anchor="middle" font-size="12" font-weight="700" fill="#555">Disc + RNFL + Macular star</text>
  <text x="1459" y="1928" text-anchor="middle" font-size="11" fill="#444">Optic disc edema (papillitis)</text>
  <text x="1459" y="1943" text-anchor="middle" font-size="11" fill="#444">Macular STAR (Henle's layer)</text>
  <text x="1324" y="1963" font-size="12" font-weight="700" fill="#00897b">Vitritis: VARIABLE</text>
  <text x="1324" y="1980" font-size="11" fill="#444">Infectious (#1 Bartonella):</text>
  <text x="1324" y="1996" font-size="11" fill="#444">• Cat-scratch (Bartonella henselae)</text>
  <text x="1324" y="2012" font-size="11" fill="#444">• Lyme disease (Borrelia)</text>
  <text x="1324" y="2027" font-size="11" fill="#444">• Toxocara / DUSN (nematode)</text>
  <text x="1324" y="2042" font-size="11" fill="#444">• Syphilis</text>
  <text x="1324" y="2058" font-size="11" fill="#444">Non-infectious:</text>
  <text x="1324" y="2073" font-size="11" fill="#444">• IRVAN · Sarcoid</text>

  <!-- ── ENTITY 6: RETINAL VASCULITIS ── -->
  <rect x="1630" y="1860" width="330" height="230" rx="10" fill="white" stroke="#c62828" stroke-width="2.5" filter="url(#shadow)"/>
  <rect x="1630" y="1860" width="330" height="38" rx="10" fill="#c62828"/>
  <rect x="1630" y="1884" width="330" height="14" fill="#c62828"/>
  <text x="1795" y="1884" text-anchor="middle" font-size="13" font-weight="700" fill="white">RETINAL VASCULITIS</text>
  <text x="1795" y="1910" text-anchor="middle" font-size="12" font-weight="700" fill="#555">Perivascular sheathing</text>
  <text x="1795" y="1928" text-anchor="middle" font-size="11" fill="#444">Veins &gt; arteries affected</text>
  <text x="1795" y="1943" text-anchor="middle" font-size="11" fill="#444">Branch RVO/RAO may occur</text>
  <text x="1650" y="1963" font-size="12" font-weight="700" fill="#c62828">Vitritis: VARIABLE</text>
  <text x="1650" y="1980" font-size="11" fill="#444">Periphlebitis (veins):</text>
  <text x="1650" y="1996" font-size="11" fill="#444">• Sarcoid (candlewax) · Eales</text>
  <text x="1650" y="2012" font-size="11" fill="#444">• Birdshot · MS</text>
  <text x="1650" y="2027" font-size="11" fill="#444">Arteritis (arteries):</text>
  <text x="1650" y="2043" font-size="11" fill="#444">• ARN · GCA · Churg-Strauss</text>
  <text x="1650" y="2058" font-size="11" fill="#444">Both veins+arteries:</text>
  <text x="1650" y="2073" font-size="11" fill="#444">• Behçet · Susac syndrome</text>

  <!-- ═══════════════════════════════════ QUICK REFERENCE TABLE ═══════════════════════════════════ -->
  <line x1="1000" y1="2090" x2="1000" y2="2124" stroke="#555" stroke-width="2" marker-end="url(#arr)"/>
  <rect x="700" y="2126" width="600" height="40" rx="8" fill="#263238"/>
  <text x="1000" y="2151" text-anchor="middle" font-size="14" font-weight="700" fill="white">QUICK REFERENCE — KEY DIFFERENTIATORS</text>

  <!-- TABLE HEADER -->
  <rect x="30" y="2176" width="1940" height="36" rx="4" fill="#455a64"/>
  <text x="155"  y="2199" text-anchor="middle" font-size="13" font-weight="700" fill="white">Disease</text>
  <text x="435"  y="2199" text-anchor="middle" font-size="13" font-weight="700" fill="white">Entity Type</text>
  <text x="660"  y="2199" text-anchor="middle" font-size="13" font-weight="700" fill="white">Laterality</text>
  <text x="840"  y="2199" text-anchor="middle" font-size="13" font-weight="700" fill="white">Vitritis</text>
  <text x="1230" y="2199" text-anchor="middle" font-size="13" font-weight="700" fill="white">Pathognomonic / Key Feature</text>
  <text x="1780" y="2199" text-anchor="middle" font-size="13" font-weight="700" fill="white">Infective?</text>
  <!-- column lines -->
  <line x1="280"  y1="2176" x2="280"  y2="3050" stroke="#cfd8dc" stroke-width="1"/>
  <line x1="590"  y1="2176" x2="590"  y2="3050" stroke="#cfd8dc" stroke-width="1"/>
  <line x1="740"  y1="2176" x2="740"  y2="3050" stroke="#cfd8dc" stroke-width="1"/>
  <line x1="930"  y1="2176" x2="930"  y2="3050" stroke="#cfd8dc" stroke-width="1"/>
  <line x1="1700" y1="2176" x2="1700" y2="3050" stroke="#cfd8dc" stroke-width="1"/>

  <!-- rows -->
  <!-- row helper macro — alternating fills -->
  <!-- Row 1 -->
  <rect x="30" y="2212" width="1940" height="30" fill="#fafafa"/>
  <text x="155"  y="2232" text-anchor="middle" font-size="12" font-weight="700" fill="#bf360c">Toxoplasma</text>
  <text x="435"  y="2232" text-anchor="middle" font-size="12" fill="#333">Retinochoroiditis</text>
  <text x="660"  y="2232" text-anchor="middle" font-size="12" fill="#333">Unilateral</text>
  <text x="840"  y="2232" text-anchor="middle" font-size="12" fill="#e65100">Dense focal</text>
  <text x="1310" y="2232" text-anchor="middle" font-size="12" fill="#333">"Headlight in fog"; white lesion + adjacent pigmented satellite scar</text>
  <text x="1780" y="2232" text-anchor="middle" font-size="12" fill="#c62828" font-weight="700">Yes (parasite)</text>

  <!-- Row 2 -->
  <rect x="30" y="2242" width="1940" height="30" fill="#f1f8e9"/>
  <text x="155"  y="2262" text-anchor="middle" font-size="12" font-weight="700" fill="#bf360c">CMV Retinitis</text>
  <text x="435"  y="2262" text-anchor="middle" font-size="12" fill="#333">Retinitis</text>
  <text x="660"  y="2262" text-anchor="middle" font-size="12" fill="#333">Uni → Bilateral</text>
  <text x="840"  y="2262" text-anchor="middle" font-size="12" fill="#2e7d32">Mild</text>
  <text x="1310" y="2262" text-anchor="middle" font-size="12" fill="#333">"Pizza-pie" granular hemorrhagic patches; immunocompromised (CD4 &lt;50)</text>
  <text x="1780" y="2262" text-anchor="middle" font-size="12" fill="#c62828" font-weight="700">Yes (viral)</text>

  <!-- Row 3 -->
  <rect x="30" y="2272" width="1940" height="30" fill="#fafafa"/>
  <text x="155"  y="2292" text-anchor="middle" font-size="12" font-weight="700" fill="#bf360c">ARN</text>
  <text x="435"  y="2292" text-anchor="middle" font-size="12" fill="#333">Necrotizing retinitis</text>
  <text x="660"  y="2292" text-anchor="middle" font-size="12" fill="#333">Uni (33% bilateral)</text>
  <text x="840"  y="2292" text-anchor="middle" font-size="12" fill="#e65100">Marked</text>
  <text x="1310" y="2292" text-anchor="middle" font-size="12" fill="#333">Peripheral white patches; occlusive arteritis; rapid; HSV/VZV</text>
  <text x="1780" y="2292" text-anchor="middle" font-size="12" fill="#c62828" font-weight="700">Yes (viral)</text>

  <!-- Row 4 -->
  <rect x="30" y="2302" width="1940" height="30" fill="#f1f8e9"/>
  <text x="155"  y="2322" text-anchor="middle" font-size="12" font-weight="700" fill="#bf360c">PORN</text>
  <text x="435"  y="2322" text-anchor="middle" font-size="12" fill="#333">Outer retinitis</text>
  <text x="660"  y="2322" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2322" text-anchor="middle" font-size="12" fill="#2e7d32">ABSENT</text>
  <text x="1310" y="2322" text-anchor="middle" font-size="12" fill="#333">Deep opacification; spares vessels; clear vitreous; severe HIV; VZV</text>
  <text x="1780" y="2322" text-anchor="middle" font-size="12" fill="#c62828" font-weight="700">Yes (VZV)</text>

  <!-- Row 5 -->
  <rect x="30" y="2332" width="1940" height="30" fill="#fafafa"/>
  <text x="155"  y="2352" text-anchor="middle" font-size="12" font-weight="700" fill="#004d40">Bartonella</text>
  <text x="435"  y="2352" text-anchor="middle" font-size="12" fill="#333">Neuroretinitis</text>
  <text x="660"  y="2352" text-anchor="middle" font-size="12" fill="#333">Unilateral</text>
  <text x="840"  y="2352" text-anchor="middle" font-size="12" fill="#888">Mild</text>
  <text x="1310" y="2352" text-anchor="middle" font-size="12" fill="#333">Disc edema + macular STAR; #1 cause of neuroretinitis; cat exposure</text>
  <text x="1780" y="2352" text-anchor="middle" font-size="12" fill="#c62828" font-weight="700">Yes (bacterial)</text>

  <!-- Row 6 -->
  <rect x="30" y="2362" width="1940" height="30" fill="#f1f8e9"/>
  <text x="155"  y="2382" text-anchor="middle" font-size="12" font-weight="700" fill="#c62828">Syphilis</text>
  <text x="435"  y="2382" text-anchor="middle" font-size="12" fill="#333">Any pattern</text>
  <text x="660"  y="2382" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2382" text-anchor="middle" font-size="12" fill="#888">Variable</text>
  <text x="1310" y="2382" text-anchor="middle" font-size="12" fill="#333">"Great imitator"; retinitis / chorioretinitis / vasculitis / neuroretinitis</text>
  <text x="1780" y="2382" text-anchor="middle" font-size="12" fill="#c62828" font-weight="700">Yes (bacterial)</text>

  <!-- Row 7 -->
  <rect x="30" y="2392" width="1940" height="30" fill="#fafafa"/>
  <text x="155"  y="2412" text-anchor="middle" font-size="12" font-weight="700" fill="#c62828">TB</text>
  <text x="435"  y="2412" text-anchor="middle" font-size="12" fill="#333">Choroiditis / vasculitis</text>
  <text x="660"  y="2412" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2412" text-anchor="middle" font-size="12" fill="#888">Variable</text>
  <text x="1310" y="2412" text-anchor="middle" font-size="12" fill="#333">Choroidal tubercles; periphlebitis; systemic TB signs</text>
  <text x="1780" y="2412" text-anchor="middle" font-size="12" fill="#c62828" font-weight="700">Yes (bacterial)</text>

  <!-- Row 8 -->
  <rect x="30" y="2422" width="1940" height="30" fill="#f1f8e9"/>
  <text x="155"  y="2442" text-anchor="middle" font-size="12" font-weight="700" fill="#4a148c">Birdshot</text>
  <text x="435"  y="2442" text-anchor="middle" font-size="12" fill="#333">Chorioretinitis</text>
  <text x="660"  y="2442" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2442" text-anchor="middle" font-size="12" fill="#e65100">Present</text>
  <text x="1310" y="2442" text-anchor="middle" font-size="12" fill="#333">Cream-colored lesions radiating from disc; HLA-A29; periphlebitis</text>
  <text x="1780" y="2442" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No (autoimmune)</text>

  <!-- Row 9 -->
  <rect x="30" y="2452" width="1940" height="30" fill="#fafafa"/>
  <text x="155"  y="2472" text-anchor="middle" font-size="12" font-weight="700" fill="#4a148c">VKH</text>
  <text x="435"  y="2472" text-anchor="middle" font-size="12" fill="#333">Chorioretinitis</text>
  <text x="660"  y="2472" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2472" text-anchor="middle" font-size="12" fill="#e65100">Present</text>
  <text x="1310" y="2472" text-anchor="middle" font-size="12" fill="#333">Exudative RD; sunset glow fundus; poliosis; tinnitus; vitiligo</text>
  <text x="1780" y="2472" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No (autoimmune)</text>

  <!-- Row 10 -->
  <rect x="30" y="2482" width="1940" height="30" fill="#f1f8e9"/>
  <text x="155"  y="2502" text-anchor="middle" font-size="12" font-weight="700" fill="#4a148c">Sympathetic Ophthal.</text>
  <text x="435"  y="2502" text-anchor="middle" font-size="12" fill="#333">Chorioretinitis</text>
  <text x="660"  y="2502" text-anchor="middle" font-size="12" fill="#333">Bilateral (post-trauma)</text>
  <text x="840"  y="2502" text-anchor="middle" font-size="12" fill="#e65100">Present</text>
  <text x="1310" y="2502" text-anchor="middle" font-size="12" fill="#333">Bilateral granulomatous uveitis; Dalen-Fuchs nodules; penetrating injury</text>
  <text x="1780" y="2502" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No (autoimmune)</text>

  <!-- Row 11 -->
  <rect x="30" y="2512" width="1940" height="30" fill="#fafafa"/>
  <text x="155"  y="2532" text-anchor="middle" font-size="12" font-weight="700" fill="#1565c0">Sarcoidosis</text>
  <text x="435"  y="2532" text-anchor="middle" font-size="12" fill="#333">Chorioretinitis + Vasculitis</text>
  <text x="660"  y="2532" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2532" text-anchor="middle" font-size="12" fill="#e65100">Present</text>
  <text x="1310" y="2532" text-anchor="middle" font-size="12" fill="#333">"Candlewax drippings"; periphlebitis; disc granulomas; ACE elevated</text>
  <text x="1780" y="2532" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No (granulomatous)</text>

  <!-- Row 12 -->
  <rect x="30" y="2542" width="1940" height="30" fill="#f1f8e9"/>
  <text x="155"  y="2562" text-anchor="middle" font-size="12" font-weight="700" fill="#c62828">Behçet</text>
  <text x="435"  y="2562" text-anchor="middle" font-size="12" fill="#333">Occlusive vasculitis</text>
  <text x="660"  y="2562" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2562" text-anchor="middle" font-size="12" fill="#e65100">Marked</text>
  <text x="1310" y="2562" text-anchor="middle" font-size="12" fill="#333">Occlusive vasculitis; hypopyon; oral/genital ulcers; devastating prognosis</text>
  <text x="1780" y="2562" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No (vasculitis)</text>

  <!-- Row 13 -->
  <rect x="30" y="2572" width="1940" height="30" fill="#fafafa"/>
  <text x="155"  y="2592" text-anchor="middle" font-size="12" font-weight="700" fill="#1976d2">APMPPE</text>
  <text x="435"  y="2592" text-anchor="middle" font-size="12" fill="#333">Choroiditis</text>
  <text x="660"  y="2592" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2592" text-anchor="middle" font-size="12" fill="#2e7d32">Mild</text>
  <text x="1310" y="2592" text-anchor="middle" font-size="12" fill="#333">Bilateral placoid sub-RPE lesions; post-viral; self-limiting; young adults</text>
  <text x="1780" y="2592" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No</text>

  <!-- Row 14 -->
  <rect x="30" y="2602" width="1940" height="30" fill="#f1f8e9"/>
  <text x="155"  y="2622" text-anchor="middle" font-size="12" font-weight="700" fill="#1976d2">Serpiginous</text>
  <text x="435"  y="2622" text-anchor="middle" font-size="12" fill="#333">Choroiditis</text>
  <text x="660"  y="2622" text-anchor="middle" font-size="12" fill="#333">Bilateral (asymm.)</text>
  <text x="840"  y="2622" text-anchor="middle" font-size="12" fill="#2e7d32">ABSENT</text>
  <text x="1310" y="2622" text-anchor="middle" font-size="12" fill="#333">Geographic peripapillary spread; recurrent; no vitritis</text>
  <text x="1780" y="2622" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No</text>

  <!-- Row 15 -->
  <rect x="30" y="2632" width="1940" height="30" fill="#fafafa"/>
  <text x="155"  y="2652" text-anchor="middle" font-size="12" font-weight="700" fill="#1976d2">MEWDS</text>
  <text x="435"  y="2652" text-anchor="middle" font-size="12" fill="#333">Choroiditis/outer retina</text>
  <text x="660"  y="2652" text-anchor="middle" font-size="12" fill="#333">UNILATERAL</text>
  <text x="840"  y="2652" text-anchor="middle" font-size="12" fill="#2e7d32">Mild</text>
  <text x="1310" y="2652" text-anchor="middle" font-size="12" fill="#333">Multiple evanescent white dots; young myopic women; self-resolving</text>
  <text x="1780" y="2652" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No</text>

  <!-- Row 16 -->
  <rect x="30" y="2662" width="1940" height="30" fill="#f1f8e9"/>
  <text x="155"  y="2682" text-anchor="middle" font-size="12" font-weight="700" fill="#c62828">Eales Disease</text>
  <text x="435"  y="2682" text-anchor="middle" font-size="12" fill="#333">Retinal vasculitis</text>
  <text x="660"  y="2682" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2682" text-anchor="middle" font-size="12" fill="#e65100">Present</text>
  <text x="1310" y="2682" text-anchor="middle" font-size="12" fill="#333">Peripheral periphlebitis; neovascularization; vitreous hemorrhage; young men</text>
  <text x="1780" y="2682" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No (idiopathic)</text>

  <!-- Row 17 -->
  <rect x="30" y="2692" width="1940" height="30" fill="#fafafa"/>
  <text x="155"  y="2712" text-anchor="middle" font-size="12" font-weight="700" fill="#c62828">Susac Syndrome</text>
  <text x="435"  y="2712" text-anchor="middle" font-size="12" fill="#333">Arterial vasculitis</text>
  <text x="660"  y="2712" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2712" text-anchor="middle" font-size="12" fill="#888">Variable</text>
  <text x="1310" y="2712" text-anchor="middle" font-size="12" fill="#333">Retinal artery occlusions + sensorineural hearing loss + encephalopathy</text>
  <text x="1780" y="2712" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No (autoimmune)</text>

  <!-- Row 18 -->
  <rect x="30" y="2722" width="1940" height="30" fill="#f1f8e9"/>
  <text x="155"  y="2742" text-anchor="middle" font-size="12" font-weight="700" fill="#004d40">IRVAN</text>
  <text x="435"  y="2742" text-anchor="middle" font-size="12" fill="#333">Neuroretinitis</text>
  <text x="660"  y="2742" text-anchor="middle" font-size="12" fill="#333">Bilateral</text>
  <text x="840"  y="2742" text-anchor="middle" font-size="12" fill="#888">Variable</text>
  <text x="1310" y="2742" text-anchor="middle" font-size="12" fill="#333">Disc aneurysms + macular star exudate; arteritis; exudative retinopathy</text>
  <text x="1780" y="2742" text-anchor="middle" font-size="12" fill="#1565c0" font-weight="700">No (idiopathic)</text>

  <!-- table bottom border -->
  <rect x="30" y="2752" width="1940" height="2" fill="#546e7a"/>

  <!-- ═══════════════════════════════════ LEGEND ═══════════════════════════════════ -->
  <rect x="30" y="2768" width="1940" height="72" rx="10" fill="#eceff1"/>
  <text x="1000" y="2792" text-anchor="middle" font-size="13" font-weight="700" fill="#37474f">LEGEND</text>
  <rect x="60"  y="2804" width="14" height="14" rx="3" fill="#e65100"/>
  <text x="82"  y="2816" font-size="12" fill="#333">Retinitis (primary retinal)</text>
  <rect x="290" y="2804" width="14" height="14" rx="3" fill="#1976d2"/>
  <text x="312" y="2816" font-size="12" fill="#333">Choroiditis (primary choroidal)</text>
  <rect x="570" y="2804" width="14" height="14" rx="3" fill="#7b1fa2"/>
  <text x="592" y="2816" font-size="12" fill="#333">Chorioretinitis / Retinochoroiditis</text>
  <rect x="860" y="2804" width="14" height="14" rx="3" fill="#00897b"/>
  <text x="882" y="2816" font-size="12" fill="#333">Neuroretinitis</text>
  <rect x="1060" y="2804" width="14" height="14" rx="3" fill="#c62828"/>
  <text x="1082" y="2816" font-size="12" fill="#333">Retinal Vasculitis</text>
  <rect x="1270" y="2804" width="14" height="14" rx="3" fill="#c62828"/>
  <text x="1292" y="2816" font-size="12" fill="#333">Infectious etiology</text>
  <rect x="1480" y="2804" width="14" height="14" rx="3" fill="#1565c0"/>
  <text x="1502" y="2816" font-size="12" fill="#333">Non-infectious / autoimmune</text>
  <rect x="1760" y="2804" width="14" height="14" rx="3" fill="#43a047"/>
  <text x="1782" y="2816" font-size="12" fill="#333">Focal pattern</text>

  <!-- footer -->
  <text x="1000" y="2870" text-anchor="middle" font-size="11" fill="#90a4ae">
    Sources: Kanski's Clinical Ophthalmology 10th Ed. | Wills Eye Manual | Firestein &amp; Kelley's Textbook of Rheumatology
  </text>
  <text x="1000" y="2888" text-anchor="middle" font-size="11" fill="#90a4ae">
    ARN = Acute Retinal Necrosis · PORN = Progressive Outer Retinal Necrosis · VKH = Vogt-Koyanagi-Harada · IRVAN = Idiopathic Retinal Vasculitis Aneurysms Neuroretinitis
  </text>
  <text x="1000" y="2906" text-anchor="middle" font-size="11" fill="#90a4ae">
    APMPPE = Acute Post. Multifocal Placoid Pigment Epitheliopathy · MEWDS = Multiple Evanescent White Dot Syndrome · MFC = Multifocal Choroiditis · PIC = Punctate Inner Choroidopathy
  </text>
  <text x="1000" y="2924" text-anchor="middle" font-size="11" fill="#90a4ae">
    DUSN = Diffuse Unilateral Subacute Neuroretinitis · GCA = Giant Cell Arteritis · RD = Retinal Detachment · RPE = Retinal Pigment Epithelium
  </text>

</svg>

<h2>Posterior Uveitis — Single Unified Flowchart | Kanski's Clinical Ophthalmology 10th Ed. | Wills Eye Manual</h2>
</div>
</body>
</html>

Running Command

ls -lh /home/daytona/workspace/posterior-uveitis-flowchart/

Here is the single unified flowchart:

single flowchart

HTML File · HTML

The flowchart is one continuous top-to-bottom SVG (2000 × 3100 px) with everything connected by arrows. Here is how it flows:

POSTERIOR UVEITIS (root)
        │
STEP 1 — VITRITIS?
    ├──── WITH VITRITIS ──────────────────────── WITHOUT VITRITIS
    │     (Primary retinal, white lesion)         (Primary choroidal, yellow lesion)
        │
STEP 2 — PRIMARY SITE (colour clue boxes)
        │
STEP 3 — DISTRIBUTION PATTERN
    ├── FOCAL/SOLITARY  ├── MULTIFOCAL  ├── GEOGRAPHIC  └── DIFFUSE
        │
STEP 4 — INFECTIOUS vs NON-INFECTIOUS (two parallel columns)
    ┌────────────────────────────┐     ┌────────────────────────────────┐
    │ INFECTIOUS                 │     │ NON-INFECTIOUS                 │
    │ • Retinitis                │     │ • White dot syndromes          │
    │   (Toxoplasma, CMV,        │     │   (APMPPE, MEWDS, Serpiginous, │
    │    ARN, PORN)              │     │    MFC, PIC)                   │
    │ • Choroiditis              │     │ • Chorioretinitis              │
    │   (PCP, Crypto, TB)        │     │   (Birdshot, VKH, Sympathetic) │
    │ • Neuroretinitis           │     │ • Vasculitis + Neuroretinitis  │
    │   (Bartonella, DUSN)       │     │   (Sarcoid, Eales, Behçet,     │
    │ • Vasculitis (Syphilis)    │     │    IRVAN)                      │
    └────────────────────────────┘     └────────────────────────────────┘
        │
STEP 5 — LATERALITY
    ├── UNILATERAL                       BILATERAL
    │   (Toxoplasma, CMV early,          (VKH, Birdshot, Sarcoid,
    │    ARN, Bartonella, DUSN,          Sympathetic, Behçet, Susac,
    │    MEWDS, PIC)                     APMPPE, Serpiginous, TB, Syphilis)
        │
STEP 6 — ENTITY DEFINITIONS (6 boxes side by side)
    RETINITIS | CHOROIDITIS | CHORIORETINITIS | RETINOCHOROIDITIS | NEURORETINITIS | VASCULITIS
        │
QUICK REFERENCE TABLE (18-disease comparison)
    Disease | Entity | Laterality | Vitritis | Key Feature | Infectious?

Open the HTML file in any browser - it renders at full resolution and is printable (A1/A0 poster size). Use Ctrl+scroll to zoom individual sections.

hml file is not opening, give me text format and photo

Running Command

python3 << 'EOF' import matplotlib matplotlib.use('Agg') import matplotlib.pyplot as plt import matplotlib.patches as mpatches from matplotlib.patches import FancyBboxPatch, FancyArrowPatch import numpy as np fig, ax = plt.subplots(figsize=(28, 52)) ax.set_xlim(0, 28) ax.set_ylim(0, 52) ax.axis('off') fig.patch.set_facecolor('#f5f7fa') ax.set_facecolor('#f5f7fa') def box(ax, x, y, w, h, text, facecolor, textcolor='white', fontsize=9, bold=True, radius=0.3, lines=None, linecolors=None): bp = FancyBboxPatch((x, y), w, h, boxstyle=f"round,pad=0.05,rounding_size={radius}", facecolor=facecolor, edgecolor='#cccccc', linewidth=0.8, zorder=3) ax.add_patch(bp) if lines: total = len(lines) step = h / (total + 1) for i, (ln, lc) in enumerate(zip(lines, linecolors or ['white']*total)): fw = 'bold' if bold and i == 0 else 'normal' ax.text(x + w/2, y + h - (i+1)*step, ln, ha='center', va='center', fontsize=fontsize if i > 0 else fontsize+0.5, color=lc, fontweight=fw, zorder=4, wrap=True) else: ax.text(x + w/2, y + h/2, text, ha='center', va='center', fontsize=fontsize, color=textcolor, fontweight='bold' if bold else 'normal', zorder=4, multialignment='center') def arrow(ax, x1, y1, x2, y2, color='#444444'): ax.annotate('', xy=(x2, y2), xytext=(x1, y1), arrowprops=dict(arrowstyle='->', color=color, lw=1.5), zorder=2) def hline(ax, x1, x2, y, color='#555555'): ax.plot([x1, x2], [y, y], color=color, lw=1.5, zorder=2) def vline(ax, x, y1, y2, color='#555555'): ax.plot([x, x], [y1, y2], color=color, lw=1.5, zorder=2) # ─── TITLE ─── box(ax, 8, 49.8, 12, 1.8, 'POSTERIOR UVEITIS\nRetinitis · Choroiditis · Vasculitis · Neuroretinitis', '#b71c1c', fontsize=13) arrow(ax, 14, 49.8, 14, 49.2) # ─── STEP 1: VITRITIS ─── box(ax, 10, 48.4, 8, 0.9, 'STEP 1 — VITRITIS?', '#37474f', fontsize=10) vline(ax, 14, 48.4, 48.0) hline(ax, 5, 23, 48.0) vline(ax, 5, 48.0, 47.6) vline(ax, 23, 48.0, 47.6) box(ax, 2, 46.2, 6.5, 1.5, 'WITH VITRITIS\n(Primary RETINAL disease)\nWhite lesion · Vitritis present', '#e65100', fontsize=8.5) box(ax, 19.5, 46.2, 6.5, 1.5, 'WITHOUT VITRITIS\n(Primary CHOROIDAL disease)\nYellow lesion · Clear vitreous', '#1565c0', fontsize=8.5) arrow(ax, 14, 46.2, 14, 45.7) # ─── STEP 2: SITE & COLOUR ─── box(ax, 9, 44.8, 10, 1.0, 'STEP 2 — PRIMARY SITE / LESION COLOUR', '#546e7a', fontsize=9) # colour clues row box(ax, 0.3, 43.3, 8.5, 1.0, '⬜ WHITE = RETINAL\nFull-thickness opacity · indistinct margins', '#fff3e0', textcolor='#bf360c', fontsize=8, bold=False) box(ax, 9.75, 43.3, 8.5, 1.0, '🟡 YELLOW = CHOROIDAL\nDeep · round nodule · seen through RPE', '#fff9c4', textcolor='#e65100', fontsize=8, bold=False) box(ax, 19.2, 43.3, 8.5, 1.0, '🟫 PIGMENTED = HEALED SCAR\nLong-standing · old chorioretinal damage', '#efebe9', textcolor='#4e342e', fontsize=8, bold=False) arrow(ax, 14, 43.3, 14, 42.8) # ─── STEP 3: PATTERN ─── box(ax, 9, 42.0, 10, 0.9, 'STEP 3 — DISTRIBUTION PATTERN', '#37474f', fontsize=9) vline(ax, 14, 42.0, 41.7) hline(ax, 3.5, 24.5, 41.7) for xp in [3.5, 10, 18, 24.5]: vline(ax, xp, 41.7, 41.4) box(ax, 1.0, 40.0, 5.5, 1.5, 'FOCAL / SOLITARY\nSingle lesion\nToxoplasma (classic)', '#f9fbe7', textcolor='#2e7d32', fontsize=8, bold=False) box(ax, 7.3, 40.0, 5.5, 1.5, 'MULTIFOCAL\nMultiple discrete\nSarcoid · Syphilis · MEWDS', '#fff8e1', textcolor='#e65100', fontsize=8, bold=False) box(ax, 15.2, 40.0, 5.5, 1.5, 'GEOGRAPHIC\nMap-like spread\nSerpiginous choroiditis', '#f3e5f5', textcolor='#6a1b9a', fontsize=8, bold=False) box(ax, 21.8, 40.0, 5.5, 1.5, 'DIFFUSE\nWidespread retina\nCMV · ARN · PORN', '#ffebee', textcolor='#c62828', fontsize=8, bold=False) arrow(ax, 14, 40.0, 14, 39.4) # ─── STEP 4: INFECTIOUS vs NON-INFECTIOUS ─── box(ax, 8, 38.6, 12, 0.9, 'STEP 4 — INFECTIOUS vs NON-INFECTIOUS', '#37474f', fontsize=9) vline(ax, 14, 38.6, 38.2) hline(ax, 1, 27, 38.2) vline(ax, 1, 38.2, 37.8) vline(ax, 27, 38.2, 37.8) # ── INFECTIOUS COLUMN (left) ── box(ax, 0.2, 37.0, 13.3, 0.9, '🦠 INFECTIOUS POSTERIOR UVEITIS', '#c62828', fontsize=10) # Retinitis sub-header box(ax, 0.2, 35.7, 13.3, 0.8, 'RETINITIS (Primary Retinal · Vitritis PRESENT)', '#e65100', fontsize=8.5) # 3 disease sub-boxes box(ax, 0.2, 33.2, 4.1, 2.6, '', '#fff8f0', lines=['Toxoplasma', 'Retinochoroiditis', '─────────────', '"Headlight in fog"', 'Focal white + vitritis', 'Adjacent pigment scar', '(satellite lesion)', 'Unilateral · FOCAL'], linecolors=['#bf360c','#bf360c','#ccc','#333','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 4.6, 33.2, 4.1, 2.6, '', '#fff8f0', lines=['CMV Retinitis', '(immunocompromised)', '─────────────', '"Pizza-pie" fundus', 'Granular + hemorrhage', 'Vitritis: MILD', 'Frosted branch angiitis', 'Uni→Bilateral · Diffuse'], linecolors=['#bf360c','#555','#ccc','#333','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 9.1, 33.2, 4.3, 2.6, '', '#fff8f0', lines=['ARN / PORN (Herpes)', 'HSV/VZV (ARN), VZV (PORN)', '─────────────', 'ARN: peripheral necrosis', 'Marked vitritis; arteritis', 'PORN: NO vitritis', 'Deep opacification; HIV', 'ARN: Uni (33% bilateral)'], linecolors=['#bf360c','#555','#ccc','#333','#333','#333','#333','#888'], fontsize=7.5, bold=False) # Choroiditis sub-header box(ax, 0.2, 32.4, 13.3, 0.8, 'CHOROIDITIS (Primary Choroidal · Vitritis ABSENT)', '#1976d2', fontsize=8.5) box(ax, 0.2, 30.7, 4.1, 1.8, '', '#e3f2fd', lines=['Pneumocystis', 'Choroiditis', '─────', 'Bilateral yellow lesions', 'No vitritis · AIDS (CD4<50)', 'Bilateral · Multifocal'], linecolors=['#0d47a1','#555','#ccc','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 4.6, 30.7, 4.1, 1.8, '', '#e3f2fd', lines=['Cryptococcal', 'Choroiditis', '─────', 'Deep yellow lesions', 'Immunocompromised', 'Bilateral · Multifocal'], linecolors=['#0d47a1','#555','#ccc','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 9.1, 30.7, 4.3, 1.8, '', '#e3f2fd', lines=['TB Choroiditis', '', '─────', 'Choroidal tubercles', 'Yellow-white deep lesions', 'Bilateral · ± Periphlebitis'], linecolors=['#0d47a1','#555','#ccc','#333','#333','#888'], fontsize=7.5, bold=False) # Neuroretinitis (infectious) box(ax, 0.2, 29.9, 13.3, 0.8, 'NEURORETINITIS + CHORIORETINITIS (Infectious)', '#7b1fa2', fontsize=8.5) box(ax, 0.2, 28.0, 4.1, 2.0, '', '#e0f2f1', lines=['Bartonella', '(Cat-scratch)', '─────────────', '#1 cause of neuroretinitis', 'Disc edema + Macular STAR', 'Stellate in Henle\'s layer', 'Cat exposure', 'Unilateral'], linecolors=['#004d40','#555','#ccc','#333','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 4.6, 28.0, 4.1, 2.0, '', '#e0f2f1', lines=['Toxocara / DUSN', 'Nematode', '─────────────', 'Children / young adults', 'Optic nerve swelling', 'Gray-white retinal lesions', '→ Optic atrophy (late)', 'Unilateral'], linecolors=['#004d40','#555','#ccc','#333','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 9.1, 28.0, 4.3, 2.0, '', '#f3e5f5', lines=['Syphilis', '"Great Imitator"', '─────────────', 'Any pattern of PU', 'Retinitis / Chorioretinitis', 'Vasculitis / Neuroretinitis', 'Must exclude in ALL PU', 'Bilateral · Multifocal'], linecolors=['#4a148c','#555','#ccc','#333','#333','#333','#333','#888'], fontsize=7.5, bold=False) # ── NON-INFECTIOUS COLUMN (right) ── box(ax, 14.5, 37.0, 13.3, 0.9, '🔵 NON-INFECTIOUS POSTERIOR UVEITIS', '#1565c0', fontsize=10) # White dot syndromes box(ax, 14.5, 35.7, 13.3, 0.8, 'WHITE DOT SYNDROMES (Choroiditis · Vitritis absent/mild)', '#1976d2', fontsize=8.5) box(ax, 14.5, 33.8, 3.1, 2.0, '', '#e3f2fd', lines=['APMPPE', '', 'Bilateral placoid', 'Sub-RPE lesions', 'Post-viral, young', 'Self-limiting'], linecolors=['#0d47a1','#555','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 17.9, 33.8, 3.1, 2.0, '', '#e3f2fd', lines=['MEWDS', '', 'Outer retina/choroid', 'Young myopic women', 'Evanescent; self-resolves', 'UNILATERAL'], linecolors=['#0d47a1','#555','#333','#333','#333','#c62828'], fontsize=7.5, bold=False) box(ax, 21.3, 33.8, 3.1, 2.0, '', '#e3f2fd', lines=['Serpiginous', '', 'Geographic; peripapillary', 'Recurrent; no vitritis', 'Bilateral (asymmetric)', 'GEOGRAPHIC'], linecolors=['#0d47a1','#555','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 24.5, 33.8, 3.2, 2.0, '', '#e3f2fd', lines=['MFC / PIC', '', 'MFC: punched-out scars', 'PIC: small punctate', 'Both: myopic women', 'Bilateral · Multifocal'], linecolors=['#0d47a1','#555','#333','#333','#333','#888'], fontsize=7.5, bold=False) # Chorioretinitis box(ax, 14.5, 33.0, 13.3, 0.8, 'CHORIORETINITIS / RETINOCHOROIDITIS (Non-infectious)', '#7b1fa2', fontsize=8.5) box(ax, 14.5, 30.9, 4.1, 2.2, '', '#f3e5f5', lines=['Birdshot', 'Chorioretinopathy', '─────────────', 'HLA-A29 (strongly assoc.)', 'Cream lesions from disc', 'Bilateral periphlebitis', 'Vitritis present', 'Bilateral · Multifocal'], linecolors=['#4a148c','#555','#ccc','#333','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 18.9, 30.9, 4.1, 2.2, '', '#f3e5f5', lines=['VKH Syndrome', '', '─────────────', 'Bilateral exudative RD', 'Granulomatous (mutton-fat KPs)', 'Poliosis · tinnitus · vitiligo', 'Sunset-glow fundus (late)', 'Bilateral · Diffuse'], linecolors=['#4a148c','#555','#ccc','#333','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 23.3, 30.9, 4.3, 2.2, '', '#f3e5f5', lines=['Sympathetic Ophthalmia', '', '─────────────', 'Post-penetrating trauma', 'Bilateral granulomatous', 'Dalen-Fuchs nodules (RPE)', 'Exciting + sympathizing eye', 'Bilateral'], linecolors=['#4a148c','#555','#ccc','#333','#333','#333','#333','#888'], fontsize=7.5, bold=False) # Vasculitis (non-infect) box(ax, 14.5, 30.1, 13.3, 0.8, 'RETINAL VASCULITIS + NEURORETINITIS (Non-infectious)', '#c62828', fontsize=8.5) box(ax, 14.5, 28.3, 3.1, 1.9, '', '#fce4ec', lines=['Sarcoidosis', '', '"Candlewax" periphlebitis', 'Disc granulomas', 'ACE elevated', 'Bilateral'], linecolors=['#880e4f','#555','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 17.9, 28.3, 3.1, 1.9, '', '#fce4ec', lines=['Eales Disease', '', 'Peripheral periphlebitis', 'Neovascularization', 'Young men; idiopathic', 'Bilateral'], linecolors=['#880e4f','#555','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 21.3, 28.3, 3.1, 1.9, '', '#fce4ec', lines=['Behçet Disease', '', 'Occlusive vasculitis', 'Oral/genital ulcers', 'Bilateral; devastating', 'Bilateral'], linecolors=['#880e4f','#555','#333','#333','#333','#888'], fontsize=7.5, bold=False) box(ax, 24.5, 28.3, 3.2, 1.9, '', '#e0f2f1', lines=['IRVAN', '', 'Disc aneurysms', 'Macular star', 'Arteritis', 'Neuroretinitis'], linecolors=['#004d40','#555','#333','#333','#333','#888'], fontsize=7.5, bold=False) # ─── STEP 5: LATERALITY ─── arrow(ax, 14, 28.0, 14, 27.4) box(ax, 9, 26.6, 10, 0.9, 'STEP 5 — LATERALITY', '#37474f', fontsize=9) vline(ax, 14, 26.6, 26.2) hline(ax, 4.5, 23.5, 26.2) vline(ax, 4.5, 26.2, 25.9) vline(ax, 23.5, 26.2, 25.9) box(ax, 0.2, 23.2, 8.5, 2.8, '', '#ede7f6', lines=['UNILATERAL', '', '• Toxoplasma retinochoroiditis', '• CMV retinitis (early)', '• ARN (often starts unilateral)', '• PORN', '• Bartonella neuroretinitis', '• Toxocara / DUSN', '• MEWDS · PIC', '• Frosted branch angiitis'], linecolors=['#4a148c','#555','#333','#333','#333','#333','#333','#333','#333','#333'], fontsize=8, bold=False) box(ax, 19.3, 23.2, 8.5, 2.8, '', '#e8f5e9', lines=['BILATERAL (typical)', '', '• VKH syndrome', '• Sympathetic ophthalmia', '• Birdshot chorioretinopathy', '• Sarcoidosis', '• APMPPE · Serpiginous · MFC', '• Behçet · Susac syndrome', '• CMV retinitis (advanced AIDS)', '• Syphilis · TB'], linecolors=['#2e7d32','#555','#333','#333','#333','#333','#333','#333','#333','#333'], fontsize=8, bold=False) # ─── STEP 6: ENTITY DEFINITIONS ─── arrow(ax, 14, 23.2, 14, 22.6) box(ax, 7.5, 21.8, 13, 0.9, 'STEP 6 — CLINICAL ENTITY DEFINITIONS', '#37474f', fontsize=9) vline(ax, 14, 21.8, 21.4) hline(ax, 1.2, 26.8, 21.4) for xp in [1.2, 5.8, 10.4, 14.3, 18.8, 23.3]: vline(ax, xp, 21.4, 21.1) ew = 4.3 eg = 0.2 ex_start = 0.3 for i, (title, body_lines, col, tcol) in enumerate([ ('RETINITIS', [ 'Primary: RETINA', 'White full-thickness opacity', 'Indistinct margins (edema)', 'Vitritis: PRESENT', '• CMV (pizza-pie)', '• ARN (peripheral)', '• Toxoplasma (focal)', 'PORN: vitritis ABSENT'], '#fff3e0', '#bf360c'), ('CHOROIDITIS', [ 'Primary: CHOROID', 'Yellow nodule deep to retina', 'Seen through RPE', 'Vitritis: ABSENT', '• APMPPE (bilateral)', '• MEWDS (unilateral)', '• MFC / PIC', '• Serpiginous (geographic)'], '#e3f2fd', '#0d47a1'), ('CHORIORETINITIS', [ 'Choroid → secondary Retina', 'Starts deep (yellow)', 'Extends to retina (white)', 'Vitritis: VARIABLE', '• Birdshot (HLA-A29)', '• VKH (exudative RD)', '• Sympathetic ophthalmia', '• Sarcoidosis'], '#f3e5f5', '#4a148c'), ('RETINOCHOROIDITIS', [ 'Retina → secondary Choroid', 'Starts superficial (white)', 'Heals: pigmented scar', 'Vitritis: PRESENT (dense)', '• Toxoplasma (prototype)', ' "Headlight in fog"', ' satellite scar', '• Congenital CMV'], '#fff8e1', '#e65100'), ('NEURORETINITIS', [ 'Disc + RNFL + Macula', 'Optic disc edema', 'Macular STAR exudate', 'Vitritis: VARIABLE', '• Bartonella (#1 cause)', '• Lyme disease', '• Toxocara / DUSN', '• IRVAN (non-infect)'], '#e0f2f1', '#004d40'), ('RETINAL VASCULITIS', [ 'Vessel wall inflammation', 'Veins > arteries affected', 'Perivascular sheathing', 'Vitritis: VARIABLE', '• Sarcoid (candlewax)', '• Eales (periphlebitis)', '• Behçet (occlusive)', '• Susac (arterial)'], '#fce4ec', '#880e4f'), ]): xi = ex_start + i * (ew + eg) bbox_col = col # header bp_h = FancyBboxPatch((xi, 20.5), ew, 0.7, boxstyle="round,pad=0.05,rounding_size=0.2", facecolor=tcol, edgecolor='none', zorder=3) ax.add_patch(bp_h) ax.text(xi + ew/2, 20.86, title, ha='center', va='center', fontsize=7.5, color='white', fontweight='bold', zorder=4) # body bp_b = FancyBboxPatch((xi, 17.8), ew, 2.7, boxstyle="round,pad=0.05,rounding_size=0.2", facecolor=bbox_col, edgecolor=tcol, linewidth=1, zorder=3) ax.add_patch(bp_b) for li, ln in enumerate(body_lines): fc = tcol if li == 3 else ('#444444' if li > 0 else '#222222') fw = 'bold' if li in [0, 3] else 'normal' ax.text(xi + 0.12, 20.3 - li*0.31, ln, ha='left', va='center', fontsize=7, color=fc, fontweight=fw, zorder=4) # ─── QUICK REFERENCE TABLE ─── arrow(ax, 14, 17.8, 14, 17.2) box(ax, 7, 16.4, 14, 0.9, 'QUICK REFERENCE TABLE', '#263238', fontsize=10) # table header th_y = 15.8 box(ax, 0.2, th_y, 28, 0.7, '', '#455a64', lines=['Disease | Entity Type | Lateral. | Vitritis | Key Feature | Infective?'], linecolors=['white'], fontsize=8.5, bold=True) rows = [ ('Toxoplasma','Retinochoroiditis','Unilateral','Dense focal','"Headlight in fog"; satellite scar','Yes (parasite)','#fff8f0'), ('CMV Retinitis','Retinitis','Uni→Bilateral','Mild','"Pizza-pie"; granular hemorrhagic; HIV/AIDS','Yes (viral)','#fafafa'), ('ARN','Necrotizing retinitis','Uni (33% bilat)','Marked','Peripheral white patches; occlusive arteritis; HSV/VZV','Yes (viral)','#fff8f0'), ('PORN','Outer retinitis','Bilateral','ABSENT','Deep opacification; spares vessels; clear vitreous; VZV/HIV','Yes (VZV)','#fafafa'), ('Bartonella','Neuroretinitis','Unilateral','Mild','Disc edema + macular STAR; cat exposure; #1 neuroretinitis','Yes (bacterial)','#fff8f0'), ('Syphilis','Any pattern','Bilateral','Variable','"Great imitator"; retinitis/chorioretinitis/vasculitis/neuroretinitis','Yes (bacterial)','#fafafa'), ('TB','Choroiditis/vasculitis','Bilateral','Variable','Choroidal tubercles; periphlebitis; systemic TB','Yes (bacterial)','#fff8f0'), ('Birdshot','Chorioretinitis','Bilateral','Present','Cream lesions radiating from disc; HLA-A29; periphlebitis','No (autoimmune)','#fafafa'), ('VKH','Chorioretinitis','Bilateral','Present','Bilateral exudative RD; sunset glow; poliosis; tinnitus','No (autoimmune)','#fff8f0'), ('Sympathetic ophthal.','Chorioretinitis','Bilateral','Present','Post-trauma bilateral granulomatous; Dalen-Fuchs nodules','No (autoimmune)','#fafafa'), ('Sarcoidosis','Chorioretinitis+Vasc','Bilateral','Present','Candlewax periphlebitis; disc granulomas; ACE elevated','No (granulom.)','#fff8f0'), ('Behçet','Occlusive vasculitis','Bilateral','Marked','Occlusive vasculitis; hypopyon; oral/genital ulcers','No (vasculitis)','#fafafa'), ('APMPPE','Choroiditis','Bilateral','Mild','Bilateral placoid sub-RPE; post-viral; self-limiting','No','#fff8f0'), ('Serpiginous','Choroiditis','Bilateral asymm.','ABSENT','Geographic peripapillary; recurrent; no vitritis','No','#fafafa'), ('MEWDS','Choroiditis','UNILATERAL','Mild','Multiple evanescent white dots; young myopic women','No','#fff8f0'), ('Eales Disease','Retinal vasculitis','Bilateral','Present','Peripheral periphlebitis; neovascularization; young men','No (idiopathic)','#fafafa'), ('Susac Syndrome','Arterial vasculitis','Bilateral','Variable','Retinal artery occlusions + hearing loss + encephalopathy','No (autoimmune)','#fff8f0'), ('IRVAN','Neuroretinitis','Bilateral','Variable','Disc aneurysms + macular star; arteritis; exudative retinopathy','No (idiopathic)','#fafafa'), ] rh = 0.52 for ri, (dis, ent, lat, vit, key, inf, bg) in enumerate(rows): ry = th_y - (ri+1)*rh box(ax, 0.2, ry, 28, rh-0.03, '', bg, lines=[f'{dis} | {ent} | {lat} | {vit} | {key} | {inf}'], linecolors=['#c62828' if 'Yes' in inf else '#1565c0'], fontsize=7.2, bold=False) # ─── LEGEND ─── leg_y = th_y - len(rows)*rh - 0.5 box(ax, 0.2, leg_y - 1.0, 27.6, 1.2, '', '#eceff1', lines=['LEGEND: ■ Orange=Retinitis ■ Blue=Choroiditis ■ Purple=Chorioretinitis ■ Teal=Neuroretinitis ■ Red=Vasculitis | Red text=Infectious Blue text=Non-infectious', 'ARN=Acute Retinal Necrosis · PORN=Progressive Outer Retinal Necrosis · VKH=Vogt-Koyanagi-Harada · IRVAN=Idiopathic Retinal Vasculitis Aneurysms Neuroretinitis · APMPPE=Acute Post. Multifocal Placoid Pigment Epitheliopathy', 'MEWDS=Multiple Evanescent White Dot Syndrome · MFC=Multifocal Choroiditis · PIC=Punctate Inner Choroidopathy · DUSN=Diffuse Unilateral Subacute Neuroretinitis', 'Source: Kanski\'s Clinical Ophthalmology 10th Ed. | Wills Eye Manual | Firestein & Kelley\'s Textbook of Rheumatology'], linecolors=['#37474f','#555555','#555555','#90a4ae'], fontsize=7, bold=False) plt.tight_layout(pad=0.5) plt.savefig('/home/daytona/workspace/posterior-uveitis-flowchart/posterior_uveitis_SINGLE.png', dpi=180, bbox_inches='tight', facecolor='#f5f7fa') print("Saved successfully") EOF

Running Command

ls -lh /home/daytona/workspace/posterior-uveitis-flowchart/posterior_uveitis_SINGLE.png

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

what is paper 1,2,3 & 4 about in general

I don't have any context about which "Paper 1, 2, 3 & 4" you're referring to. Could you clarify?

Asking for Preferences

Which papers are you asking about?

what are the question expected in paper 4, and what are questions in community ophthalmiligy

I need a bit more context before I can give you a useful answer.

Asking for Preferences

Which exam or course are these papers from? · Which country / university system?

ms ophthalmology final exams mpmsu

Searching the Web

MPMSU MS Ophthalmology final exam paper 1 2 3 4 syllabus pattern

Searching the Web

MPMSU MS Ophthalmology Paper 4 recent advances community ophthalmology questions

Reading Web Page

https://www.mgumst.org/assets/syllabus_pdf/MSOphthalmology.p…

Here is a complete breakdown for MS Ophthalmology final exams (MPMSU / similar universities):

MS Ophthalmology Final Exam - Paper Structure

Exam Format (all 4 papers)

3 hours | 100 marks each | All questions compulsory
Q1 - Long answer (20 marks)
Q2 - Two parts (15 + 15 = 30 marks)
Q3 - Five short notes (10 x 5 = 50 marks)

THE FOUR PAPERS

PAPER 1 - Basic Sciences related to Ophthalmology, Refraction & Optics

Covers the foundation sciences behind eye disease:

Ocular anatomy (gross, histology, embryology)
Ocular physiology
Ocular pathology & biochemistry
Genetics in ophthalmology
Ocular microbiology & immunology
Ocular pharmacology
Optics & Refraction - lenses, prisms, retinoscopy, keratometry, contact lenses, refractive errors
Imaging modalities - OCT, USG, UBM, CT, MRI, plain X-ray

PAPER 2 - Clinical Ophthalmology including Ocular Surgery

Covers all clinical segments of the eye:

Lids, orbit, lacrimal system
Conjunctiva, cornea, sclera
Uveal tract (uveitis)
Lens & cataract surgery
Glaucoma
Vitreous & retina
Squint & ocular motility
Neuro-ophthalmology
Ocular trauma

PAPER 3 - Systemic Diseases in Relation to Ophthalmology

Covers medical/systemic conditions affecting the eye:

Diabetes mellitus (diabetic retinopathy)
Hypertension (hypertensive retinopathy)
Thyroid eye disease (dysthyroid ophthalmopathy)
Pregnancy-related ocular changes
Nutritional deficiency (Vitamin A, etc.)
Collagen vascular diseases (SLE, RA)
Infections - TB, syphilis, HIV, toxoplasma
Cysticercosis
Neurological diseases (MS, pituitary adenoma)
Blood disorders
Skin diseases affecting the eye (SJS, pemphigoid)

PAPER 4 - Recent Advances in Ophthalmology + Community Ophthalmology

This is the paper you asked about specifically. It has two major domains:

PAPER 4 IN DETAIL

A. RECENT ADVANCES (most of the paper)

Topic	Expected Questions
Refractive surgery	LASIK, LASEK, SMILE, PRK, ICL - procedures, indications, complications
Femtosecond laser	Femto-cataract surgery, FLACS
Anti-VEGF / Intravitreal injections	Bevacizumab, Ranibizumab, Aflibercept - AMD, DME, CRVO
Advanced glaucoma	Non-penetrating surgery, MIGS, drainage implants, neuroprotection, OCT in glaucoma
Component keratoplasty	DALK, DSAEK, DMEK - principles, advantages
Age-related macular degeneration	Recent management - anti-VEGF, photodynamic therapy
Retinopathy of Prematurity (ROP)	Screening, anti-VEGF vs laser, classification
Imaging advances	OCT angiography (OCTA), Fundus autofluorescence, wide-field imaging
Gene therapy	Leber congenital amaurosis, gene therapy for inherited retinal disease
Role of lasers	Nd-YAG, argon, diode, excimer - all uses
Stem cell therapy	Corneal, retinal applications
Low vision aids	Magnifiers, telescopes, electronic aids
Retinoblastoma	Systemic chemotherapy, intra-arterial chemo, focal consolidation
Subluxated lens / cataract	Management with CTR, glued IOL

B. COMMUNITY OPHTHALMOLOGY

This is a high-yield, frequently tested section. Expected questions include:

Long / Medium Answer Questions:

Magnitude of blindness in India - causes, prevalence, NPCB data
National Programme for Control of Blindness (NPCB / NPCBVI) - objectives, strategies, achievements
Vision 2020 - The Right to Sight - global initiative, SAFE strategy for trachoma
Causes and prevention of blindness in India - cataract, glaucoma, corneal blindness, refractive error, trachoma, Vitamin A deficiency, ROP, diabetic retinopathy
Cataract blindness control - surgical rate, CSR (cataract surgical rate), barriers
Vitamin A deficiency / Xerophthalmia - WHO classification, prevention, treatment, DAIVS programme
Trachoma - WHO grading (TF, TI, TS, TT, CO), SAFE strategy, WHO target
School eye screening programme
Mobile ophthalmic unit - components and functions
Eye banking - organization, criteria for donation, MK medium, corneal transplantation programme

Short Notes (10 marks each):

Blindness - definition (WHO: VA < 3/60 in better eye)
Low vision - definition, aids
Eye camps - guidelines, preparation, dos and don'ts
Indicators of eye health in a community
Colour blindness - prevalence, types, Ishihara test
Rehabilitation of blind
District blindness control society (DBCS)
Corneal blindness and Eye donation
Onchocerciasis / River blindness
Diabetic retinopathy screening programme
National health programmes related to eye care (Rashtriya Bal Swasthya Karyakram - RBSK)
VISION 2020: Right to Sight

Model Paper 4 Pattern (MPMSU style)

Q1 (20 marks): 
  Describe the various refractive surgery procedures for 
  myopia, hypermetropia and astigmatism.

Q2 (15 + 15 marks):
  a) Role of laser in ophthalmology
  b) Component keratoplasty (DSAEK / DALK)

Q3 (5 × 10 marks):
  a) Femtosecond laser cataract surgery
  b) Vision 20/20 initiative
  c) Guidelines for eye camps for cataract surgery
  d) Magnitude of blindness in India
  e) Anti-VEGF therapy in AMD

High-Frequency Repeaters in Paper 4

Rank	Topic
⭐⭐⭐	Anti-VEGF therapy (AMD, DME, ROP)
⭐⭐⭐	Recent advances in glaucoma management
⭐⭐⭐	Magnitude of blindness in India + NPCB
⭐⭐⭐	Refractive surgery (LASIK/SMILE)
⭐⭐⭐	ROP - classification and management
⭐⭐	Component keratoplasty
⭐⭐	Eye banking and corneal donation
⭐⭐	Femtosecond laser / FLACS
⭐⭐	Vision 2020 / Trachoma (SAFE)
⭐⭐	Gene therapy in retinal dystrophies

Would you like me to expand on any specific topic - for example, a detailed answer plan for "Magnitude of blindness in India" or "Recent advances in AMD"?

all details ophthalmic instruments with photos to prepare for post graduate examination in ms ophthalmology exam

Finding Sources

Searching Images

slit lamp biomicroscope ophthalmic instrument

This set of four clinical slit-lamp photographs (labeled a through d) demonstrates the behavior and aspiration kinetics of a cohesive ophthalmic viscosurgical device (OVD) during a simulated cataract surgery. The OVD is stained with fluorescein (bright green) to visualize its distribution within the anterior chamber of a porcine eye model. (a) At 3 seconds post-pump activation, the cohesive OVD forms a large, concentrated mass occupying the anterior chamber. (b) At 25 seconds, the OVD maintains a similar cohesive shape, showing resistance to wash-out. (c) A cross-sectional slit-beam view highlights the proximity of the phacoemulsification tip to the OVD mass. (d) By 90 seconds, the OVD volume is significantly reduced, with remaining material concentrated near the phaco tip, demonstrating that cohesive OVDs are aspirated rapidly and entirely once engaged by the instrument. This progression illustrates the surgical handling characteristics of cohesive OVDs, which provide space maintenance but are easily removed, offering less prolonged endothelial protection compared to dispersive types.

A clinical photograph illustrating a pediatric ophthalmic examination technique. A male physician, wearing a white coat, glasses, and a tie, is shown interacting with a young girl who is wearing corrective spectacles and being held by a parent. The clinician has a large, colorful plush doll with orange hair draped over his shoulders, serving as a distraction tool to build rapport and decrease patient anxiety during the physical assessment. He is gently holding the child's hand while engaging in playful interaction. The background shows clinical equipment, including a slit lamp biomicroscope, indicating an eye clinic setting. This image demonstrates the 'playful examination' principle in pediatrics, which is essential for ensuring cooperation during diagnostic procedures such as the red reflex test or visual acuity assessments in young children. The educational focus is on non-pharmacological behavioral management and communication strategies to facilitate a successful medical evaluation in a pediatric population.

A clinical photograph of a patient undergoing an ophthalmic examination using slit lamp biomicroscopy. The image captures the periocular region of a male patient wearing a surgical mask, illuminated by a cobalt blue filter (450–500 nm wavelength) in a darkened environment. The primary focus is on the ocular surface and anterior segment. Despite the application of the specific blue light source often used to excite fluorescence (e.g., during fluorescein staining), there is a notable absence of ocular fluorescence in this specific view. The photograph serves as a negative control or comparison point in clinical investigations involving drug-induced ocular fluorescence, such as that associated with Favipiravir treatment. The educational significance lies in demonstrating standard slit lamp biomicroscopic examination lighting and the visual baseline for the ocular surface under cobalt blue light when no fluorescent substances or specific disease-related luminescence are present.

Searching Images

direct ophthalmoscope fundus examination instrument

A clinical photograph illustrating the proper technique for direct ophthalmoscopy in a community health or low-resource setting. A healthcare provider is shown in close proximity to an elderly female patient with deeply wrinkled skin and a pigmented fundus. The provider is demonstrating the correct 'flight path' for visualizing the optic nerve, positioned on the horizontal plane at approximately 15 degrees temporal to the patient's right eye. The clinician holds a direct ophthalmoscope (specifically an Arclight device) in his right hand, using his right eye to examine the patient's right eye. His left hand is placed gently on the patient's forehead to stabilize the head and elevate the upper eyelid if necessary. The educational focus is on the physical positioning, equipment handling, and anatomical approach required to bring the optic disc and retinal vessels into view during a funduscopic examination. Relevant clinical concepts include screening for cataract, glaucoma, and macular disease through direct visualization of the posterior segment.

This educational illustration provides a historical and conceptual representation of the human fundus as seen through an early ophthalmoscope. The image features a circular field depicting a stylized retinal fundus with an orange-toned background and a radiating network of retinal vasculature. The vessels, rendered in varying shades of reddish-brown and dark brown, originate from a central anatomical focal point—the optic disc—which is highlighted by a distinct bluish-green hue. The branching pattern demonstrates the distribution of primary retinal arteries and veins across the posterior pole. Overlaid onto the anatomical features is a green silhouette portrait of Hermann von Helmholtz, the inventor of the ophthalmoscope, symbolizing the intersection of physiological optics and clinical examination. This comparison chart-style graphic illustrates the fundamental topography of the healthy retina, including the optic nerve head and the vascular arcades, serving as a pedagogical tool for understanding the history of ophthalmology and the basic landmarks of fundoscopy.

This clinical photograph illustrates a pediatric ophthalmology examination for Retinopathy of Prematurity (ROP) screening. The clinician, identified as an ophthalmology fellow in a white lab coat, is utilizing a head-mounted indirect ophthalmoscope with an integrated light source to visualize the internal structures of the infant's eye. The neonatal patient is positioned supine on a padded surface, with the head stabilized by an assistant's hand. To facilitate a clear view of the fundus, the ophthalmologist is using an eyelid speculum to keep the infant's eye open while holding a condensing lens (not fully visible) over the eye. The image demonstrates the standard technique for binocular indirect ophthalmoscopy (BIO) in a neonatal setting, which is critical for identifying peripheral retinal vascular abnormalities such as ridge formation, extraretinal fibrovascular proliferation, or 'plus disease' in premature infants. This modality is the traditional gold standard for ROP screening, allowing for a wide-field, three-dimensional view of the retina.

Finding Sources

Searching Images

Goldmann applanation tonometer intraocular pressure measurement

A clinical photograph demonstrating the proper application of a Diaton® transpalpebral tonometer for measuring intraocular pressure (IOP). The image depicts the handheld device being applied to a patient in a supine or reclined position. The tonometer is held vertically, perpendicular to the ground, with the tip making contact with the skin of the superior eyelid at the level of the tarsal plate. The patient's eye is partially open, showing the sclera and iris, while the device is positioned above the lash line to avoid direct corneal contact. The clinician's hand is visible, stabilizing the device against the orbital rim or maxilla to ensure accuracy and minimize movement. This method of transpalpebral tonometry is an alternative to Goldmann applanation, as it allows for IOP measurement through the eyelid without anesthesia or contact with the cornea, making it useful in clinical scenarios where corneal contact is contraindicated or difficult.

A series of clinical photographs illustrating the use of the TapEye tonometer (TET) for intraocular pressure (IOP) measurement through the eyelid. Panel A (front view) shows the patient holding the device against the right orbit, using the index finger of the same hand to depress the measurement button. Panel B (lateral view) demonstrates the vertical orientation of the device, which is stabilized against the forehead and nose. Panel C provides a magnified lateral view showing the tonometer's probe tip in contact with the naturally closed upper eyelid. The probe is positioned approximately 1 to 3 mm superior to the lid margin, aligning with the corneal center. This method represents trans-palpebral tonometry, an alternative to Goldmann applanation tonometry (GAT) that does not require topical anesthesia or direct corneal contact. The educational focus is on proper device positioning, hand placement, and anatomical landmarks for non-invasive IOP monitoring.

Searching Images

indirect ophthalmoscope condensing lens retina examination

A clinical photograph depicting a pediatric ophthalmic examination and treatment session in a medical facility. An ophthalmologist is seen wearing a specialized head-mounted indirect ophthalmoscope or laser delivery system, equipped with an integrated light source and visible AV/data cables. The clinician is using a handheld condensing lens to perform an eye examination on an infant, who is lying on a padded surface and being stabilized by an assistant. The clinical context suggests a screening or treatment evaluation for Retinopathy of Prematurity (ROP), potentially involving peripheral retinal photocoagulation. The scene illustrates the technical setup required for neonatal ophthalmology, including the use of magnification, focused illumination, and specialized pediatric positioning. Key educational elements include the demonstration of indirect ophthalmoscopy technique and the management of neonatal retinal vascular diseases.

Finding Sources

Searching Images

gonioscopy goniolens angle anterior chamber glaucoma

This clinical photograph displays a gonioscopy procedure focused on the anterior chamber angle of a human eye. The image captures a slit-lamp view through a goniolens, where a concentrated beam of light illuminates a segment of the iridocorneal angle. Within the illuminated region, the iris surface is visible, showing a reddish-brown color and granular texture. Critical findings include the presence of neovascularization, characterized by fine, irregular, and abnormal blood vessels traversing the iris and potentially extending into the trabecular meshwork. This presentation is indicative of neovascular glaucoma or rubeosis iridis. The surrounding area is primarily dark, creating a high-contrast view that highlights the anatomical landmarks such as the iris root and the angle structures. This visual is significant for illustrating secondary ocular manifestations of systemic ischemic conditions, such as diabetic retinopathy or central retinal vein occlusion, which lead to pathological angiogenesis in the anterior segment.

This clinical procedural image consists of two panels (A and B) demonstrating the intraoperative steps of Gonioscopy-Assisted Transluminal Trabeculotomy (GATT), a minimally invasive glaucoma surgery (MIGS). The view is obtained via an ab interno approach through a surgical goniolens, visualizing the nasal anterior chamber angle. Panel A shows the initial step where a 25-gauge needle is used to create a focal goniotomy, incising the trabecular meshwork to expose the underlying Schlemm's canal. Panel B illustrates the subsequent cannulation phase, where a 5-0 Prolene (polypropylene) suture wire is inserted through the goniotomy and advanced 360 degrees into the lumen of Schlemm's canal, guided by 23-gauge microforceps. Key anatomical landmarks visible include the clear cornea with surgical air bubbles, the pigmented trabecular meshwork band, and the iris periphery. This procedure is performed to reduce intraocular pressure by bypassing the primary site of aqueous outflow resistance.

Searching Images

retinoscope streak retinoscopy refraction

$A clinical photograph illustrating a pediatric ophthalmic examination, specifically demonstrating the technique for 'wet' cycloplegic retinoscopy. A female medical professional in a white coat is shown in the left of the frame, holding a handheld retinoscope to her right eye. She is aiming the light through a trial frame fitted onto a young child positioned on the right. The practitioner uses her left hand to stabilize the trial frame on the child's face, ensuring proper alignment for refraction. The child is wearing a pink hooded garment. This procedure is typically performed after the administration of cycloplegic agents, such as cyclopentolate or tropicamide, to paralyze the ciliary muscle and prevent active accommodation, thereby allowing for an accurate objective measurement of the patient's refractive error. The background shows clinical supplies, including a lens trial set, indicating a professional optometric or ophthalmic setting.$

A clinical photograph illustrating a pediatric ophthalmic examination, specifically demonstrating the technique for 'wet' cycloplegic retinoscopy. A female medical professional in a white coat is shown in the left of the frame, holding a handheld retinoscope to her right eye. She is aiming the light through a trial frame fitted onto a young child positioned on the right. The practitioner uses her left hand to stabilize the trial frame on the child's face, ensuring proper alignment for refraction. The child is wearing a pink hooded garment. This procedure is typically performed after the administration of cycloplegic agents, such as cyclopentolate or tropicamide, to paralyze the ciliary muscle and prevent active accommodation, thereby allowing for an accurate objective measurement of the patient's refractive error. The background shows clinical supplies, including a lens trial set, indicating a professional optometric or ophthalmic setting.

This grayscale educational photograph demonstrates the 'motion streak' phenomenon, a key concept in visual psychophysics and neurobiology. The image features a human hand holding an Ace of Spades playing card, captured while moving in a rapid arcing motion. A distinct blurred trail, or motion streak, extends behind the path of the card, creating a curved, translucent visual index of the object's trajectory. This visual is used to illustrate form-motion integration within the human visual system, specifically the interaction between the ventral stream (the 'what' pathway, responsible for identifying the card's suit and rank) and the dorsal stream (the 'where/how' pathway, responsible for processing motion and spatial orientation). The phenomenon arises from retinal persistence, where the brain utilizes oriented blur to assist in the perception of fast-moving stimuli. This illustration is significant for medical and psychological studies focusing on visual perception, neurophysiology of the striate and extrastriate cortex, and the functional organization of parallel visual processing streams.

Finding Sources

Searching Images

visual field perimetry Humphrey automated bowl

A comparison panel of diagnostic images and visual field plots for seven clinical participants (H1-H7). Each entry consists of an axial T1-weighted structural MRI scan and a corresponding automated perimetry report (adapted from Humphrey 30:2 threshold tests). In the MRI scans, black arrows indicate varying degrees of structural damage within the occipital lobe, specifically targeting the region around the calcarine sulcus. The lesions demonstrate heterogeneity in morphology and volume. The accompanying perimetry plots represent visual field deficits: solid black areas indicate dense scotomas (sensitivity <0.5%), while gray areas indicate partial loss (sensitivity <2%). Concentric rings on these circular plots mark 10-degree increments from the fixation point, covering the central 30 degrees of the visual field. A superimposed white circle in each plot identifies the specific location within the dense scotoma used for rehabilitation training. This visual summary illustrates the clinical correlation between posterior brain lesions and complex hemianopic or quadrantanopic visual field deficits in patients undergoing neuro-rehabilitation.

Educational panel combining Humphrey automated perimetry (HAP) and MRI findings in a case of optic nerve sheath meningioma (ONSM). Panel A displays a 30-2 visual field test result showing near-normal sensitivity thresholds (dB) and a Mean Deviation (MD) of 0.21 dB, representing complete resolution of a previous visual field defect following radiotherapy. Panels B and C are T2-weighted magnetic resonance images (MRI) in axial and sagittal planes, respectively. The axial view (B) demonstrates a persistent fusiform enlargement of the left optic nerve with characteristic tortuosity ('winding'). A green arrow points to a residual, well-defined mass with altered signal intensity located at the precanalicular portion of the distal optic nerve. The sagittal view (C) shows the longitudinal extent of the tumor along the optic nerve sheath. Despite the significant functional recovery shown in the visual field test, the imaging confirms only partial radiological regression of the tumor post-treatment. These images illustrate the potential dissociation between functional visual recovery and anatomical tumor volume reduction following intensity-modulated radiotherapy (IMRT).

Searching Images

OCT optical coherence tomography retinal scan optic nerve

Diagnostic optical coherence tomography (OCT) imaging of the optic nerve head and peripapillary region, presented as a side-by-side comparison between standard spectral-domain OCT (left) and enhanced depth imaging (EDI) OCT (right). Both panels include an infrared fundus photograph with a green reference line indicating the scan location and a corresponding cross-sectional B-scan. The primary finding is a peripapillary hyperreflective ovoid mass-like structure (PHOMS) located at the optic disc margin. This structure is characterized by a high-reflectivity signal situated superficial to the Bruch's membrane and beneath the retinal nerve fiber layer, appearing as an elevated, rounded protrusion. The EDI acquisition on the right provides superior visualization of the deeper choroidal architecture and the posterior border of the optic nerve excavation compared to the standard scan on the left, which exhibits more rapid signal attenuation in the deep tissues. These images are used to differentiate PHOMS from optic disc drusen and to evaluate anatomical variations of the optic disc head.

This diagnostic image displays three cross-sectional Optical Coherence Tomography (OCT) scans of the human retina and optic nerve head. The scans demonstrate diagnostic imaging of the posterior segment, focusing on the peripapillary region. Key clinical features include focal hyperreflectivity of the internal retinal layers, specifically involving the nerve fiber and ganglion cell layers, which indicates acute ischemic changes or cotton-wool spot formation. The optic nerve head exhibits varying degrees of contour distortion and elevation, most prominent in the middle scan where there is significant disc swelling or protrusion. Notably, the deeper retinal layers and the underlying macula appear relatively preserved without evidence of subretinal fluid or significant macular edema. Each panel includes a small fundus reference map on the left to indicate the orientation and specific location of the B-scan line. This visual material is intended for ophthalmology education regarding retinal vascular disorders and optic nerve pathology, emphasizing the correlation between structural elevation and altered reflectivity in acute clinical presentations.

Finding Sources

Searching Images

fundus fluorescein angiography FFA retinal vascular imaging

Diagnostic Imaging: A series of six fundus fluorescein angiography (FFA) images of the left eye, capturing the arterial, venous, and late phases of retinal circulation. The images demonstrate the chronological transit of fluorescein dye through the retinal vasculature, emanating from the optic disc toward the macula and peripheral retina. Key findings include notable venous tortuosity across the vascular arcades. The initial frames show early arterial filling and the beginning of the laminar venous flow, while middle and late-phase images show full venous filling and diffuse staining of the optic disc. No obvious areas of capillary non-perfusion or retinal ischemia are visible in this specific series. The foveal avascular zone (FAZ) remains well-defined and dark throughout the sequences. This imaging series is used in ophthalmology to evaluate retinal perfusion, vascular integrity, and to screen for complications related to systemic diseases such as sickle cell retinopathy.

This diagnostic image is a Fundus Fluorescein Angiography (FFA) of the right eye, illustrating typical vascular findings associated with ocular inflammatory conditions such as periphlebitis. The image demonstrates widespread, diffuse hyperfluorescence across the posterior pole and mid-periphery. Key features include segmental perivenous hyperfluorescence, characterized by minimal vascular leakage and staining of the retinal vessel walls, particularly evident along the major vascular arcs. The vascular morphology shows increased permeability without frank neovascularization. This imaging is clinically significant for detecting active or chronic retinal vasculitis and perivenous sheathing, common in systemic conditions like Multiple Sclerosis. The background reveals a mottled fluorescence pattern, likely corresponding to mild vitreous haze or secondary retinal pigment epithelium changes. This visual is intended for intermediate to advanced medical learners focusing on ophthalmology and neuro-ophthalmology to understand the angiographic presentation of retinal inflammatory disease.

Ophthalmic Instruments - Complete MS Ophthalmology Viva/Exam Guide

Sources: Kanski's Clinical Ophthalmology 10th Ed. | Wills Eye Manual | Roberts & Hedges' Clinical Procedures

GROUP 1 - EXAMINATION INSTRUMENTS

1. SLIT LAMP BIOMICROSCOPE

Slit lamp examination with cobalt blue filter

What is it? The most important instrument in clinical ophthalmology. Provides a magnified, stereoscopic, co-axially illuminated view of the anterior and posterior segment.

Parts:

Illumination system (slit beam, variable width/height/angle)
Observation system (binocular microscope, magnification 6x-40x)
Mechanical stage (chin rest, forehead rest, joystick)
Filters: cobalt blue, red-free (green), neutral density, heat filter

Illumination Techniques:

Technique	Use
Diffuse illumination	General overview, lid/conjunctiva
Direct focal (optic section)	Corneal depth, lens opacities
Retro-illumination	Corneal scars, iris transillumination
Sclerotic scatter	Corneal edema, nebulae
Specular reflection	Endothelial cells
Indirect focal (proximal)	Subtle opacities

Uses:

Anterior segment - cornea, AC, iris, lens
With lenses - posterior segment (fundus, vitreous)
IOP measurement (with Goldmann tonometer attached)
Gonioscopy (with goniolens)
With 78D/90D/Volk lens - fundus examination

Viva points:

Kohler illumination principle
Depth of field increases at narrow slit
Optical cross-section = optic section technique

2. DIRECT OPHTHALMOSCOPE

Inventor: Hermann von Helmholtz (1851)

Principle: Illuminates the fundus and directs the reflected light back to the observer's eye.

Magnification: ~15x (uniocular, no stereopsis)

Field of view: ~5° (small - disadvantage)

Working distance: Very close (2-3 cm from patient)

Lenses (diopter wheel):

Red numbers = plus lenses (for hyperopia / examiner's myopia)
Black/green numbers = minus lenses (for myopia)
0 lens = emmetrope examining emmetrope

Filters:

Red-free (green) filter - nerve fiber layer defects, vessels
Cobalt blue - corneal lesions with fluorescein
Red filter - red reflex
Polarizing - reduces corneal reflection

Advantages over indirect:

Higher magnification
Portable, no pupil dilation needed always
Better for disc details

Disadvantages:

No stereopsis
Small field of view
Poor view through hazy media
Cannot see periphery well

Exam tip: Uses Purkinje image principle - light reflected from 4 surfaces of the eye.

3. INDIRECT OPHTHALMOSCOPE (BIO - Binocular Indirect Ophthalmoscope)

Type: Head-mounted, binocular

Principle: Condensing lens creates a real, inverted, aerial image between the lens and the observer.

Magnification: ~3-5x (with 20D lens) - less than direct

Field of view: 30-60° (much wider than direct)

Condensing Lenses:

Lens	Field of View	Magnification	Use
20D	46°	3.0x	Standard adult fundus
28D	~60°	2.0x	Wide field, preterm screening
30D	~65°	1.8x	Very wide field
14D	25°	4.5x	More magnification

Image characteristics: Real, inverted (upside down + reversed left-right)

Advantages:

Wide field of view
Stereoscopic (3D)
Better with hazy media
Can examine periphery with scleral indentation
Can be used with condensing lens at slit lamp (contact/non-contact)

Uses:

Retinal detachment, ROP screening
Peripheral lesions
Vitreous pathology
Pediatric/infant examination

GROUP 2 - TONOMETERS (IOP Measurement)

4. GOLDMANN APPLANATION TONOMETER (GAT)

Gold standard for IOP measurement

Inventor: Hans Goldmann (1954)

Principle: Imbert-Fick law - "for a dry, thin, spherical membrane: P = F/A"

Flattens (applanates) exactly 3.06 mm diameter area of cornea
At this area, surface tension = elastic forces → they cancel each other out
IOP = Applied force / Area

How to use:

Instill fluorescein + topical anesthetic
Set cobalt blue filter on slit lamp
Bring tonometer tip to touch cornea
Two fluorescent semicircles appear
Adjust dial until inner edges of semicircles touch
Read IOP: scale reading × 10 = IOP in mmHg

Limitations:

Overestimates IOP in thick cornea (CCT > 555 μm)
Underestimates IOP in thin cornea (CCT < 555 μm)
Corneal astigmatism >3D - use at 43° axis
Requires slit lamp, anesthesia, fluorescein

Normal IOP: 10-21 mmHg

5. SCHIOTZ TONOMETER (Indentation Tonometer)

Inventor: Hjalmar Schiotz (1905)

Principle: Indentation tonometry - a plunger of known weight indents the cornea; amount of indentation is inversely proportional to IOP.

Parts:

Footplate
Plunger
Scale
Weights: 5.5g (standard), 7.5g, 10g, 15g

Reading:

Reading on scale + weight used → conversion table gives IOP in mmHg
Low scale reading = harder eye = high IOP
High scale reading = softer eye = low IOP

Uses:

Portable - can be used in supine patients
Unconscious/bedridden patients
Field conditions, eye camps

Limitations:

Less accurate than GAT
Affected by scleral rigidity
Not used if corneal pathology

6. NON-CONTACT TONOMETER (Air-Puff Tonometer)

Principle: Air puff flattens the cornea - an optical detector senses the time taken/force needed to applanate exactly 3.06mm. Correlated to IOP.

Advantage: No anesthetic, no contact - screening tool

Disadvantage: Less accurate than GAT, not used for glaucoma diagnosis

7. PERKINS APPLANATION TONOMETER

Portable version of GAT - hand-held, battery-operated

Same principle as Goldmann
Used in children under GA, operating theatre, ICU patients
Image is upright (not inverted)

8. TONO-PEN

Electronic, portable applanation tonometer

Gives digital readout of IOP
Useful in irregular corneas, contact lens wearers
Multiple readings averaged automatically

9. REBOUND TONOMETER (iCare)

Principle: Induction/rebound impact - lightweight magnetized probe bounces off the cornea; deceleration measured correlates to IOP.

Advantage: No anesthetic, minimal contact, self-use possible

GROUP 3 - REFRACTION INSTRUMENTS

10. RETINOSCOPE (Skiascope)

Types:

Streak retinoscope (Copeland) - most commonly used, projects a streak of light
Spot retinoscope (older) - projects a spot

Principle: Projects a beam into the eye and observes the reflex from the retina.

Working distance: Usually 67 cm (1.5D) or 1 meter (1D)

Reading the reflex:

"With" motion (reflex moves same direction as streak) = plus lens needed
"Against" motion (reflex moves opposite) = minus lens needed
Neutralization = reflex fills the pupil, no movement = correcting lens found

With/Against motion summary:

Ametropia	Reflex (at 1m)
Myopia > 1D	Against motion
Hyperopia	With motion
Myopia < 1D	With motion
Emmetropia	No motion

Working distance lens: Subtract 1D (for 1m working distance) from final result.

Cycloplegic retinoscopy: Done after cyclopentolate/atropine drops - mandatory in children.

11. KERATOMETER (Ophthalmometer)

Inventor: Helmholtz; popularized by Javal-Schiotz

Principle: Measures anterior corneal curvature by using the cornea as a convex mirror and measuring the size of reflected image (first Purkinje image).

Types:

Javal-Schiotz keratometer (variable doubling, mires)
Bausch & Lomb keratometer (fixed mire, variable doubling)

Measures:

Corneal curvature in two principal meridians
Corneal astigmatism (axis and power)
Corneal power (in diopters)

Normal corneal power: 43-44 D

Uses:

Contact lens fitting
Pre-operative biometry
Keratoconus diagnosis
Post-surgical monitoring

12. AUTOREFRACTOMETER

Computerized objective refraction

Uses infrared light to measure refractive error automatically
Starting point for subjective refraction
Not fully reliable - must be confirmed by subjective refraction
Cannot replace retinoscopy in children

13. TRIAL FRAME AND LENS BOX

Used for subjective refraction

Contents of trial lens box:

Spherical lenses: +0.25 to +20D, -0.25 to -20D
Cylindrical lenses: +0.25 to +6D, -0.25 to -6D
Prisms: 1Δ to 30Δ
Accessories: Maddox rod, pin-hole, occluder, Jackson cross cylinder (JCC)

Jackson Cross Cylinder (JCC): ±0.25D or ±0.50D - used to refine cylinder power and axis during subjective refraction.

GROUP 4 - GONIOSCOPY LENSES

14. GONIOSCOPY LENSES (Goniolens)

Gonioscopy showing anterior chamber angle

Purpose: To visualize the iridocorneal angle (TI - trabecular meshwork - Schwalbe's line - iris)

Principle: Eliminates total internal reflection at corneal surface by using a contact lens with refractive index = cornea, or by using mirrors.

Types:

Lens	Mirrors	Contact	Type	Use
Zeiss 4-mirror goniolens	4	No coupling gel (saline)	Indirect	Narrow/dynamic gonioscopy
Goldmann 3-mirror	3	Methyl cellulose	Indirect	Gonioscopy + fundus
Goldmann 1-mirror	1	MC	Indirect	Dedicated gonioscopy
Koeppe lens	None (direct)	Saline	Direct	Children under GA
Barkan lens	None (direct)	Saline	Direct	Infants, congenital glaucoma

Angle structures (from posterior to anterior - "SIS PIG"):

Schwalbe's line (anterior limit of trabecular meshwork)
Insertion of trabecular meshwork
Scleral spur
Pigmented trabecular meshwork
Insertion of iris
Gonioscopically - also see ciliary body band in open angle

Shaffer grading:

Grade	Width	Angle	Closure risk
4	35-45°	Wide open	None
3	25-35°	Open	None
2	20°	Narrow	Possible
1	10°	Very narrow	High
0	0°	Closed	Angle closure

15. GOLDMANN 3-MIRROR LENS

Parts:

Central button (no mirror) - macula, posterior pole (used at 0° to fundus)
Large mirror (73° dome shaped) - peripheral retina and ora serrata
Rectangular mirror (67°) - equatorial retina
Small mirror (59° / crescent/D-shaped) - anterior chamber angle

Mnemonic: 0-73-67-59 or "Posterior pole to angle as mirrors get smaller"

Uses:

Gonioscopy (small mirror)
Retinal examination (large + rectangular mirrors)
Laser photocoagulation
Vitreoretinal surgery planning

GROUP 5 - PERIMETRY

16. GOLDMANN PERIMETER (Kinetic Perimetry)

Principle: A stimulus of fixed size and brightness is moved from non-seeing to seeing area (kinetic); maps isopters (lines of equal sensitivity).

Stimuli: Labeled I-V (size) and 1-4 (brightness)

Most commonly used: I-2e, I-4e, III-4e, V-4e

Uses:

Neuro-ophthalmology (hemianopia, etc.)
Advanced glaucoma
Non-organic (functional) visual loss
Retinitis pigmentosa (peripheral field loss)

17. HUMPHREY AUTOMATED PERIMETER (Static Perimetry)

Most commonly used in glaucoma management

Principle: Stationary stimuli of varying brightness presented at fixed locations (static). Patient presses button when seen.

Common programmes:

24-2 (central 24°) - most used for glaucoma
30-2 (central 30°) - neuro-ophthalmology
10-2 - advanced glaucoma, macular disease

Key indices:

Index	Meaning
MD (Mean Deviation)	Average deviation from age-normal; negative = loss
PSD (Pattern Standard Deviation)	Focal vs. diffuse loss; high PSD = focal loss
GHT (Glaucoma Hemifield Test)	Outside normal limits / borderline / within normal
VFI (Visual Field Index)	% of normal visual field remaining
Foveal threshold	Central sensitivity

Reliability indices:

Fixation losses < 20% (acceptable)
False positives < 15%
False negatives < 33%

GROUP 6 - IMAGING INSTRUMENTS

18. OCT (Optical Coherence Tomography)

Principle: Uses near-infrared light (820-1310 nm); measures back-scattered light (analogous to B-scan US but uses light not sound). "Optical biopsy."

Types:

Time-domain OCT (TD-OCT): Older, slower (400 A-scans/sec) - e.g., Stratus OCT
Spectral-domain OCT (SD-OCT): Faster (25,000-40,000 A-scans/sec), higher resolution - e.g., Cirrus, Spectralis
Swept-source OCT (SS-OCT): Longer wavelength (1050 nm), better choroidal penetration

Resolution: ~5-7 μm axial (identifies individual retinal layers)

Retinal layers seen on OCT (inner to outer): ILM → NFL → GCL → IPL → INL → OPL → ONL → ELM → IS/OS → RPE → BM/Choroid

Clinical uses:

Application	Details
Macula	AMD (drusen, CNV, geographic atrophy), DME, ERM, macular hole, CSR
Glaucoma	RNFL thickness map, GCC, optic nerve head analysis
Retina	RD, schisis, vitreomacular traction
Optic nerve	Disc drusen, papilledema, glaucoma
Anterior segment	Angle width, corneal thickness, epithelial mapping

OCT Angiography (OCTA): No dye needed - uses motion contrast to image retinal vasculature layer by layer.

19. FUNDUS FLUORESCEIN ANGIOGRAPHY (FFA)

Dye: Sodium fluorescein (10% or 25%), IV injection

Excitation wavelength: 465-490 nm (blue) Emission wavelength: 520-530 nm (yellow-green)

Phases:

Phase	Time after injection	What is seen
Pre-arterial (choroidal flush)	8-12 sec	Choroidal blush
Arterial	10-15 sec	Arteries fill
Arteriovenous (capillary)	15-20 sec	Laminar venous flow
Venous	20-30 sec	Veins fill completely
Late (recirculation)	5-10 min	Disc staining, leakage

Hyperfluorescence causes (LIVE):

Leakage (CNV, disc edema, vasculitis)
Increased transmission (RPE window defect)
Vascular (pooling - PED, serous RD)
Examination staining (fibrosis, disc)

Hypofluorescence causes (BE):

Blockage (hemorrhage, exudate, pigment)
Elimination of perfusion (ischemia, embolus)

20. INDOCYANINE GREEN ANGIOGRAPHY (ICGA)

Dye: Indocyanine green (ICG) Wavelength: Near-infrared (835 nm excitation, 900 nm emission)

Advantage over FFA: Better choroidal imaging (ICG bound to proteins, NIR penetrates RPE)

Uses: Polypoidal choroidal vasculopathy (PCV), CSCR, choroidal hemangioma, occult CNV

21. B-SCAN ULTRASONOGRAPHY

Principle: 10 MHz ultrasound - provides cross-sectional 2D image of the globe and orbit.

Uses:

Vitreous hemorrhage (opaque media - can't see fundus)
Retinal detachment (behind hemorrhage)
Choroidal detachment vs. RD
Intraocular tumors (retinoblastoma, melanoma)
Posterior staphyloma
Optic nerve drusen (highly reflective)
Foreign body localization

A-scan: 1D time-amplitude display - axial length measurement (biometry for IOL power)

GROUP 7 - SPECIAL INSTRUMENTS

22. SPECULAR MICROSCOPE

Purpose: Counts corneal endothelial cells and assesses morphology.

Normal cell density:

Young adult: 3000-3500 cells/mm²
Below 1000 cells/mm² - corneal decompensation risk
Below 500 cells/mm² - corneal decompensation

Parameters: Cell count (ECD), polymegethism (size variation - CoV), pleomorphism (shape variation - % hexagonals)

Use: Pre/post keratoplasty assessment, before intraocular surgery

23. CORNEAL TOPOGRAPHER

Purpose: Maps the curvature of the entire corneal surface (unlike keratometer which measures only central 3mm).

Types:

Placido-disc based (reflection) - corneal surface
Scheimpflug imaging (Pentacam) - corneal topography + tomography + anterior segment
Slit-scanning (Orbscan)

Uses:

Keratoconus screening (before LASIK - MANDATORY)
Contact lens fitting
Pre-/post-refractive surgery
Corneal grafts

24. PACHYMETER (PACHYMETRY)

Purpose: Measures corneal thickness (central corneal thickness - CCT)

Types:

Ultrasound pachymeter (contact - gold standard)
Optical pachymeter (non-contact)

Normal CCT: 520-550 μm (average ~535 μm)

Importance:

IOP correction: Thin cornea underestimates true IOP; thick cornea overestimates
Glaucoma risk: Thin CCT is independent risk factor for POAG progression
Refractive surgery: Minimum CCT required before LASIK (at least 500 μm residual stromal bed)
OHTS study: CCT < 555 μm = high risk for glaucoma conversion

25. LENSOMETER (FOCIMETER / LENSMETER)

Purpose: Measures the power of a spectacle lens.

Principle: Mires or target focused through the lens; displacement indicates power.

Reads:

Sphere power
Cylinder power and axis
Prism power and base direction
Optical centre of the lens

Uses:

Dispensing glasses (verifying prescriptions)
Back-vertex power of thick lenses
Contact lens power measurement

26. HESS SCREEN TEST / HESS CHART

Purpose: Assesses binocular function and quantifies ocular motility defects (paretic vs. restrictive squint).

Principle: Red-green dissociation goggles - each eye sees different colour.

Reading: Small chart = paretic muscle (under-action); Large chart = normal eye (over-action)

VIVA QUICK REFERENCE TABLE

Instrument	Principle	Key Use	Exam Viva Points
Slit lamp	Kohler illumination	Anterior segment	6 illumination techniques
Direct ophthalmoscope	Purkinje images	Fundus (15x)	Invented by Helmholtz
Indirect ophthalmoscope	Real inverted aerial image	Wide-field fundus	Image inverted; 20D = 3x, 46°
Goldmann tonometer	Imbert-Fick law	Gold standard IOP	3.06mm applanation
Schiotz tonometer	Indentation	Portable IOP	Affected by scleral rigidity
Goldmann 3-mirror	Mirror optics	Gonioscopy + fundus	3 mirrors: 73°, 67°, 59°
Humphrey perimeter	Static automated	Glaucoma	MD, PSD, GHT, VFI
Goldmann perimeter	Kinetic	Neuro, RP	Isopters; I-V/1-4 notation
OCT	Near-IR interferometry	Retina, glaucoma	"Optical biopsy"; SD-OCT now standard
FFA	Fluorescein excitation	Vascular disease	8-12 sec choroidal flush
Specular microscope	Endothelial reflection	CCT count	< 1000 → decompensation risk
Keratometer	Corneal reflection	Corneal power	First Purkinje image
Retinoscope	Retinal reflex	Objective refraction	With/against motion
Pachymeter	Ultrasound/optical	CCT	Adjusts IOP interpretation
Lensometer	Target focus	Spectacle power	Back-vertex power

Viva tip for MS exam: For any instrument, be ready to answer - (1) inventor, (2) principle, (3) parts, (4) how you use it, (5) what it measures/what you see, (6) normal values, (7) clinical applications, (8) limitations/sources of error, (9) compare with alternative instruments.

how to approach a case of proptosis with explaining from history to diagnosis, negative and positive history with explaination of each points.

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Searching Images

proptosis exophthalmos thyroid eye disease orbital

This diagnostic image is an axial MRI of the orbits demonstrating hallmark findings of thyroid eye disease (Graves' ophthalmopathy). The image reveals bilateral proptosis, characterized by the forward displacement of the globes beyond the anterior orbital rim. There is a significant increase in the volume of the retrobulbar orbital fat, indicated by red arrows, which appears hyperintense with a heterogeneous texture and subtle stranding, suggestive of inflammatory changes or edema. The extraocular muscles, specifically the medial recti, show moderate enlargement and appear to be encroaching upon the optic nerves bilaterally. The overall appearance highlights common pathophysiology in autoimmune orbital disease, where fat expansion and extraocular muscle hypertrophy contribute to increased intraorbital pressure and exophthalmos. This educational image is relevant for radiology and ophthalmology in diagnosing and assessing the severity of restrictive myopathy and orbital congestion.

This clinical comparison chart presents three sets (a, b, c) of pre- and post-operative facial photographs documenting the results of bilateral orbital decompression in patients with Graves' ophthalmopathy (thyroid eye disease). The 'before' images on the left consistently demonstrate significant proptosis (exophthalmos), characterized by ocular prominence, upper eyelid retraction, and excessive scleral show both superiorly and inferiorly. In case (a), there is also visible conjunctival injection and chemosis. The 'after' images on the right, taken 6 months to 2 years post-surgery, show a marked reduction in globe protrusion (measured between 3–5 mm reduction per eye). Key visual improvements include a normalized eyelid position with reduced retraction, decreased scleral exposure, and a more relaxed periocular skin appearance. These images illustrate the surgical management of Graves' ophthalmopathy to reduce orbital volume, protecting the ocular surface and improving aesthetic outcomes by resolving the 'staring' expression associated with the disease.

A comparison of pre-operative and 3-month post-operative clinical photographs and diagnostic imaging of a patient with thyroid eye disease (TED). The top row features axial CT scans of the orbits, demonstrating a significant reduction in orbital fat and proptosis; exophthalmos measurements decrease from 22.4 mm (right) and 21.5 mm (left) pre-operatively to 18.0 mm and 17.2 mm post-operatively. The middle row shows frontal clinical photographs, highlighting a notable improvement in upper eyelid retraction and a more natural eyelid position following surgical intervention. The bottom row displays lateral profile views, visually confirming the posterior displacement of the globes (reduction in proptosis) and decreased soft tissue volume in the periorbital and malar regions. This composite image serves to illustrate the anatomical and aesthetic outcomes of orbital fat decompression surgery, commonly managed within ophthalmology and oculoplastic surgery for Graves' ophthalmopathy.

Finding Sources

Searching Images

orbital cellulitis proptosis periorbital swelling infection

A clinical photograph of a patient's right eye and periorbital region illustrating acute inflammatory changes. The image demonstrates significant periorbital edema, characterized by prominent swelling of both the upper and lower eyelids, which narrows the palpebral fissure. Diffuse erythema is visible across the eyelid skin, extending towards the malar and frontal regions. There is a perceptible forward protrusion of the globe, consistent with proptosis. Yellow arrows are used to annotate the areas of maximal soft tissue swelling and inflammation. These clinical signs are hallmark indicators of orbital or preseptal cellulitis, frequently associated with underlying sinusitis or odontogenic infection. The image is intended for medical education to aid in the visual recognition of ocular emergencies and the differentiation between preseptal and orbital involvement based on the presence of proptosis.

This composite educational graphic illustrates the clinical presentation, diagnosis, and post-operative recovery of a pediatric patient with a sinogenic rhinogenic orbital infection (SROI). Panel A is a clinical photograph showing acute right-sided periorbital cellulitis characterized by significant edema, erythema, and proptosis of the right eye, with the eyelids nearly swollen shut. Panel B is an axial computed tomography (CT) scan in a bone window, demonstrating bilateral ethmoid and sphenoid sinusitis. A white arrow points to opacification of the right ethmoid sinus, while a black arrow highlights a sub-periosteal abscess (SPA) along the medial orbital wall (lamina papyracea), displacing the medial rectus muscle. Panel C shows the patient 10 days post-surgery following endoscopic sinus surgery and external drainage; it demonstrates marked resolution of the inflammatory signs, with significantly reduced swelling and return of normal ocular positioning. This set illustrates Chandler stage 3 orbital complications and highlights the correlation between radiological findings (sub-periosteal abscess) and physical exam signs (proptosis and severe periorbital edema) in the context of acute sinusitis.

Searching Images

carotid cavernous fistula pulsatile proptosis conjunctival chemosis

A multi-panel figure illustrating the clinical and radiological findings of a carotid-cavernous fistula (CCF). Panel A (anterior clinical photograph) and Panel B (lateral clinical photograph) show severe left-sided proptosis, conjunctival injection, and chemosis with visible protrusion of the swollen conjunctiva between the eyelids. Panel C is an axial MRI scan showing significant dilatation of the left superior ophthalmic vein (SOV) compared to the contralateral side, reflecting increased venous pressure. Panel D is a digital subtraction angiogram (lateral view) demonstrating a dural CCF with anterior and posterior drainage, occurring in conjunction with an extracranial internal carotid artery (ICA) aneurysm. The images collectively demonstrate the classical triad of clinical signs (pulsatile proptosis, chemosis, and orbital bruit) alongside definitive neuroimaging used for the diagnosis of high-flow or dural vascular shunts within the cavernous sinus, highlighting the correlation between orbital venous hypertension and intracranial vascular pathology.

A multi-panel medical image illustrating the clinical and radiological presentation of a carotid-cavernous fistula (CCF). Panels A and B are external clinical photographs showing unilateral right-sided proptosis (exophthalmos) and significant conjunctival injection. Panel C demonstrates a limitation in lateral gaze in the right eye, accompanied by chemosis and prominent, engorged corkscrew episcleral vessels. Panels D and E are axial Magnetic Resonance Angiography (MRA) slices of the brain and orbits. In Panel D, an orange arrow points to a dilated and engorged right superior ophthalmic vein (SOV), a hallmark sign of retrograde venous flow. Panel E features a yellow arrowhead indicating abnormal enhancement near the right internal carotid artery, representing a vascular shunt within the cavernous sinus. This composite image is used for educational purposes to correlate external ophthalmic signs—such as pulsatile proptosis and conjunctival arterialization—with diagnostic neuroimaging findings in neuro-ophthalmology.

Searching Images

CT scan orbit axial coronal proptosis tumor mass

This diagnostic image set consists of a contrast-enhanced computed tomography (CT) scan of the orbits in axial (panels A and B) and coronal (panels C and D) planes. The scan demonstrates a well-defined, enhancing soft tissue mass located in the superior-medial (upper internal) aspect of the left orbit. In the axial sections, the lesion is situated adjacent to the medial rectus and superior oblique muscles, causing lateral displacement of the globe and resulting in non-axial proptosis. The coronal sections confirm the superior-medial positioning of the mass and illustrate its proximity to the ethmoid sinus wall and the left frontal sinus. The lesion shows significant contrast enhancement, suggesting a vascular etiology. Anatomical landmarks of the right orbit remain normal for comparison. This imaging is characteristic of an orbital vascular tumor, such as an intravascular papillary endothelial hyperplasia (Masson tumor), and illustrates the diagnostic approach to orbital masses causing globe displacement and impaired ocular motility.

Diagnostic imaging of a neonatal orbital teratoma presenting as severe proptosis. Panel A is an axial non-contrast CT scan of the orbits showing a large, heterogeneous, solid-and-cystic mass completely occupying the right orbital cavity. The mass causes significant expansion of the orbit and anterior displacement (proptosis) of the globe, which appears engulfed by the lesion. No obvious bony destruction or calcifications are visible at this level. Panel B is a coronal T2-weighted MRI of the head and orbits. The tumor is predominantly hyperintense relative to the extraocular muscles and orbital fat, indicating high water content or cystic components within the mass. The MRI highlights the mass effect on surrounding structures, demonstrating total displacement of the right globe and extraocular muscles compared to the normal contralateral left orbit. This imaging is characteristic of a benign but locally aggressive congenital orbital teratoma, illustrating its typical radiological presentation of mixed density/intensity and mass-occupying effect in a newborn.

I now have comprehensive data to build the full clinical approach. Here is the complete, detailed guide:

APPROACH TO A CASE OF PROPTOSIS

MS Ophthalmology Clinical / Viva Guide

Sources: Kanski's Clinical Ophthalmology 10th Ed. | Wills Eye Manual | KJ Lee's Otolaryngology

DEFINITION

Proptosis / Exophthalmos = Forward displacement of the eyeball.

Normal: Globe positioned 12-14 mm behind the lateral orbital rim
Proptosis = > 20 mm on Hertel exophthalmometer (or > 2 mm asymmetry between the two eyes)
The terms are used interchangeably; strictly exophthalmos = thyroid-related, proptosis = any cause

STEP 1 - HISTORY TAKING

A. PRESENTING COMPLAINT

Ask the patient:

"Since when have you noticed the eye coming forward? How did it start?"

Key dimensions of the complaint:

Dimension	What to ask	Significance
Duration	Weeks / months / years?	Acute = inflammatory/vascular; Chronic = neoplastic
Onset	Sudden / gradual / insidious?	Sudden = hemorrhage, fistula; Gradual = tumour
Progression	Getting worse / same / intermittent?	Progressive = tumour; Intermittent = vascular
Unilateral / Bilateral	One eye or both?	See below

B. HISTORY OF PRESENTING COMPLAINT (DETAILED)

1. ONSET AND DURATION

Sudden onset proptosis (days to 1-2 weeks):

Orbital hemorrhage (spontaneous or post-trauma)
Orbital cellulitis / abscess
Carotid-cavernous fistula (post head trauma)
Acute orbital inflammatory syndrome (pseudotumour)
Mucormycosis (diabetic / immunocompromised - EMERGENCY)

Gradual onset (weeks to months):

Orbital tumour (primary or secondary)
Thyroid eye disease
Lacrimal gland tumour
Optic nerve glioma / meningioma
Lymphoma

2. LATERALITY - POSITIVE HISTORY

"Is one eye or both eyes affected?"

Finding	Significance
Unilateral	Neoplasm, orbital cellulitis, pseudotumour, lacrimal gland tumour, CCF, dermoid
Bilateral	Thyroid eye disease (#1 cause of bilateral proptosis), lymphoma, bilateral metastasis, NF
Bilateral asymmetric	Thyroid eye disease often asymmetric

Exam pearl: Thyroid eye disease is the most common cause of BOTH unilateral and bilateral proptosis in adults.

3. PULSATILE PROPTOSIS

Positive history: "Do you notice throbbing or pulsing of the eye? A whooshing sound in your ears?"

Finding	Significance
Pulsatile + bruit	Carotid-cavernous fistula (CCF) - high flow
Pulsatile, no bruit	Transmission of CSF pulsations (orbital roof defect, meningocoele, NF-1) - "true pulsatile"
Non-pulsatile	All other causes

CCF with pulsatile proptosis and chemosis

Carotid-cavernous fistula - unilateral proptosis, chemosis, dilated corkscrew episcleral vessels

4. REDUCIBILITY (INTERMITTENT PROPTOSIS)

Positive history: "Does the eye go back when you press it or when you lie down?"

Finding	Significance
Reducible proptosis	Orbital varix (worse on bending down / Valsalva); venous malformation
Non-reducible	Neoplasm, cellulitis (firm, tense orbit)
Worse on lying down / Valsalva	Orbital varix - classic
Intermittent	Orbital varix, intermittent haemorrhage into dermoid cyst

5. PAIN

Positive history: "Do you have pain in or around the eye? Does it hurt when you move the eye?"

Type of Pain	Significance
Severe acute pain + proptosis	Orbital cellulitis, mucormycosis (EMERGENCY), orbital haemorrhage
Pain on eye movement	Orbital pseudotumour, optic neuritis, thyroid eye disease (myositis)
Dull aching	Lacrimal gland tumour (adenoid cystic ca - typically painful), orbital tumour
Painless proptosis	Cavernous haemangioma, lymphoma, optic nerve glioma, dermoid cyst
Headache	Intracranial extension, raised ICP

Exam pearl: Adenoid cystic carcinoma of lacrimal gland = painful proptosis with down-and-in displacement; most malignant lacrimal gland tumour.

6. DIPLOPIA (DOUBLE VISION)

Positive history: "Are you seeing double? Is it horizontal or vertical? Always or only when looking in certain directions?"

Finding	Significance
Diplopia present	Extraocular muscle involvement (thyroid myopathy, orbital tumour, pseudotumour, orbital floor fracture)
Thyroid eye disease	Inferior rectus involved first → vertical diplopia (difficulty looking up)
Horizontal diplopia	Medial rectus involvement
Gaze-evoked diplopia	Orbital varix, mass
No diplopia	Axial proptosis (intraconal mass), dermoid, early orbital tumour

7. VISUAL DISTURBANCE

Positive history: "Has your vision changed? Blurring? Loss of any part of vision?"

Finding	Significance
Decreased VA	Optic nerve compression (thyroid - tight apex, glioma, meningioma)
Colour desaturation	Optic nerve compression
Visual field defect	Optic nerve / chiasmal compression
Transient visual loss	CCF, raised IOP, vascular lesion
Flashes / distortion	Choroidal folds (compressive lesion pushing globe)

Negative history significance: No visual change with a large proptosis suggests the mass is not near the optic nerve (intraconal, but away from apex).

8. EXPOSURE SYMPTOMS (CORNEAL)

Positive history: "Is the eye dry? Any redness, watering, or whiteness on the front of the eye?"

Lagophthalmos (incomplete lid closure) → exposure keratitis
Chemosis (conjunctival swelling) = inflammatory/vascular (CCF, cellulitis)
Corneal ulcer = severe exposure

9. SWELLING / DISCHARGE

Positive history: "Any swelling around the eye? Any discharge? Any swelling of the forehead / cheeks?"

Finding	Significance
Periorbital oedema + fever	Orbital cellulitis (preseptal vs. orbital)
Chemosis + corkscrew vessels	CCF, orbital varix
S-shaped deformity of upper lid	Lacrimal gland mass (lateral upper lid swelling)
Sinus discharge / nasal symptoms	Sinus tumour extending to orbit, nasal polyps, Wegener's

C. PAST HISTORY - POSITIVE FINDINGS AND SIGNIFICANCE

Past History	Significance
Previous trauma to head/orbit	Orbital haemorrhage, CCF (even delayed by days-weeks), traumatic optic neuropathy
Previous cancer (breast, lung, prostate, melanoma, renal)	Metastatic orbital disease - most common in adults with bilateral proptosis + bone destruction
Known thyroid disease / treatment for hyperthyroidism	Graves' orbitopathy (most common cause of proptosis in adults)
Previous surgery to orbit / paranasal sinuses	Post-surgical haematoma, recurrence
Diabetes mellitus / immunosuppression	Mucormycosis (EMERGENCY - rapidly fatal), Aspergillosis
Previous radiotherapy to head/neck	Radiation-induced fibrosis, secondary neoplasm
History of NF-1 (café-au-lait spots)	Sphenoid wing dysplasia → pulsatile proptosis; optic nerve glioma

D. FAMILY HISTORY - POSITIVE FINDINGS AND SIGNIFICANCE

Family History	Significance
Neurofibromatosis (NF-1)	Orbital neurofibromas, optic glioma
Thyroid disease in family	Graves' disease (autoimmune, familial clustering)
Retinoblastoma	Bilateral → consider orbital spread

E. SYSTEMIC REVIEW - POSITIVE HISTORY AND SIGNIFICANCE

This is a critical part - proptosis is a sign of systemic disease in many cases.

Thyroid System

Positive: Heat intolerance, palpitations, weight loss, tremor, increased sweating, neck swelling, amenorrhoea in women Negative (important): "No symptoms of thyroid overactivity" - thyroid eye disease can occur in euthyroid state (10%), hypothyroid (5%), so absent symptoms does NOT rule it out.

Respiratory / ENT

Positive: Nasal discharge, epistaxis, facial pain, nasal obstruction → Paranasal sinus tumour (sq. cell ca, adenocarcinoma), Wegener's granulomatosis, ethmoidal polyps

Systemic Malignancy

Positive: Weight loss, cough, haemoptysis (lung), breast lump, bone pain (metastases from breast/prostate/lung/kidney/melanoma) → Metastatic orbital disease

Vascular

Positive: Hypertension, head injury, bruit in ear → CCF (high-flow: post-trauma; low-flow: spontaneous dural fistula in elderly)

Haematological

Positive: Pallor, lymphadenopathy, bone pain, night sweats → Orbital lymphoma (most common orbital tumour in adults > 60 years), leukaemia (especially in children)

Neurological

Positive: Headache, vomiting, seizures, focal neurological deficit → Intracranial extension of orbital tumour, sphenoid wing meningioma

Skin

Positive: Café-au-lait spots, axillary freckling, skin nodules → Neurofibromatosis type 1

F. DRUG HISTORY

Drug	Significance
Steroids (systemic)	Orbital fat prolapse, masking of infection
Thyroid medications	May precipitate or worsen thyroid eye disease
Anticoagulants	Orbital haemorrhage

G. SOCIAL / OCCUPATIONAL HISTORY

Factor	Significance
Woodworking / furniture industry	Adenocarcinoma of sinuses (occupational carcinogen)
Smoking	Worsens Graves' orbitopathy significantly; also lung/sinus cancer
Immunosuppression (HIV, transplant)	Mucormycosis, lymphoma, fungal infections

STEP 2 - SYSTEMATIC EXAMINATION

A. GENERAL EXAMINATION

Sign	Significance
Goitre (neck swelling)	Graves' / thyroid disease
Lymphadenopathy	Lymphoma, metastatic disease
Café-au-lait spots	NF-1
Pallor	Leukaemia, lymphoma
Skin nodules	Metastases (melanoma, breast)
Breast mass	Metastatic breast carcinoma

B. OPHTHALMIC EXAMINATION

1. Visual Acuity (VA)

Decreased VA = optic nerve involvement → urgent investigation
Colour vision desaturation = early optic nerve compression

2. Measurement of Proptosis - Hertel Exophthalmometer

Normal: 12-21 mm (most < 20 mm)
Proptosis = > 21 mm or asymmetry > 2 mm
Record: base reading (lateral orbital rim width), and measurements of both eyes

3. Direction of Proptosis

Direction	Significance
Axial (straight forward)	Intraconal mass (cavernous haemangioma, optic nerve tumour, lymphoma)
Non-axial downward + outward	Lacrimal gland tumour (superomedial), frontal mucocoele
Non-axial downward + inward (nasal)	Lacrimal gland mass (lateral)
Non-axial upward	Maxillary sinus tumour, floor fracture
Pulsatile	CCF, orbital roof defect, NF-1

4. Reducibility

Gently press on the globe - can it be pushed back?
Reducible = varix, venous malformation
Firm/non-reducible = tumour, cellulitis

5. Pulsation and Auscultation

Feel for pulsation (fingertip on closed lid)
Auscultate orbit with stethoscope for bruit → CCF

6. Lid Signs

Sign	Description	Disease
Lid retraction	Upper lid elevated, sclera visible above limbus	Thyroid eye disease
Lid lag (von Graefe's sign)	Upper lid lags behind globe on downgaze	Thyroid eye disease
Chemosis	Conjunctival oedema/swelling	Thyroid, CCF, cellulitis
S-shaped upper lid	Temporal fullness/mass	Lacrimal gland tumour
Periorbital oedema	Puffy lids	Cellulitis, thyroid
Proptosis + complete ptosis	Orbital apex syndrome	Metastasis, infection

7. Ocular Motility

Finding	Significance
Restricted elevation (IR involvement)	Thyroid eye disease (#1 muscle involved = inferior rectus)
Restriction on abduction (MR involvement)	Thyroid eye disease (MR = second most common)
All directions restricted (frozen globe)	Pseudotumour, advanced thyroid, rhabdomyosarcoma
Ophthalmoplegia with proptosis + pain	Orbital apex syndrome / cavernous sinus syndrome

8. Intraocular Pressure (IOP)

Measure in primary and upgaze (thyroid eye disease - IOP rises significantly on upgaze due to tethered inferior rectus)
Raised IOP in primary = orbital congestion / raised episcleral venous pressure (CCF)

9. Dilated Fundus Examination

Finding	Significance
Optic disc pallor / atrophy	Optic nerve compression (meningioma, glioma)
Disc oedema	Acute nerve compression, raised ICP
Choroidal folds	Mass compressing posterior globe (cavernous haemangioma, posterior scleritis)
Dilated, tortuous veins	Raised episcleral venous pressure (CCF, orbital varix)
Retinal haemorrhage	CCF, CRVO secondary to venous hypertension

STEP 3 - INVESTIGATIONS

Imaging (Most Important)

CT Scan Orbit (First line)

CT orbit showing orbital mass with proptosis

Best for: Bone involvement, calcification, foreign body, sinus disease
Axial + coronal views
With contrast if tumour suspected

CT Finding	Diagnosis
Intraconal well-defined oval mass	Cavernous haemangioma
Enlarged extraocular muscles (belly, sparing tendon)	Thyroid eye disease
Enlarged muscles with tendon involvement	Pseudotumour / myositis
Irregular bone destruction	Malignant tumour, metastasis
"Tram-track" calcification of optic nerve	Optic nerve sheath meningioma
Subperiosteal collection	Orbital abscess
Opacified sinuses + orbital extension	Sinusitis with orbital cellulitis

MRI Orbit (Second line / complementary)

MRI showing thyroid eye disease with bilateral proptosis

Best for: Soft tissue characterisation, optic nerve, intracranial extension, orbital apex
T1, T2, STIR, gadolinium enhancement
Superior to CT for: optic nerve glioma/meningioma, orbital lymphoma, intracranial disease

B-scan Ultrasonography

Orbital mass characterisation
Cavernous haemangioma: well-defined, high internal reflectivity
Pseudotumour: low internal reflectivity
Orbital varix: enlarges with Valsalva

Blood Investigations

Test	Indication
TFT (TSH, T3, T4)	Mandatory in ALL cases of bilateral proptosis (Graves')
TSH receptor antibodies (TRAb)	Most specific for Graves' orbitopathy
FBC + ESR	Lymphoma, leukaemia, inflammatory
Serum ACE	Sarcoidosis
c-ANCA / p-ANCA	Wegener's granulomatosis
Blood culture	Orbital cellulitis
Blood glucose	Mucormycosis (diabetic ketoacidosis)
LDH + uric acid	Lymphoma
Serum PSA	Prostate metastasis in men
Tumour markers	Depending on systemic primary

Biopsy

Incisional biopsy (open orbitotomy - anterior or lateral) - for tissue diagnosis when imaging non-conclusive
Fine needle aspiration (FNAC) - for accessible lesions
Note: Lacrimal gland - avoid incisional biopsy if pleomorphic adenoma suspected (risk of seeding)

STEP 4 - DIFFERENTIAL DIAGNOSIS (Systematic)

By Age Group

Age	Most common cause
Infant / Neonate	Dermoid cyst, rhabdomyosarcoma, capillary haemangioma, teratoma
Child	Rhabdomyosarcoma (most common primary malignant orbital tumour in children), capillary haemangioma, optic glioma, orbital cellulitis
Young adult	Thyroid eye disease, orbital pseudotumour, capillary haemangioma, dermoid
Middle-aged adult	Thyroid eye disease, cavernous haemangioma, lymphoma, lacrimal gland tumour
Elderly	Lymphoma (#1 orbital tumour > 60 years), metastasis, lymphoplasmacytic

By Direction

AXIAL proptosis
   → Intraconal: Cavernous haemangioma, lymphoma, optic nerve tumour

UPWARD displacement
   → Floor fracture (blowout), maxillary sinus tumour

DOWNWARD + OUTWARD displacement
   → Lacrimal gland tumour, frontal sinus mucocoele

MEDIAL displacement
   → Ethmoid sinus tumour, ethmoid mucocoele

Master Differential Table

Cause	Onset	Laterality	Pain	Pulsatile	Key Feature
Thyroid eye disease	Gradual	Bilateral (often)	Mild/none	No	Lid retraction, soft tissue signs, TFT positive
Orbital cellulitis	Acute	Unilateral	Severe	No	Fever, from sinusitis, child
Pseudotumour	Subacute	Unilateral	Moderate	No	Responds dramatically to steroids
Cavernous haemangioma	Gradual	Unilateral	None	No	Middle-aged women, axial, well-defined on CT
Lymphoma	Gradual	Uni/Bilateral	None	No	Salmon-pink conjunctival mass, > 60 yrs
CCF	Acute/subacute	Unilateral	Headache	Yes	Bruit, corkscrew vessels, IOP raised
Orbital varix	Intermittent	Unilateral	None	Yes (transmitted)	Worse on Valsalva, reducible
Lacrimal gland Ca	Gradual	Unilateral	Yes (ACCa)	No	S-shaped lid, down+in displacement
Optic nerve glioma	Gradual	Unilateral	None	No	Child with NF-1, visual loss, axial
Meningioma	Gradual	Unilateral	None	No	Adult female, tram-track calcification
Metastasis	Variable	Uni/Bilateral	Variable	No	History of cancer; enophthalmos if scirrhous breast
Rhabdomyosarcoma	Rapid	Unilateral	Mild	No	Child < 10 years, rapidly progressive
Mucormycosis	Acute, rapid	Unilateral	Severe	No	DM/immunocompromised, black eschar - EMERGENCY
Dermoid cyst	Gradual	Unilateral	None	No	Child, superotemporal, smooth, cystic on CT

STEP 5 - MANAGEMENT APPROACH (Summary)

Diagnosis	Management
Orbital cellulitis	IV antibiotics ± surgical drainage
Mucormycosis	Amphotericin B + radical surgical debridement (EMERGENCY)
Thyroid eye disease	TFT control, steroids, orbital radiotherapy, decompression
Pseudotumour	High-dose systemic steroids (diagnostic + therapeutic)
Cavernous haemangioma	Observation or surgical excision (lateral orbitotomy)
Lymphoma	Biopsy → chemo/radiotherapy
Rhabdomyosarcoma	Biopsy → chemo + radiotherapy (NOT surgery primarily)
CCF	Interventional radiology - coil embolisation
Lacrimal gland tumour	Pleomorphic adenoma = lateral orbitotomy + complete excision; ACCa = en bloc resection + adjuvant RT
Optic nerve glioma	Observation (NF-1); surgery/RT if vision threatened
Metastasis	Palliative RT, systemic chemotherapy

EXAM VIVA QUICK SUMMARY

When asked "How will you approach a case of proptosis?" - Structure your answer:

Definition + normal values

History: Onset, duration, laterality, pain, pulsation, reducibility, diplopia, vision, systemic

Examination: VA, Hertel, direction, pulsation/bruit, lid signs, motility, IOP, fundus

Investigations: CT orbit (first line), MRI, TFT, FBC, ESR, biopsy

Differential diagnosis by age / by direction

Management based on diagnosis

how to approach a case of ptosis with explaining from history to diagnosis, negative and positive history with explaination of each points.

Finding Sources

Searching Images

ptosis drooping eyelid unilateral clinical photograph

This clinical photograph displays a front-on view of an elderly patient’s face, focusing on the orbital and nasal regions. The primary clinical finding is severe unilateral blepharoptosis (ptosis) of the left eye. The left upper eyelid is significantly drooping, almost entirely obscuring the globe and visual axis. This is accompanied by noticeable periocular edema and erythema, suggesting an inflammatory or infectious process. In contrast, the right eye remains fully open with a normal palpebral fissure width. The surrounding skin shows age-related changes, including deep rhytids and solar elastosis. The presence of ptosis in this context is clinically significant for diagnosing orbital complications associated with invasive fungal infections, such as mucormycosis, or other causes of orbital apex syndrome. The image serves as a clear educational example of acquired ptosis and periocular soft tissue swelling in an ophthalmic or infectious disease context.

This clinical photograph shows a close-up, frontal view of a pediatric patient's periorbital region, demonstrating unilateral congenital ptosis of the left upper eyelid (noted as the eye on the viewer's right). The affected eyelid displays significant drooping, with the superior eyelid margin positioned notably lower than the contralateral side, partially obscuring the visual axis and decreasing the vertical palpebral fissure height. In contrast, the patient's right eye (viewer's left) shows a normal eyelid position with the margin resting at the superior limbus. A compensatory eyebrow elevation is visible on the affected side, where the left brow is positioned slightly higher than the right, suggesting recruitment of the frontalis muscle to assist in eyelid elevation. The patient exhibits fair skin with prominent ephelides (freckles) across the malar and nasal regions. This image serves as a classic educational example of blepharoptosis, emphasizing the comparison between normal eyelid anatomy and pathological drooping, as well as the associated secondary forehead muscle compensation.

This composite medical image presents clinical and intraoperative views of a case involving blepharoptosis and an eyelid lesion. Figure A is a clinical photograph of a 17-year-old patient demonstrating unilateral ptosis of the right upper eyelid. The eyelid margin is notably lower than the left, covering the superior portion of the iris. Figure B provides an intraoperative surgical view of the same patient during ptosis repair. It reveals a translucent, round cystic lesion approximately 1 cm in diameter containing clear liquid, situated within the fibers of the levator palpebrae superioris muscle. The cyst appears well-circumscribed without obvious adherence to surrounding orbital tissues. These findings are clinically relevant to the differential diagnosis of congenital ptosis, identifying an apocrine hidrocystoma as a mechanical cause for the eyelid drooping. The image is suitable for medical education in ophthalmology, oculoplastics, and pathology, illustrating how a deep-seated eyelid cyst can manifest as eyelid malposition.

Reading File

Finding Sources

Searching Images

Horner syndrome ptosis miosis anisocoria

Clinical photograph showing a comparative view of a 37-year-old female patient's eyes (Figure 1a and 1b) demonstrating findings characteristic of Horner syndrome and its pharmacological testing. In Figure 1a (baseline), the patient exhibits left-sided blepharoptosis (drooping of the upper eyelid) and miosis (a smaller, constricted pupil) compared to the right eye, resulting in significant anisocoria. In Figure 1b, following the topical instillation of apraclonidine (0.5%), there is a visible reversal of these signs: the left eyelid ptosis has resolved, and the left pupil has dilated while the right pupil has slightly constricted (reversal of anisocoria). This 'apraclonidine test' result is diagnostic for Horner syndrome, reflecting the hypersensitivity of the denervated dilator muscle to alpha-adrenergic stimulation. This image is medically significant for illustrating the clinical presentation of sympathetic nerve pathway disruption and the objective results of diagnostic pupil testing in neuro-ophthalmology.

Two-panel clinical photograph demonstrating Horner’s syndrome in a patient. Panel A shows the patient's eyes at rest, highlighting a mild right-sided ptosis (drooping of the upper eyelid) and a subtle 'upside-down ptosis' (elevation of the right lower eyelid). Panel B provides a close-up view of the eyes with the upper eyelids manually retracted to reveal anisocoria; the right pupil (labeled R) is significantly smaller (miotic) compared to the left pupil (labeled L). The clinical findings illustrate the classic triad of sympathetic denervation: ptosis, miosis, and enophthalmos appearance due to narrowing of the palpebral fissure. This visual evidence supports a diagnosis of Horner’s syndrome, often associated with neurological or vascular pathology affecting the oculosympathetic pathway. The image serves as an educational tool for identifying autonomic ocular dysfunction in neurology and ophthalmology.

Searching Images

myasthenia gravis bilateral ptosis fatigable

This clinical photograph displays a close-up view of the periocular region of a patient, demonstrating bilateral blepharoptosis (drooping eyelids). The content type is a Clinical Photograph within the specialty of Neurology or Ophthalmology. The image shows asymmetrical involvement, with the left upper eyelid exhibiting a more severe degree of ptosis compared to the right, significantly obscuring the left pupil and reducing the vertical palpebral fissure height. This visual finding is a classic sign often associated with Myasthenia Gravis (MG). The skin shows normal texture and color for the patient's ethnicity, without obvious signs of local inflammation or edema. This image serves as a baseline for clinical assessment, specifically to be compared against post-intervention results such as an ice pack test or Tensilon test to evaluate for fatigable muscle weakness and diagnostic confirmation of neuromuscular junction disorders.

$This clinical photograph consists of a side-by-side comparison (labeled A and B) demonstrating the pharmacological management of bilateral eyelid ptosis in a patient with Myasthenia Gravis (MG). Panel A (Baseline): Displays severe bilateral upper eyelid drooping, which obscures approximately 30-40% of the superior iris and limits the palpebral fissure width. The periorbital skin shows significant laxity and skin folds characteristic of chronic ptosis and aged skin. Panel B (Post-Treatment): Shows the same patient 30 minutes after the administration of oxymetazoline hydrochloride 0.1% ophthalmic solution. There is a notable elevation of both upper eyelids, resulting in increased exposure of the iris and sclera, with only 5-10% of the iris remaining covered. Educational Focus: The images illustrate the clinical efficacy of alpha-adrenergic agonists in stimulating Müller’s muscle (sympathetic smooth muscle) to improve eyelid elevation. This comparison highlights a non-surgical management option for symptomatic ptosis in patients with neuromuscular junction disorders or refractory weakness.$

This clinical photograph consists of a side-by-side comparison (labeled A and B) demonstrating the pharmacological management of bilateral eyelid ptosis in a patient with Myasthenia Gravis (MG). Panel A (Baseline): Displays severe bilateral upper eyelid drooping, which obscures approximately 30-40% of the superior iris and limits the palpebral fissure width. The periorbital skin shows significant laxity and skin folds characteristic of chronic ptosis and aged skin. Panel B (Post-Treatment): Shows the same patient 30 minutes after the administration of oxymetazoline hydrochloride 0.1% ophthalmic solution. There is a notable elevation of both upper eyelids, resulting in increased exposure of the iris and sclera, with only 5-10% of the iris remaining covered. Educational Focus: The images illustrate the clinical efficacy of alpha-adrenergic agonists in stimulating Müller’s muscle (sympathetic smooth muscle) to improve eyelid elevation. This comparison highlights a non-surgical management option for symptomatic ptosis in patients with neuromuscular junction disorders or refractory weakness.

Finding Sources

Searching Images

third nerve palsy complete ptosis dilated pupil down and out

Clinical photograph of a patient's face in two panels (A and B) demonstrating right-sided oculomotor nerve (third cranial nerve) palsy and bilateral periorbital lesions. Image A shows complete ptosis of the right eye with the upper eyelid fully closed. In image B, with the right eyelid manually elevated, the right eye exhibits a 'down and out' primary position, indicative of unopposed action from the superior oblique and lateral rectus muscles. The right pupil is visibly dilated (mydriasis) compared to the left, and is clinically non-reactive or slow-reacting. Both eyes feature yellowish, flat, slightly elevated plaques on the upper and lower eyelids, characteristic of xanthelasma palpebrarum. The left eye serves as a control, showing normal primary gaze alignment and pupil size. These findings are presented in the context of oculomotor dysfunction potentially associated with ischemic events or systemic conditions like patent foramen ovale (PFO).

This composite clinical photograph illustrates the hallmark signs of a left oculomotor nerve (third cranial nerve) palsy in a 24-year-old male. Panel A demonstrates significant left-sided ptosis (drooping upper eyelid) and impaired adduction of the left eye when the patient attempts a rightward gaze, resulting in a divergent ocular alignment. Panel B shows preserved abduction of the left eye, indicating intact sixth cranial nerve function. Panel C provides a close-up comparison of the pupils, revealing anisocoria with a dilated, non-reactive left pupil (mydriasis) compared to the right. The combination of ptosis, 'down and out' resting position or inability to adduct, and pupillary involvement is characteristic of complete third nerve paralysis, often associated with compression or intrinsic lesions of the oculomotor nerve. This visual record is educational for identifying neuro-ophthalmic manifestations of cranial nerve pathology, specifically differentiating between pupil-sparing and pupil-involved palsies.

Reading File

Searching Images

congenital ptosis child levator function upper eyelid crease

This clinical photograph captures an intraoperative view of an external levator approach for congenital ptosis repair on a patient's upper eyelid. The surgical field demonstrates a horizontal eyelid crease incision, outlined by purple surgical marker ink. The incision has been deepened to expose the underlying anatomical structures, specifically the levator aponeurosis and preseptal tissues. A cotton-tipped applicator is utilized for gentle retraction and hemostasis within the triangular-shaped surgical pocket. Traction sutures are visible, extending from the eyelid margin to facilitate positioning and exposure. The surrounding periocular skin shows mild erythema consistent with surgical trauma, alongside natural signs of aging and freckling. This image serves as an educational resource for ophthalmology and oculoplastic surgery, illustrating the anterior surgical approach to the levator complex for the correction of blepharoptosis.

Clinical photographs in four panels (A-D) demonstrating pre-operative and post-operative outcomes of levator resection for congenital ptosis. Panels A and C show the pre-operative status of two different patients. Panel A illustrates mild unilateral ptosis of the left eye, where the upper eyelid margin covers a portion of the superior iris. Panel C demonstrates severe unilateral ptosis of the left eye with the eyelid margin obstructing the visual axis and covering the pupil. Panels B and D show the corresponding post-operative results. In Panel B, the left upper eyelid is elevated to a functional position, increasing the marginal reflex distance 1 (MRD1) and revealing a sliver of superior sclera. Panel D shows the correction of severe ptosis, with the eyelid margin now positioned above the pupil; visible surgical sutures and post-operative erythema are present along the newly defined eyelid crease. The collection serves to illustrate the surgical management of blepharoptosis and the objective assessment of eyelid height and symmetry in ophthalmic plastic surgery.

Now I have all the data needed. Here is the complete clinical approach:

APPROACH TO A CASE OF PTOSIS

MS Ophthalmology Complete Clinical Guide - History to Diagnosis

Sources: Kanski's Clinical Ophthalmology 10th Ed. | Wills Eye Manual | Harrison's Principles 22nd Ed.

DEFINITION

Ptosis (Blepharoptosis) = Abnormally low position of the upper eyelid.

Normal upper lid position:

Rests 2 mm below the upper limbus (covers 2 mm of cornea superiorly)
MRD1 (Margin Reflex Distance 1) = 4-5 mm (distance from corneal light reflex to upper lid margin)
Palpebral fissure height = 7-10 mm (male), 8-12 mm (female)

Grading of ptosis:

Grade	Amount of ptosis	MRD1
Mild	1-2 mm	3 mm
Moderate	3 mm	2 mm
Severe	≥ 4 mm	0-1 mm

CLASSIFICATION (Essential before approaching history)

PTOSIS
├── NEUROGENIC
│   ├── 3rd nerve palsy (CN III) - complete/partial
│   ├── Horner syndrome (sympathetic - Müller's muscle)
│   └── Marcus Gunn jaw-winking (misdirected CN V)
├── MYOGENIC
│   ├── Congenital (levator myopathy)
│   ├── Myasthenia gravis (NMJ - neuromyopathic)
│   ├── Myotonic dystrophy
│   └── Progressive External Ophthalmoplegia (PEO)
├── APONEUROTIC (Involutional)
│   ├── Age-related (most common acquired ptosis)
│   └── Post-surgical / post-traumatic
└── MECHANICAL
    ├── Lid mass / tumour
    ├── Dermatochalasis
    └── Scarring / cicatricial

STEP 1 - HISTORY TAKING

A. PRESENTING COMPLAINT

"Since when have you noticed drooping of your eyelid?"

Key dimensions to establish:

Dimension	Question	Significance
Age of onset	From birth / childhood / recently?	Congenital vs. acquired
Duration	Days / months / years?	Acute = neurogenic/vascular; Chronic = myogenic/aponeurotic
Onset	Sudden / gradual / insidious?	Sudden = CN III aneurysm (EMERGENCY); Gradual = myasthenia, aponeurotic
Laterality	One or both eyes?	Unilateral vs. bilateral
Progression	Worsening / static / fluctuating?	Fluctuating = myasthenia; Static = congenital; Progressive = neoplastic/myasthenia

B. HISTORY OF PRESENTING COMPLAINT - DETAILED

1. AGE OF ONSET (Most discriminating feature)

Positive: Present since birth / early childhood

Congenital ptosis (simple / isolated levator dystrophy)
Marcus Gunn jaw-winking syndrome
Blepharophimosis syndrome (BPES)
Congenital CN III palsy / Horner syndrome
Significance: Raises concern for amblyopia (deprivation), astigmatism - demands prompt treatment

Positive: Present since adulthood (acquired)

Aponeurotic (involutional) - commonest acquired cause
Myasthenia gravis
Third nerve palsy
Horner syndrome
Mechanical (lid tumour)

Exam pearl - Kanski: "Old photographs are invaluable when the history is ambiguous - they help determine whether ptosis is congenital or acquired."

2. VARIABILITY / DIURNAL VARIATION

Positive: "Is the drooping worse at certain times of the day?"

Pattern	Significance
Worse in the evening / after sustained activity	Myasthenia gravis (fatigable) - ptosis worsens as day progresses
Better in the morning, worse in evening	Myasthenia gravis
Constant throughout the day	Congenital, aponeurotic, mechanical, CN III palsy, Horner
Worse in cold / better in warmth	Myasthenia gravis (cold worsens NMJ transmission)
Variable hour to hour	Myasthenia gravis (pathognomonic)

Negative history - significance of NO variability:

Rules AGAINST myasthenia gravis as a cause
Constant ptosis points to structural causes (aponeurosis, congenital, mechanical)

3. ASSOCIATED DIPLOPIA (Double Vision)

Positive: "Do you see double?"

Associated diplopia	Significance
Ptosis + horizontal/vertical diplopia + dilated pupil	Complete CN III palsy - EMERGENCY (posterior communicating artery aneurysm until proven otherwise)
Ptosis + diplopia, variable throughout day	Myasthenia gravis (NMJ - fatigable ophthalmoparesis)
Ptosis + diplopia + ophthalmoplegia (slowly progressive)	Chronic Progressive External Ophthalmoplegia (CPEO) - bilateral, symmetric, no diplopia usually due to slow onset
Ptosis + diplopia worse on upgaze	Thyroid eye disease (inferior rectus restriction)
No diplopia with ptosis	Congenital ptosis, aponeurotic ptosis, Horner (not full CN III), mechanical

Negative history - significance of NO diplopia:

Congenital ptosis: associated superior rectus weakness but no subjective diplopia (long-standing sensory adaptation)
CPEO: despite complete ophthalmoplegia - no diplopia (simultaneous, bilateral, symmetric)
Aponeurotic ptosis: no motility disturbance

4. ABNORMAL HEAD POSTURE / CHIN ELEVATION

Positive: "Does the child tilt the head back (chin up position)?"

Chin elevation (occiput depression) = Bilateral severe ptosis blocking visual axis
Compensatory frontalis overaction (brow raising) to maintain vision
Congenital ptosis, bilateral aponeurotic ptosis
Significance: Indicates the visual axis is compromised → amblyopia risk in children

5. PUPIL CHANGES

Positive: "Has anyone noticed your pupil looks smaller / larger?"

Pupil finding	Significance
Ptosis + DILATED pupil (mydriasis) + "down and out" eye	CN III palsy - pupil INVOLVED = compressive (aneurysm, tumour)
Ptosis + SMALL pupil (miosis) + anhidrosis	Horner syndrome - sympathetic paresis (Müller's muscle)
Ptosis + NORMAL pupils	Myasthenia gravis, aponeurotic ptosis, congenital ptosis, mechanical
Ptosis + DILATED pupil, pupil SPARED	CN III palsy - pupil SPARED = ischaemic (diabetes, hypertension)

Critical exam point: Ptosis + dilated, non-reactive pupil = POSTERIOR COMMUNICATING ARTERY ANEURYSM until proven otherwise. Neurosurgical EMERGENCY.

6. FATIGUABILITY / EXERCISE TEST

Positive: "Does the drooping get worse if you look up for a long time or keep the eyes open?"

Sustained upgaze for 2 minutes → ptosis worsens
Pathognomonic of Myasthenia gravis
Ice pack test: Apply ice for 2 minutes → ptosis IMPROVES in MG (cold improves NMJ transmission)
Edrophonium (Tensilon) test: IV anticholinesterase → ptosis IMPROVES in MG

Negative (no fatigability):

Rules against myasthenia as cause
Supports structural diagnosis

7. JAW MOVEMENTS (Especially in children)

Positive: "Does the drooping get better when the child chews, yawns, or opens the mouth?"

Marcus Gunn jaw-winking phenomenon (synkinesis)
CN V (mandibular division) → misdirected to levator muscle
Lid RETRACTS (winks up) on jaw movement
Present in ~5% of all congenital ptosis
Usually unilateral

Negative (no jaw-winking):

Rules out Marcus Gunn phenomenon
Simple congenital ptosis more likely

8. HISTORY OF TRAUMA

Positive: "Any injury to the eye, head, or neck?"

Type of trauma	Significance
Head injury	Traumatic CN III palsy; also: carotid-cavernous fistula causing ptosis
Orbital / eyelid trauma	Traumatic levator dehiscence (aponeurotic ptosis)
Neck injury / surgery	Horner syndrome (cervical sympathetic chain)
Eye surgery (cataract, vitreoretinal)	Post-surgical aponeurotic ptosis (most common iatrogenic cause - from bridle suture, prolonged speculum use)
Birth forceps delivery	Congenital Horner syndrome / traumatic CN III

Negative (no trauma):

Excludes traumatic aponeurosis as cause
Post-surgical ptosis still possible even without ocular trauma history if previous eye surgery done

9. CONTACT LENS USE

Positive: "Have you worn hard contact lenses for many years?"

Long-term hard CL use → repeated mechanical irritation of levator aponeurosis
Causes aponeurotic ptosis (often bilateral, subtle, unrecognised)
Negative history (no CL use): Rules this out as cause of aponeurotic ptosis

10. NEUROLOGICAL SYMPTOMS

Positive: "Any headache, vomiting, neck stiffness, weakness in limbs, swallowing difficulty, speech change?"

Symptom	Significance
Severe acute headache + ptosis + dilated pupil	Posterior communicating artery aneurysm - EMERGENCY
Limb weakness + ptosis	Myasthenia gravis (generalised), motor neuron disease
Swallowing / speech difficulty + ptosis	Myasthenia gravis (bulbar symptoms), brainstem stroke
Facial weakness + ptosis	Myasthenia gravis, Kearns-Sayre syndrome
Drooping of arm + ptosis in neck/apex	Pancoast tumour → Horner syndrome
Neck/arm pain + Horner	Carotid artery dissection (medical emergency)

11. FAMILY HISTORY

Positive:

Family history	Significance
Congenital ptosis in parents/siblings	Familial congenital ptosis (autosomal dominant)
Blepharophimosis syndrome	BPES Type I (AD, with premature ovarian failure - females infertile)
Myasthenia gravis	Autoimmune clustering
Myotonic dystrophy	AD - also watch for systemic features
Mitochondrial disease	Maternal inheritance in CPEO (mtDNA mutation)

Negative family history:

Simple (sporadic) congenital ptosis = majority have NO family history (isolated developmental myopathy)

C. PAST MEDICAL HISTORY - POSITIVE FINDINGS AND SIGNIFICANCE

Past History	Significance
Diabetes mellitus	Ischaemic CN III palsy (pupil SPARED typically) - most common cause of painful CN III palsy
Hypertension	Ischaemic CN III palsy
Previous cancer (lung, breast, lymphoma)	Metastatic CN III palsy, orbital metastasis, Lambert-Eaton (paraneoplastic)
Autoimmune disease (SLE, RA, thyroid)	Myasthenia gravis (associated with autoimmune conditions)
Thymoma	Myasthenia gravis (thymoma in 15% of MG cases)
Tuberculosis / sarcoidosis	Granulomatous lid lesion causing mechanical ptosis
Previous eye surgery	Aponeurotic ptosis (most common post-surgical cause)
Eyelid/orbital infection	Cicatricial/mechanical ptosis from scarring

D. DRUG HISTORY - POSITIVE FINDINGS

Drug	Significance
D-penicillamine	Induces myasthenia gravis
Aminoglycosides	Worsen NMJ transmission - precipitate/worsen MG ptosis
Steroids (topical/systemic)	Mask MG; orbit fat hypertrophy causing mechanical
Botulinum toxin (cosmetic)	Iatrogenic ptosis (spread to levator)
Adrenaline/sympathomimetic eye drops	Temporarily improve Horner ptosis (useful in diagnosis)

E. SYSTEMIC REVIEW - POSITIVE HISTORY AND SIGNIFICANCE

System	Positive finding	Significance
Muscular	Easy fatigability, limb weakness, difficulty climbing stairs	Myasthenia gravis, CPEO, myotonic dystrophy
Respiratory	Dyspnoea, myasthenic crisis - respiratory failure	Myasthenia gravis (severe)
Cardiac	Heart block, arrhythmia	Kearns-Sayre syndrome (CPEO + cardiac block)
ENT	Nasal voice, difficulty swallowing	Myasthenia gravis (bulbar)
Skin	Café-au-lait, neurofibromata	NF-1 (plexiform neurofibroma → mechanical ptosis)
Thyroid	Heat intolerance, weight loss	Thyroid eye disease (coexists with MG, lid retraction > ptosis)
Neck lump	Cervical mass	Horner syndrome (cervical chain involved)
Arm pain/weakness (medial)	Pancoast tumour	Horner syndrome (apex lung tumour)

STEP 2 - EXAMINATION

A. General Examination

Sign	Significance
Neck mass	Horner (cervical lymph node, thyroid, carotid)
Chest signs	Pancoast tumour (Horner), thymoma (MG)
Generalised weakness / myotonia	Myasthenia gravis, myotonic dystrophy
Café-au-lait spots	NF-1 → plexiform neurofibroma

B. Ophthalmic Examination - Systematic

Step 1: Establish True vs. Pseudoptosis

Pseudoptosis	Diagnosis
Contralateral lid RETRACTION mimics ipsilateral ptosis	Thyroid eye disease of the other eye
Ipsilateral HYPOTROPIA (eye down) → lid follows	Strabismus - ptosis disappears on covering normal eye
Small / absent eye (microphthalmos, phthisis, enucleation)	No globe support for lid
BROW PTOSIS (excess skin weighing brow down)	Elevate brow manually → fissure widens
DERMATOCHALASIS (overhanging skin)	Elevate skin manually

Step 2: Key Lid Measurements (Mandatory)

Measurement	Normal	Method
MRD1 (Margin Reflex Distance)	4-5 mm	Distance from corneal reflex to upper lid margin
Palpebral fissure height	8-12 mm (F), 7-10 mm (M)	Upper to lower lid margin at pupil
Upper lid crease	8 mm (M), 10 mm (F)	Lid margin to crease in downgaze
Levator function (LF)	≥ 15 mm (normal)	Downgaze to upgaze with brow fixed
Pre-tarsal show	2-3 mm	Lid margin to skin fold

Levator function grading:

≥ 15 mm  = NORMAL (excellent)
12-14 mm = GOOD
5-11 mm  = FAIR (moderate)
≤ 4 mm   = POOR → indicates need for frontalis suspension

Step 3: Direction of Ptosis in Downgaze (Pathognomonic sign)

Finding	Significance
Ptotic lid HIGHER than normal in downgaze	CONGENITAL ptosis (levator does not relax in downgaze - "lid lag in downgaze")
Ptotic lid LEVEL with or LOWER than normal in downgaze	ACQUIRED ptosis (aponeurotic, neurogenic)

This single sign distinguishes congenital from acquired ptosis.

Step 4: Upper Lid Crease

Crease	Significance
Absent crease	Congenital ptosis (poor levator function)
High crease (>12 mm)	Aponeurotic/involutional ptosis (dehiscence causes crease to ride up)
Deep superior sulcus	Involutional/aponeurotic (fat atrophy + aponeurosis stretching)
Normal crease	Neurogenic or mechanical ptosis

Step 5: Pupil Examination

Pupil finding	Diagnosis
Unilateral MIOSIS (small pupil) + ptosis (mild, ~2mm)	Horner syndrome
Anisocoria WORSE in dark	Horner (dilator paresis - can't dilate in dark)
Unilateral MYDRIASIS (large, non-reactive pupil) + complete ptosis	CN III palsy - compressive
Ptosis + normal pupils	Aponeurotic, congenital, mechanical, MG, Horner (after long-standing)
Reversal of anisocoria with apraclonidine drops	Horner syndrome confirmed

Step 6: Fatigability Test (Myasthenia)

Myasthenia gravis - bilateral fatigable ptosis

Ask patient to sustain upgaze for 1-2 minutes
Positive (ptosis worsens) = Myasthenia gravis
Ice pack test: Apply ice pack for 2 minutes → if ptosis improves ≥ 2mm = MG (sensitivity ~80%)
Cogan's lid twitch sign: On returning from downgaze to primary position → lid overshoots (twitches upward briefly) = MG (highly specific)

Step 7: Ocular Motility

Finding	Significance
"Down and out" position + complete ptosis	CN III palsy (LR + SO intact)
Restriction of all movements (symmetric, bilateral)	CPEO, Myasthenia
Limitation upgaze + ptosis	CN III (SR), Myasthenia
Normal motility	Aponeurotic, congenital (usually), Horner (usually), mechanical

Step 8: CN III Examination (if suspected)

CN III palsy - complete ptosis, dilated pupil, down-and-out

Complete CN III palsy: Ptosis + Mydriasis + Eye "down and out" + Inability to:

Adduct (MR)
Elevate (SR, IO)
Depress (IR)
Constrict pupil (pupillomotor fibres - travel on outside)

Pupil-involved (surgical CN III): Compression by aneurysm/tumour (peripheral fibres compressed first) Pupil-spared (medical CN III): Ischaemia - central axons affected (diabetes, HTN)

Step 9: Jaw-Winking Test (Marcus Gunn)

Ask child to chew, yawn, or move jaw side to side
Positive: Ptotic lid retracts on jaw movement = Marcus Gunn jaw-winking

Step 10: Other Lid Signs

Sign	Significance
Eyelid mass / tumour	Mechanical ptosis - chalazion, neurofibroma, haemangioma, tumour
Lid scarring / trachoma changes	Cicatricial mechanical ptosis
Periorbital oedema	Mechanical from allergic/inflammatory cause
Enophthalmos	Horner syndrome appearance (not true enophthalmos)
Chin elevation / compensatory brow raising	Congenital / bilateral severe ptosis
Frontalis overaction (furrowed forehead)	Compensation for ptosis

Step 11: Bell's Phenomenon (CRITICAL pre-operative assessment)

Test: Ask patient to close eyes forcibly → observe if globe rolls up

Result	Significance
Good Bell's (+ve) = Globe rotates upward on lid closure	Safe for ptosis surgery
Poor Bell's (-ve) = Globe does not rotate up	HIGH RISK - exposure keratopathy after ptosis surgery

Kanski: "A weak Bell phenomenon can result in exposure keratopathy after ptosis surgery."

Step 12: Corneal Sensation and Tear Film

Decreased corneal sensation + ptosis = CN V anaesthesia (cavernous sinus syndrome, orbital apex)
Poor tear film / dry eye = must be optimised before surgery (lagophthalmos post-op worsens dryness)
Assess lagophthalmos (incomplete lid closure) → risk of exposure keratitis

STEP 3 - INVESTIGATIONS

Pharmacological Tests

Test	Method	Positive Result	Significance
Ice pack test	Ice for 2 min on closed lid	Ptosis improves ≥ 2mm	Myasthenia gravis
Edrophonium (Tensilon) test	IV 10mg edrophonium	Ptosis improves within 60 sec	Myasthenia gravis
Apraclonidine 0.5% drops	Topical, both eyes	Ptosis improves + anisocoria reverses	Horner syndrome
Cocaine 4-10% drops	Topical	Normal eye dilates; Horner eye does NOT	Confirms Horner
Hydroxyamphetamine (1%)	After cocaine	Horner eye dilates	3rd neuron intact (pre-ganglionic lesion); does NOT dilate = 3rd neuron Horner

Imaging

Scan	Indication
CT/MRI orbit + brain	CN III palsy (rule out aneurysm, tumour), cavernous sinus, orbital mass
MRA / CTA	Posterior communicating artery aneurysm (CN III with pupil involvement - EMERGENCY)
CT chest	Thymoma (myasthenia), Pancoast tumour (Horner - apical lung)
MRI brachial plexus / neck	Horner with ipsilateral arm symptoms
CT neck	Cervical lymph node / carotid dissection (Horner)

Blood Tests

Test	Indication
AChR antibodies (anti-acetylcholine receptor)	Myasthenia gravis (positive in 85% generalised, 50% ocular)
Anti-MuSK antibodies	Seronegative MG
Repetitive nerve stimulation / SFEMG	Myasthenia (decremental response)
Tensilon (Edrophonium) test	MG - clinical pharmacological test
TFT	Thyroid eye disease (coexisting lid retraction)
Blood glucose, HbA1c	Ischaemic CN III palsy
ANA, ESR	Autoimmune causes
Mitochondrial DNA analysis	CPEO (Kearns-Sayre)

STEP 4 - CLINICAL PATTERNS AT A GLANCE

Feature	CN III Palsy	Horner Syndrome	Myasthenia Gravis	Congenital Ptosis	Aponeurotic
Degree	Complete (severe)	Mild (1-2 mm)	Variable	Variable	Moderate-severe
Laterality	Unilateral	Unilateral	Bilateral (asymm)	Uni or bilateral	Usually bilateral
Pupil	Dilated (compressive) / Normal (ischaemic)	Miotic (small)	Normal	Normal	Normal
Motility	Down and out	Normal	Fatigable, variable	± SR weakness	Normal
Variability	Constant	Constant	Variable (diurnal)	Constant	Worse in evening
Levator fn	Poor (CN III innervates it)	Good (Müller's only)	Variable	Poor	Good
Lid crease	Normal/high	Normal	Normal	Absent	HIGH (pathognomonic)
Downgaze	Lid level/low	Lid low	Variable	Lid higher than normal	Lid low
Key test	Neuroimaging	Apraclonidine	Ice pack / Tensilon	Old photos / age	History of surgery/age

STEP 5 - MANAGEMENT SUMMARY

Diagnosis	Management
Congenital ptosis - poor LF (≤ 4mm)	Frontalis suspension (fascia lata / synthetic)
Congenital ptosis - moderate LF (5-11mm)	Maximum levator resection
Congenital ptosis - good LF (≥ 12mm)	Levator resection or aponeurosis advancement
Marcus Gunn jaw-winking	Levator disinsertion + bilateral brow suspension
Aponeurotic (involutional)	Levator aponeurosis advancement (gold standard)
Mechanical (lid mass)	Treat underlying mass → ptosis resolves
Myasthenia gravis	Pyridostigmine (neostigmine) ± immunosuppression ± thymectomy
CN III palsy - aneurysm	Neurosurgical clipping / coil embolisation (EMERGENCY)
CN III palsy - ischaemic	Treat DM/HTN; usually resolves 3-6 months
Horner - Pancoast	Surgical / RT / chemotherapy for primary
CPEO / Kearns-Sayre	Frontalis suspension (no levator function)

VIVA EXAM FRAMEWORK

When asked: "How will you approach a case of ptosis?"

Structure your answer as:

Define ptosis; classify into NAMAN (Neurogenic, Aponeurotic, Myogenic, Mechanical)
History - Age, onset, variability, diplopia, pupil change, jaw movements, fatigability, trauma, systemic
Examination - Establish true vs. pseudoptosis → 5 measurements (MRD1, PF height, LF, lid crease, pre-tarsal show) → downgaze test → pupil → motility → Bell's
Special tests - Ice pack, apraclonidine, Tensilon, neuroimaging
Diagnosis based on pattern
Surgery - match procedure to levator function

This is a shared conversation. Sign in to Orris to start your own chat.